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ABBREVIATION KEY 
α-ZAL    α-zearalanol 
α-ZEL    α-zearalenol 
ABC    ATP-binding cassette 
ACN    acetonitrile 
AcNIV    mono-acetylnivalenol 
a-DON    mono-acetyldeoxynivalenol 
ANOVA   analysis of variance  
ATP    adenosine triphosphate 
AUC    area under the plasma concentration-time curve 
β-ZAL    β-zearalanol 
β-ZEL    β-zearalenol 
BEA    beauvericin 
BEMEFA   Belgian Association of Feed Manufacturers 
BLAST    basic local alignment search tool 
BW    body weight 
Caco-2    human colorectal adenocarcinoma cell 
CAST    Council for Agricultural Science and Technology 
cDNA    copy-deoxyribonucleic acid 
Cl    clearance 
CLDN    claudin 
Cmax    maximum plasma concentration 
Ct    threshold cycle 
CYP    cytochrome P450 
d    day 
Da    dalton 
DAcDON   di-acetyldeoxynivalenol 
DAcNIV   di-acetylnivalenol 
DAS    diacetoxyscirpenol 
DNA    deoxyribonucleic acid 
DOM-1   deepoxy-deoxynivalenol 
DON    deoxynivalenol 
dsDNA    double stranded DNA 
EC    Ethical Committee 
EDTA    ethylenediaminetetra-acetic  acid 
EFSA    European Food Safety Authority 
ELISA    enzyme-linked immunosorbent assay 
 Abbreviation key 
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ERK    extracellular signal-regulated kinases 
F    absolute oral bioavailability 
FA    fusaric acid 
FB    fumonisin B 
FUC    fusarochromanone 
FUP    fusaproliferin 
FUS    fusarenone-X 
g    g-force 
GAP    Good Agricultural Practice 
GAPDH   glyceraldehydes-3-phosphate dehydrogenase 
GCY    glucose, yeast extract and peptone 
GI(T)    gastro-intestinal (tract) 
GOIs    genes of interest 
h    hour 
H6PD    hexose-6-phosphate dehydrogenase 
HcK    hematopoietic cell kinase 
HCT    human cell-line derived from colon-carcinoma microtissues 
HIF-1α    hypoxia-inducible factor 1 subunit alpha 
HKG    housekeeping gene 
HMOX    heme-oxygenase 
HPLC    high-performance liquid chromatography 
HPRT    hypoxanthine-guanine phosphoribosyl transferase 
HT-2    HT-2 toxin 
IPEC    intestinal porcine epithelial cell 
IS    internal standard 
iv    intravenous(ly) 
JAMs    junctional adhesion molecules 
JNK    c-Jun N-terminal kinases 
kel    elimination rate constant 
kg    kilogram 
LC    liquid chromatography 
LD50    lethal dose for 50% of subjects 
LOD    limit of detection 
LOQ    limit of quantification 
μg    microgram 
μl    microliter 
μm    micrometer 
MAPK    mitogen-activated protein kinase 
MAS    monoacetoxyscirpenol 
 Abbreviation key 
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MDR1    multiple drug resistance 1 
MDZ    midazolam 
mg    milligram 
min    minute 
ml    milliliter 
MON    moniliformin 
mRNA    messenger RNA 
MRP2    multidrug resistance-associated protein 2 
MS/MS   tandem mass spectrometry 
MUCL    Mycothèque de l’Université Catholique de Louvain 
n    number 
NADPH   nicotinamide adenine dinucleotide phosphate 
NCBI    National Center for Biotechnology Information  
NEO    neosolaniol 
ng    nanogram 
NIV    nivalenol 
1-OH-midazolam  1-hydroxy-midazolam 
4-OH-midazolam  4-hydroxy-midazolam 
OTA    ochratoxin A 
p.a.    post administration 
PBS    phosphate buffered saline 
PCD    programmed cell death 
PCR    polymerase chain reaction 
P-gp    P-glycoprotein 
PKR    RNA-activated protein kinase 
po    per os, oral(ly) 
PXR    pregnane X receptor 
(q)RT-PCR   (quantitative) Real-Time Polymerase Chain Reaction 
Raf-1    RAF proto-oncogene serine/threonine-protein kinase 
Rhoa    Ras homolog gene family, member A 
RNA    ribonucleic acid 
ROS    reactive oxygen species 
RPL7    60s ribosomal protein L7 
s    second 
SD    standard deviation 
SRM    selected reaction monitoring 
T-2    T-2 toxin 
t1/2el    elimination half-life 
TEER    trans-epithelial electrical resistance 
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TLR    toll-like receptor 
Tmax    time to maximum plasma concentration 
UPLC    ultra performance liquid chromatography 
Vd    volume of distribution 
vol    volume 
v/v    volume/volume 
wk    week 
XOR    xanthine oxidoreductase 
ZAN    zearalanone 
ZEN    zearalenone 
ZO    zonula occludens 
ZOH    α and β isomers of ZEN 
ZONAB   zonula occludens-associated nucleic acid binding protein 
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1. The poultry industry with emphasis on broiler chickens 
 
The poultry industry is one of the largest and fastest growing agro-based industries in the 
world.  Table 1 summarizes the chicken meat production worldwide. 
Table 1. World chicken meat production (million tones) (adapted from Evans et al., 1012).  
Region 2000 2005 2006 2007 2008 2009 2010 2011 2012 
Africa 2.8 3.4 3.4 3.7 4.0 4.2 4.4 4.6 4.7 
Americas 27.2 32.7 33.7 35.3 37.4 36.7 38.4 39.2 39.4 
Asia 18.7 22.5 23.5 24.9 26.4 27.2 28.6 29.9 31.0 
Europe 9.4 10.7 10.8 11.7 12.1 13.4 13.8 14.2 14.5 
Oceania 0.7 0.9 1.0 1.0 1.0 1.0 1.1 1.3 1.3 
WORLD 58.7 70.2 72.3 76.7 80.8 82.5 86.2 89.2 90.9 
 
The production of chicken meat is expected to grow due to export to ‘emerging markets’, 
namely China, India, Russia and the Middle-East. 
Good management of a chicken husbandry is indispensable. The main goal is to convert feed 
into viable, disease-free poults as efficiently as possible. Over the last decades intensive 
selection programs were set up for broilers. Thanks to this selection, broiler chickens are 
actually the most effective meat-producing animals next to fish (Decuypere et al., 2010). 
Stable equipment has to be appropriate for ad libitum feed and drinking water availability. In 
addition, accurate light schedules have to be applied to allow maximum feeding but also 
taking the animal welfare into account. Owing to the high-density housing, ventilation and 
litter management are important matters to reduce stress and possible lesions (Elson, 2010). 
Besides management and biosecurity, vaccination is necessary to control infectious diseases 
in the modern poultry industry. Although vaccines never assure complete protection, they 
are essential to protect the birds against pathogens that can reduce their performances 
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(Cserep, 2009). Moreover, it is generally accepted that prevention is more cost effective 
than treatment. In practice, vaccination in poultry is applied to uniform populations and not 
to individuals. Besides viral infections, parasite and bacterial infections are important 
concerns in the poultry industry. Intervention strategies are chosen based on their economic 
and biological efficiency. Spray medication or drinking water medication are the most 
applied methods for mass treatment (Collett, 2009).  
Progress in vaccination schedules and antimicrobial chemotherapy has made respiratory 
problems less important than gut health issues. According to own assessments and from 
veterinary diagnostic labs it can be concluded that actually gut health problems are the most 
important health problem in broilers.  
A lot of pathogens responsible for gut lesions have already been described and methods of 
disease control have evolved with the intensification of the poultry industry. Initially, the 
focus was on clinical diseases of serious nature, but now the focus is on the non-defined 
subclinical diseases and birds’ welfare. Hot topic is the influence of mycotoxins on the 
performance of broilers, with special attention to hepatic, intestinal and reproduction 
problems. 
 
2. Mycotoxins as contaminants of animal feed 
 
2.1 Classification and occurrence of mycotoxins 
Fungi are able to contaminate a multitude of agricultural products such as cereal grains, 
maize, nuts and fruits. A large number of metabolites can be formed by these fungi including 
mycotoxins. Mycotoxins are called secondary metabolites because they are not necessary 
for the survival of the fungi (Keller et al., 2005). Toxins can, however, provide an ecological 
advantage for the fungus in certain environments. Due to mycotoxin production, plants can 
for example become more susceptible which makes the invasion of other fungi easier. 
Mycotoxins are produced by filamentous fungi and are characterized by a low molecular 
weight. Thousands of mycotoxins exist, but only a few present significant food and feed 
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safety challenges. Contamination of feed with mycotoxins leads to heavy economic losses as 
a result of decreased animal production throughout the world (Zain, 2011). 
Mycotoxins of importance for the poultry industry are mainly produced by fungi of the 
genera Aspergillus, Fusarium or Penicillium. From an economic point of view, Fusarium 
mycotoxins are the most significant (Devegowda and Murthy, 2005). The most commonly 
found Fusarium mycotoxins are the trichothecenes, zearalenone, fumonisin and 
moniliformin. The mycotoxins produced by Fusarium species from cereals are illustrated in 
Table 2. Many mycotoxin-producing Fusarium species are common causal organisms of 
Fusarium head blight, foot rot and root rot disease of cereals. 
Table 2. Mycotoxigenic Fusarium species associated with cereals and their mycotoxins 
(adapted from Logrieco et al., 2002). 
 
Fusarium species   Mycotoxins 
F. acuminatum 
F. anthophilum 
F. avenaceum 
F. cerealis 
F. chlamydosporum 
F. culmorum 
F. equiseti 
F. graminearum 
F. heterosporum 
F. nygamai 
F. oxysporum 
F. poae 
F. proliferatum 
F. sambucinum 
F. semitectum 
F. sporotrichioides 
F. subglutinans 
F. tricinctum 
F. verticillioides 
T-2, MON, HT-2, DAS, MAS, NEO, BEA 
BEA 
MON, BEA 
NIV, FUS, ZEN, ZOH 
MON 
DON, ZEN, NIV, FUS, ZOH, a-DON 
ZEN, ZOH, MAS, DAS, NIV, DAcNIV, FUS, FUC, BEA 
DON, ZEN, NIV, FUS, a-DON, DAcDON, DAcNIV 
ZEN, ZOH 
BEA, FB1, FB2 
MON, BEA 
DAS, NIV, FUS, MAS, T-2, HT-2, NEO, BEA 
FB1, BEA, MON, FUP, FB2 
DAS, T-2, NEO, ZEN, MAS, BEA 
ZEN, BEA 
T-2, HT-2, NEO, MAS, DAS 
BEA, MON, FUP 
MON, BEA 
FB1, FB2, FB3 
  
Bold letters indicate the important mycotoxins. Abbreviations: a-DON (mono-acetyldeoxynivalenols: 3-aDON 
and 15-aDON); AcNIV (mono-acetylnivalenol); BEA (beauvericin); DAcDON (di-acetyldeoxynivalenol: 3,15-
aDON); DAcNIV (di-acetylnivalenol: 4,15-AcNIV); DAS (diacetoxyscirpenol); DON (deoxynivalenol); FB1 
(fumonisin B1); FB2 (fumonisin B2); FB3 (fumonisin B3); FUP (fusaproliferin); FUS (fusarenone-X); FUC 
(fusarochromanone); HT-2 (HT-2 toxin); MAS (monoacetoxyscirpenol); MON (moniliformin); NEO (neosolaniol); 
NIV (nivalenol); T-2 (T-2 toxin); ZEN (zearalenone); ZOH (α and β isomers of ZEN) 
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Different factors influence the occurrence of mycotoxins. The temperature, the relative 
humidity and the CO2 concentration in the atmosphere are considered as the main pre-
harvest factors (Ingram 1999; Miraglia et al., 2009). However, good agricultural practice 
(GAP) is essential to reduce contamination during harvest and storage (Magan and Aldred, 
2007). Figure 1 illustrates the different factors affecting the mycotoxins’ occurrence in the 
food and feed chain. 
 
Figure 1. Factors affecting mycotoxin occurrence in the food and feed chain (adapted from 
CAST, 2003). 
 
 
Binder (2007) reported the results of a two-year survey undertaken to evaluate the presence 
of mycotoxins in feed and feed raw materials. In total 2,753 assays were performed on 1,507 
samples from European and Mediterranean markets. The following mycotoxins were 
analyzed: aflatoxin B1, ochratoxin A, deoxynivalenol, T-2 toxin, zearalenone and fumonisins. 
Results revealed that 52% of the samples were contaminated with deoxynivalenol, T-2 and 
zearalenone, as major contaminants. Therefore, in this thesis we mainly focused on these 
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three mycotoxins. Several other studies also reported the occurrence and also the co-
occurrence of mycotoxins in feed in Europe (Streit et al., 2012).  
However, it is difficult to infer trends in the mycotoxin contamination of feedstuffs. One of 
the reasons is the fact that the occurrence patterns are expected to change as a 
consequence of rising average temperatures (Miraglia et al., 2009). For example, the 
prevalence of Fusarium graminearum is likely to increase in Northern Europe due to the 
expected changes in weather conditions for the upcoming years (Parikka et al., 2012). In 
addition, analysis methods used are different and sampling methods are rarely described. 
Nevertheless, sampling is considered as an important source of error in mycotoxin analysis 
due to the frequent inhomogeneous distribution of moulds and/or toxins (Whitaker, 2003).  
An overview of the field contamination with DON, T-2 or ZEN for 2012 is given in Table 3. For 
this study the majority of the samples were taken in Belgium (144 samples). Other samples 
were collected in Germany (15 samples), France (20 samples), the Netherlands (6 samples) 
and Luxembourg (2 samples). 
 
Table 3. Mycotoxin monitoring in Belgium, Germany, France, the Netherlands and 
Luxembourg for 2012 (adapted from Belgian Association of Feed Manufacturers (BEMEFA), 
2012). 
 
 
DON  
DON level (μg/kg) < 
400 
400-
700 
700-
1000 
1000-
1250 
1250-
1750 
1750-
2500 
>2500 
number of 
samples 
154 30 19 6 9 3 2 
 
T-2  
T-2 level (μg/kg) <100 100-200 >200 
number of samples 121 1 0 
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ZEN  
ZEN level (μg/kg) <75 75-100 100-200 >200 
number of samples 155 4 2 5 
 
2.2 Toxicity and metabolism of Fusarium mycotoxins 
 
Trichothecenes contain sesquiterpene rings characterized by a 12,13-epoxy-trichothec-9-ene 
nucleus, responsible for their toxicity (Hussein and Brasel, 2001). This group of toxins is 
characterized by a molecular weight of approximately 200-500 Da (Pestka, 2007). The 
Fusarium trichothecenes can be divided in four groups: A, B, C and D. Type A does not 
contain a carbonyl group on C-8 (represented by R5 in Figure 2). Group B is characterized by 
a carbonyl group on C-8. Members of group C have another epoxy-group between the C-7 
and C-8 or C-8 and C-9 positions, respectively. A macrocyclic ring between C-4 and C-15 is 
typical for group D (Wu et al., 2010). Group A and B represent the most important members. 
 
R
5
R
4
CH3
OCH3
R
1
R
2
O
R
3
 
 
 
Figure 2. Chemical structures of DON, T-2 and their major metabolites. 
 
 
Most toxic type A trichothecene is T-2 toxin (T-2). The mycotoxin T-2 is rapidly metabolized 
to a variety of metabolites and eliminated in the excreta within 48h (Dohnal et al., 2008; 
Yoshizawa et al., 1980a). Different studies and animal models have shown that the major 
metabolic pathway is hydrolysis which occurs at the C-4 position, resulting in HT-2. 
 R1 R2 R3 R4 R5 
DON OH H OH OH O 
3-
aDON OAc H OH OH O 
15-
aDON OH H OAc OH O 
T-2 OH OAc OAc H OCOCH2CH(CH3)2 
HT-2 OH OH OAc H OCOCH2CH(CH3)2 
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Structures of both T-2 and HT-2 are illustrated in Figure 2. HT-2 can be hydroxylated to 3’-
OH-HT-2 in the liver or can be hydrolyzed to T-2 tetraol via T-2 triol. It is also possible that T-
2 is hydroxylated immediately to 3’-OH-T-2. De-epoxidation and glucuronidation of the 
different compounds can also be a metabolic pathway (Weidner et al., 2012; Wu et al., 2010; 
Yoshizawa et al., 1980b). Especially in poultry, several uncharacterized metabolites of T-2 
were found and they are still not identified (Young et al., 2007). Some metabolites are 
equally or even more toxic than T-2 (Dohnal et al., 2008). Increased toxicity of T-2 has even 
been observed owing to enterohepatic circulation (Coddington et al., 1989; Sokolovic et al., 
2008). Retention of a large part of T-2 in the bile has been observed in broiler chickens, 
indicating the important role of the biliary excretion system in the elimination of this 
mycotoxin (Chi et al., 1978).  
The B group includes deoxynivalenol (DON) and its acetylated derivates: 3-aDON and 15-
aDON (Logrieco et al., 2002; Placinta et al., 1999). Figure 2 illustrates the structures of these 
B trichothecenes. DON is one of the least acutely toxic trichothecenes, but of particular 
interest owing to its high prevalence (Rotter et al., 1996). The majority of the ingested DON 
in broilers is quickly, nearly completely, absorbed in the stomach and proximal part of the 
intestines. De-epoxidation of DON to deepoxy-deoxynivalenol (DOM-1) occurs in the 
proximal part of the small intestines (Awad et al., 2011; He et al., 1992; King et al., 1984). 3-
aDON can be metabolized to DON and DOM-1. For 15-aDON, following metabolites can be 
found: deepoxy-15-aDON, DON and DOM-1 (Young et al., 2007). Both 3-aDON and 15-aDON 
were reported equivalently or less toxic than DON for a longtime (Pestka, 2007). However, a 
recent study reported that 15-aDON is more toxic compared to DON and 3-aDON both in 
vitro and in vivo (Pinton et al., 2012).  
Besides the group of trichothecenes, the mycotoxin zearalenone (ZEN) also is an important 
mycotoxin, more precisely as activator of the oestrogen receptor. ZEN is also known as 6-
(10-hydroxy-6-oxo-trans-1-undecenyl)-β-resocylic acid µ-lactone (Bennett and Klich, 2003) 
(Figure 3). An in vitro study demonstrated that ZEN can be metabolized to α-zearalenol (α-
ZEL) and β-zearalenol (β-ZEL), with β-ZEL being the most prominent (Malekinejad et al., 
2006). The affinity of these metabolites for the oestrogen receptor compared to ZEN can be 
ranged as follows: α-ZEL > ZEN > β-ZEL. A recent in vivo study showed that besides the above 
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mentioned metabolites, ZEN can also be transformed to α-zearalanol (α-ZAL) and β-
zearalanol (β-ZAL) in broiler chickens (Yunus et al., 2012a). Only low rates of glucuronidation 
could be demonstrated in chickens compared to other animals (Malekinejad et al., 2006), 
suggesting that glucuronidation of ZEN is not the main metabolic pathway in chickens. 
 
 
O
R2 R1
OH O CH3
 
 
Figure 3. Chemical structures of zearalenone (ZEN), α-zearalenol (α-ZEL) and β-zearalenol (β-
ZEL).  
 
 
The toxicokinetic profiles of DON, T-2 and ZEN have already been investigated in vivo in pigs 
and ruminants. For poultry, only old data of toxicokinetic studies performed with 
radiolabeled toxins are available. 
 
2.3 Implication for the health of broilers 
 
Intake of rather high doses of mycotoxins may lead to mycotoxicosis, which can be 
characterized by several clinical signs (Binder, 2007). The type and concentration of the 
mycotoxin, the duration of exposure and the species, age, gender, immunological status of 
the animal are determinants for the symptoms. Synergistic effects between several 
mycotoxins can cause different diseases (Conkova et al., 2003). 
The main target of Fusarium mycotoxins are rapidly proliferating and differentiating cells and 
tissues, with a high protein turnover, including the small intestines, liver and immune cells. 
The immunotoxicity of type A trichothecenes, especially T-2, is lower than the type B 
trichothecenes (Sharma, 1993). DON can both suppress and stimulate immunity, even at 
 R1 R2 
ZEN O OH 
α-ZEL OH (α) OH 
β-ZEL OH (β) OH 
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equal doses (Rotter et al., 1996). T-2 and DON induce immunosuppression at high doses, but 
immunostimulation at low doses (Sokolovic et al., 2008). Adverse effects due to the 
presence of trichothecenes include decreased T- and B-lymphocyte counts, reduced 
antibody production and suppression of the lymphocyte proliferation (Girish and Smith, 
2008). The exact mode of action of these mycotoxins on the immune system is beyond the 
aim of the research presented in this thesis.  
Our focus was on the parameters leading to economic losses in the broiler industry, namely 
the zootechnical parameters feed intake and body weight. We also investigated the effects 
of DON and T-2 on the hepatic and intestinal function in broiler chickens. The possible 
effects of ZEN on these organs were not studied as ZEN is known to cause reproduction 
problems, which is of principal interest for laying hens and parent flocks.  
2.3.1 DON mycotoxicosis 
All animal species have been shown to be susceptible to DON, also called vomitoxin. 
However, the degree of susceptibility varies among the different species, ranged from the 
most sensitive to the most resistant: pigs>mice>rats> poultry ≈ ruminants (Prelusky et al., 
1994). Differences in absorption, distribution, metabolism and excretion of DON among 
animal species might account for this differential sensitivity.  
Acute mycotoxicosis due to consumption of DON is rarely seen in poultry. For DON in broiler 
chickens the LD50 is set at 140 mg DON/kg BW (Huff et al., 1981). However, chronic exposure 
to DON at low or moderate levels can cause anorexia, diarrhea, decreased live weight gain 
and altered nutritional efficiency (Pestka and Smolinski, 2005). For broiler chickens, different 
studies already reported the negative effects of DON on zootechnical parameters, such as 
feed intake and body weight (gain). Results of these studies are summarized in Table 4. 
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Table 4. Summary of the effects of DON on feed intake and body weight in broiler chickens. 
 
Dose in feed  Exposure time Decreased feed 
intake 
Decreased body 
weight (BW) 
Reference 
16 mg/kg DON 21 days reduced feed 
efficiency 
no (Kubena et al., 
1989b) 
3.4 mg/kg DON 35 days no no (Bergsjo and 
Kaldhusdal, 1994) 
15 mg/kg DON 21 days no no (Kubena et al., 1997) 
8.2 mg/kg DON, 
20.3 mg/kg fusaric 
acid, 
0.2 mg/kg ZEN 
56 days yes (finisher phase) yes (finisher phase) (Swamy et al., 2002) 
21.2 mg/kg DON, 
1.4 mg/kg NIV, 
500 μg/kg 15-aDON, 
300 μg/kg 3-aDON, 
<50 μg/kg HT-2, 
<20 μg/kg T-2, 
406 μg/kg ZEN, 
< 0.2 μg/kg OTA, 
219 μg/kg ergot 
alkaloids 
35 days yes yes (Dänicke et al., 2003) 
5.9 mg/kg DON, 
19.1 mg/kg fusaric 
acid, 
0.4 mg/kg ZEN, 
0.3 mg/kg 15-aDON 
 
9.5 mg/kg DON, 
21.4 mg/kg FA, 
0.7 mg/kg ZEN, 
0.5 mg/kg 15-aDON 
56 days no (starter period) 
yes, linearly (grower 
phase) 
recovery in the 
finisher phase 
BW gain followed the 
same trend as  the 
feed intake 
(Swamy et al., 
2004b) 
10 mg/kg DON 42 days no  no (Awad et al., 2004) 
12.6 mg/kg DON, 
traces of ZEN, 
traces of 15-aDON 
84 days 
(broiler 
breeders) 
no no (Yegani et al., 2006) 
5 mg/kg DON 21 days no no (Awad et al., 2006b) 
10 mg/kg DON 42 days no no (Awad et al., 2006a) 
1.36-1.52 mg/kg DON, 
traces of 3-aDON, 
traces of ZEN and 
other Fusarium 
mycotoxins 
35 days yes, during the first 
three weeks 
yes (Dänicke et al., 2007) 
18 mg/kg DON 21 days no yes, cubically (Xu et al., 2011) 
1 or 5 mg/kg DON 35 days no no (Awad et al., 2011) 
1.68 mg/kg DON, 
0.145 mg/kg 
 
12.209 mg/kg DON, 
1.049 mg/kg ZEN 
35 days Yes yes, during the first 
three weeks 
(Yunus et al., 2012b) 
Dotted line (----) separates two different experimental groups within one study. 
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Results seem to be variable, making it impossible to establish a simple dose-response 
relationship between growth depression and dietary concentrations of DON. In addition, 
artificially versus naturally contaminated feed seems to give different effects. In general, 
naturally contaminated feed led to more pronounced effects (Rotter et al., 1996). The 
presence of other toxins or other compounds in the feed can also be a possible explanation 
(Smith et al., 1997).  
The way DON causes feed refusal has been investigated and was committed to a 
neuropharmacological effect. DON can act directly on the central nervous system, more 
specific on the serotoninergic system. Via this pathway DON was demonstrated to cause 
anorexia and emesis in pigs (Prelusky and Trenholm, 1993; Swamy et al., 2004a). In addition, 
an effect of DON on the peripheral serotonin receptors has been described in rodents 
(Fioramonti et al., 1993). Especially in broilers, higher cerebral levels of norepinephrine were 
found after exposure to DON, antagonizing the effect of serotonin on appetite suppression 
(Swamy et al., 2004a). This mechanism may explain the less severe feed refusal seen in 
broiler chickens. Conditioned taste aversion has also been reported in the presence of DON, 
mediated by the area postrema, which can be responsible for an emetic action too (Prelusky 
and Trenholm, 1993). The mechanism by which DON induces diarrhea was investigated in a 
human intestinal cell line and was associated with the inhibition of the sodium-glucose 
transport protein 1 transporter, resulting in a decrease of D-glucose associated water 
absorption and thus increased water content in the intestinal lumen (Maresca et al., 2002). A 
decreased glucose uptake was also observed in chickens after exposure to DON (Awad et al., 
2008b; Awad et al., 2007b). 
In addition, it has to be mentioned that broilers seem to be able to adapt to DON-
contaminated diets (Awad et al., 2011). But also in pigs and rats the development of a kind 
of tolerance to low concentrations has been observed (Morrissey and Vesonder, 1985; 
Prelusky et al., 1994). Development of tolerance occurs with most anorexic compounds, 
more specifically with the compounds relying on a central serotoninergic mechanism 
(Silverstone, 1992).  
 
General introduction 
 
 
 
20  
 
2.3.2 T-2 mycotoxicosis 
Symptoms of T-2 mycotoxicosis are almost the same as for DON. The differences are only in 
the extent and the severity of the changes. The mycotoxin T-2 is considered the most acutely 
toxic member of the family of the trichothecenes and exposure can occur through different 
routes (Sokolovic et al., 2008). The LD50 of T-2 is 6.3 mg/kg BW in broiler chickens (Chi et al., 
1977b). A wide range of toxic effects can be caused by chronic exposure to T-2 in animals: 
weight loss, emesis, diarrhea, lesions in liver and digestive system,… (Li et al., 2011). 
Especially in chickens reduced egg production, impaired egg hatch and feather alterations 
are other symptoms of chronic exposure to T-2 (Diaz et al., 1994; Wyatt et al., 1975). Most 
relevant chronic toxicity studies in poultry were summarized in a scientific opinion published 
by the European Food Safety Authority (EFSA) (Anonymous, 2011). Effects of T-2 on 
zootechnical parameters as reported by the EFSA are illustrated in Table 5.  
T-2 is a neurotoxin, able to damage the blood-brain barrier and cause changes in the activity 
of serotonine which explains the reduced feed intake (Wang et al., 1998). An increase in 
brain indoleamines, e.g. serotonin, induced by T-2 can contribute to feed refusal 
(MacDonald et al., 1988). In addition, T-2 causes lesions in the oral cavity which can also be a 
factor responsible for a decreased feed intake (Wyatt et al., 1973). Other authors reported 
that one single dose of 5 mg/kg T-2 or feeding at concentrations of 1 to 5 mg/kg T-2 for at 
least one week, are necessary to cause lesions in the mouth (Sokolovic et al., 2008). 
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Table 5. Summary of the effects of T-2 on feed intake and body weight in broiler chickens 
(adapted from Anonymous, 2011). 
 
Dose in the feed Exposure 
time 
Decreased feed 
intake 
Decreased body 
weight (BW) 
Reference 
1, 2, 4, 8 or 16 mg/kg T-
2 
21 days yes (from a 
concentration of 4 
mg/kg T-2) 
yes (from a 
concentration of 4 
mg/kg T-2) 
(Wyatt et al., 1973) 
0.2, 0.4, 2 or 4 mg/kg T-
2 
63 days yes (from a 
concentration of 4 
mg/kg T-2) 
yes (from a 
concentration of 4 
mg/kg T-2) 
(Chi et al., 1977a) 
4 mg/kg  T-2 21 days  yes (Kubena et al., 1989a; 
Kubena et al., 1989b) 
8 mg/kg T-2 and 3.5 
mg/kg aflatoxin 
21 days  yes (Kubena et al., 1990) 
0.11, 0.53 or 1.05 mg/kg 
T-2 
35 days no no (Sklan et al., 2001) 
2 mg/kg  T-2 28 days no yes (Diaz et al., 2005) 
0.5, 1.5, 4.5 or 13.5 
mg/kg  T-2 
17 days yes (from a 
concentration of 
4.5 mg/kg T-2) 
yes (from a 
concentration of 
4.5 mg/kg T-2) 
(Rezar et al., 2007) 
Starter (D0-D21): 1.04 
mg/kg T-2, 0.49 mg/kg 
HT-2 
Finisher (D22-D39): 0.12 
mg/kg T-2, 0.02 mg/kg 
HT-2 
39 days  yes at 21 days (Weber et al., 2010) 
0.31 mg/kg T-2 
0.26 mg/kg HT-2 
21 days no no (Pal et al., 2009) 
 
From the collected data about dietary exposure to trichothecenes we can conclude that the 
variable effects of trichothecenes on performance of poultry indicate that zootechnical traits 
might not be a sensitive indicator of their toxicity. Only clinical signs and production 
parameters but no suitable biomarkers were evaluated in these studies. Therefore, research 
has to be focused on the negative impact of trichothecenes on the intestines and the liver at 
the molecular level and a possible link to reduced performance.  
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2.4 Implications for men’s health 
 
Besides direct intake of mycotoxin contaminated cereals and related food products, another 
route of exposure for men that has to be considered for Fusarium toxins is the transfer from 
animal feed to poultry tissues, possibly leading to residues in animal products. There is 
limited information available on the occurrence of trichothecenes in eggs or meat. For laying 
hens, very low transmission levels of DON or T-2 to the eggs have been reported, namely 
0.19% and 0.17% of the administered dose, respectively (Chi et al., 1978; Prelusky et al., 
1987). El-Banna et al. (1983) fed hens with rations contaminated with 5 mg/kg DON for 192 
days and no traces of DON were found in the tissues or eggs using a GC-MS method (gas 
chromatography-mass spectrometry) with a detection limit of 10 µg DON/kg. DON and 
DOM-1 were analyzed in the liver of broilers after feeding concentrations of DON up to 5 
mg/kg feed for five weeks. Both DON and DOM-1 were not detected in the liver (Awad et al., 
2011). From these studies we may conclude that if the guidance levels as stated by the EFSA 
are respected for DON, risks are limited. For T-2, no similar studies have been published to 
our knowledge. 
 
2.5 Principles of mycotoxin management 
 
Basically, the best way to minimize the risk for a mycotoxin to come into the food chain 
would be to prevent its formation in crop production and/or during storage of the 
feedstuffs. However, under field conditions the presence of mycotoxins can never be fully 
excluded (Bhat et al., 2010). Whereas there are many factors involved in mycotoxin 
contamination, the climate is the main driving force of fungal colonization and mycotoxins 
production (Miraglia et al., 2009; Paterson and Lima, 2010). It is generally accepted that 
rainfall just before and during flowering of the crop favours the infection of crops with fungi 
belonging to the Fusarium species. It has also been demonstrated that the weather 
conditions during winter may have an influence on the survival of primary inoculums 
(Landschoot et al., 2011, 2012). Management of mycotoxins in livestock comprises all stages 
from ‘farm to fork’ (Miraglia et al., 2009). Pre-harvest prevention strategies are the use of 
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mold resistant crop varieties, GAP and the application of fungicides (Siegel and Babuscio, 
2011). However, the use of fungicides not automatically results in a reduction of the 
mycotoxin contamination (Edwards, 2004). Exposure of Fusarium to sublethal 
concentrations of some fungicides might even stimulate mycotoxin production (Audenaert 
et al., 2011). Post-harvest methods comprise optimal storage conditions (effective drying, 
temperature control,…) (Magan and Aldred, 2007).  
Before further processing of the feedstuffs, mycotoxin concentration and pattern must be 
determined (Döll and Dänicke, 2011) as mycotoxins are resistant to different production 
steps (Scudamore et al., 2008). Trichothecenes are known to be heat stable and are not 
degraded during normal food processing or autoclaving (Bullerman and Bianchini, 2007; 
Pestka and Smolinski, 2005). In Europe, maximum levels for products intended for animal 
feed production have been set by the European Commission. Table 6 illustrates the guidance 
level determined in the Commission Recommendation of 17 August 2006 for DON and ZEN 
(Anonymous, 2006). For T-2, the Belgian Federal Agency for the Safety of the Food Chain 
currently imposes a limit of 0.4 mg/kg feed for T-2 and HT-2 in poultry feed. On the other 
hand, Table 7 shows the very recent European Commission Recommendation of 27 March 
2013 for T-2 and HT-2 (Anonymous, 2013).  
If the mycotoxin concentration is lower than the guidance level, feedstuff can be used for 
feeding. However, if the mycotoxin concentration is higher than the recommended levels, 
action is necessary. There are different possibilities: technical decontamination prior to 
feeding or in vivo decontamination in the animal (Döll and Dänicke, 2011). Physical, chemical 
or biological treatments of contaminated feed is not efficient and expensive (Jouany, 2007). 
In vivo decontamination is frequently applied in livestock using feed additives, called 
mycotoxin detoxifying agents.  
A scientific report was recently submitted to the EFSA with the title: ‘Review of mycotoxin 
detoxifying agents used as feed additives: mode of action, efficacy and feed/food safety’ 
(Anonymous, 2009). In this report, mycotoxin detoxifying agents are divided in two different 
categories: adsorbing agents and biotransforming agents. This distinction is made on the fact 
that the first group is able to bind the mycotoxins in contaminated feed in the 
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gastrointestinal tract of the animal. Ideally, this complex does not dissociate in the 
gastrointestinal tract of the animal, resulting in an efficient elimination via faeces and hereby 
preventing or minimizing exposure of animals to mycotoxins. Adsorbing agents can consist of 
aluminosilicates (e.g. bentonite, montmorillonite, zeolite, phyllosilicates), activated carbon, 
complex indigestible carbohydrates (cellulose, polysaccharides from the cell walls of yeasts 
and bacteria such as glucomannans and peptidoglycans) and synthetic polymers 
(cholestyramine and polyvinylpyrrolidone) (Anonymous, 2009). The biotransforming agents, 
such as bacteria, yeasts, fungi and enzymes, are responsible for the degradation of 
mycotoxins into less or non-toxic metabolites.  
 
The EFSA stated that these detoxifiers have to be registered as feed additives belonging to 
the class of ‘substances for reduction of the contamination of feed by mycotoxins’. Prior to 
registration, both efficacy and safety of the detoxifying agents have to be proven 
(Anonymous, 2010).  
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Table 6. The guidance values on the presence of deoxynivalenol and zearalenone in products 
intended for animal feeding (relative to a feedingstuff with a moisture content of 12%), as 
determined in the Commission Recommendation 2006/576/EC. 
 
(*) Particular attention has to be paid to cereals and cereal products fed directly to the animals that their use in 
a daily ration should not lead to the animal being exposed to a higher level of these mycotoxins than the 
corresponding levels of exposure where only the complete feedingstuffs are used in a daily ration. 
(**) The term ‘cereals and cereal products’ includes not only the feed materials listed under heading 1 ‘Cereal 
grains, their products and by-products’ of the non-exclusive list of main feed materials referred to in part B of 
the Annex to Council Directive 96/25/EC of 29 April 1996 on the circulation and use of feed materials (OJ L 125, 
23.5.1996, p.35) but also other feed materials derived from cereals in particular cereal forages and roughages. 
 
 
 
 
 
 
Mycotoxin Products intended for animal feed Guidance value in 
mg/kg  
Deoxynivalenol Feed materials (*) 
-Cereals and cereal products (**) with the 
exception of maize by-products 
-Maize by-products 
Complementary and complete feedstuffs with 
the exception of: 
-Complementary and complete feedingstuffs 
for pigs 
-Complementary and complete feedingstuffs 
for calves (<4 months), lambs and kids 
       
8 
 
12 
5 
 
0.9 
 
2 
Zearalenone Feed materials (*) 
-cereals and cereal products (**) with the 
exception of maize by-products 
-maize by-products 
Complementary and complete feedingstuffs 
-complementary and complete feedingstuffs 
for piglets and gilts 
-complementary and complete feedingstuffs 
for sows and fattening pigs 
-complementary and complete feedingstuffs 
for calves, dairy cattle, sheep (including lamb) 
and goats (including kids) 
 
2 
 
3 
 
0.1 
 
0.25 
 
0.5 
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Table 7. Indicative levels for the sum of T-2 and HT-2 toxin in cereals and cereals products, as 
determined in the Commission Recommendation 2013/165/EU.  
 
 Indicative levels for the sum of T-2 and 
HT-2 (µg/kg) from which onwards/ 
above which investigations should be 
performed, certainly in case of 
repetitive findings (*)  
1. Unprocessed cereals (**)  
1.1. barley (including malting barley)  and maize  200 
1.2. oats (with husk) 1000 
1.3. wheat, rye and other cereals   100 
 
2. Cereal products for feed and compound feed 
(***)  
 
2.1. oat milling products (husks)  2000 
2.2. other cereal products  500 
2.3. compound feed, with the exception of feed 
for cats 
250 
(*) The levels referred to in this Annex are indicative levels above which, certainly in the case of repetitive 
findings, investigations should be performed on the factors leading to the presence of T-2 and HT-2 toxin or on 
the effects of feed and food processing. The indicative levels are based on the occurrence data available in the 
EFSA database as presented in the EFSA opinion. The indicative levels are not feed and food safety levels.   
(**) Unprocessed cereals are cereals which have not undergone any physical or thermal treatment other than 
drying, cleaning and sorting. 
(***) The indicative levels for cereals and cereal products intended for feed and compound feed are relative to 
a feed with a moisture content of 12 %. 
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3 The gastro-intestinal tract and the liver as a target for trichothecene 
mycotoxins 
The digestive tract of poultry consists of a crop, which is a dilatation of the esophagus. The 
main function of the crop is storage of feed. Absorption of drugs in esophagus or crop is 
minimal since both parts of the digestive tract are characterized by keratinized stratified 
squamous epithelia (Lumeij, 1994). The avian stomach consists of two different parts: a 
proventriculus or glandular stomach and a ventriculus or gizzard, where grit is stored that 
aids in the physical grinding of feed. After the stomach, following parts of the digestive 
system can be distinguished: small intestines, two ceca, a rectum and a cloaca (Martinez et 
al., 2002) (Figure 4). The small intestine can be divided in three different parts in broiler 
chickens, but in the literature some discrepancy exists how this should be done. Therefore, 
our applied criteria are described below. The first part is just behind the gizzard and is also 
called the duodenal loop or duodenum. In the chicken the duodenum is the most important 
site for nutrient digestion and absorption (Vermeulen et al., 2002). The second part is 
situated at the level of the Meckel’s diverticulum and is called jejunum. The last part, the 
ileum, is situated before the ileo-cecorectal transition. In chicken, ingesta can pass through 
the whole digestive tract very quickly. Fifty percent of ingesta pass in 12h and after 24h all 
passage is complete. Besides the movement of ingesta from proximal to distal, also three 
reverse peristaltic cycles are observed in chickens: from the gizzard to the proventriculus 
and the crop, from the duodenum to the gizzard and from the rectum to the caeca (Hoerr, 
1998). 
 
General introduction 
 
 
 
28  
 
 
Figure 4. Anatomy of chicken’s digestive tract (adapted from Duke, 1984). 
 
 
In addition, the liver also plays an important role as first line defense mechanism by the 
process called first-pass effect. The liver has an exposed position within the body as the 
gateway of the portal blood draining the gastrointestinal tract. Almost all the drugs absorbed 
in the gastro-intestinal tract have to enter the portal vein and encounter the hepatocytes 
(Hu and Li, 2011).  
Both liver and intestines can interact on the oral bioavailability of drugs or xenobiotics. 
Consequently when mycotoxins interact with the intestinal or hepatic function, 
bioavailability of these drugs and xenobiotics can be influenced. 
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3.1 Effects at the gastro-intestinal level 
Mode of action 
Trichothecenes have an affinity for the 60S subunit of ribosomes, which leads to inhibition of 
the protein synthesis at the initiation, elongation or termination step (Rocha et al., 2005) 
(Figure 5). T-2 is active at the initiation phase, while DON acts as inhibitor of the elongation 
and/or termination step (Awad et al., 2008a; Sokolovic et al., 2008). Besides the effects on 
the protein synthesis, trichothecenes exert other effects on eukaryotic cells such as 
inhibition of the RNA and DNA synthesis as well as adverse effects on the mitochondrial 
function (Minervini et al., 2004; Ueno, 1984). 
Trichothecenes can also induce apoptosis, a programmed cell death (PCD) response both in 
vitro and in vivo (Minervini et al., 2004; Pestka et al., 2004; Yang et al., 2000). DON was 
classified as a strong PCD inducer, while T-2 is a weak inducer (Shifrin and Anderson, 1999). 
The induction of apoptosis may require both translational arrest and mitogen-activated 
protein kinase (MAPK) activity. MAPK’s are components of a signaling cascade that regulate 
cell survival in response to stress (Iordanov et al., 1997). T-2 induces apoptosis by activation 
of c-Jun N-terminal kinases (JNK), p38 and MAPK’s, but the precise mechanism has not yet 
been elucidated (Sokolovic et al., 2008). The process is also called ‘ribotoxic stress response’ 
(Iordanov et al., 1997). Sergent et al. (2006) demonstrated that DON inhibits intestinal cell 
proliferation at concentration corresponding to those found in nature. DON induces namely 
the phosphorylation of p38, extracellular signal-regulated kinases (ERK) and JNK and 
concomitantly disrupts the intestinal permeability (Sergent et al., 2006). The trichothecene-
mediated signal transduction pathway in mammalian cells is shown in Figure 5. 
The link between ribosomal RNA damage and the induction of MAPK signaling pathways 
remains an unrevealed paradox (Pestka, 2007). Two different kinases have been pointed out 
until now which potentially mediate signaling of the trichothecene-mediated MAPK 
activation, namely RNA-activated protein kinase (PKR) and hematopoietic cell kinase (Hck) 
(Zhou et al., 2003; Zhou et al., 2005). However, the presence of other signal transducing 
proteins can not be excluded and the exact mechanism of action has still to be elucidated. 
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Different studies also reported that trichothecenes are able to induce the production of free 
radicals, causing membrane and DNA damage (Atroshi et al., 1997; Leal et al., 1999; 
Minervini et al., 2005; Rizzo et al., 1994; Vila et al., 2002). Oxidative stress can thus be 
considered as a possible underlying mechanism involved in the toxicity of trichothecenes. 
However, some contradictory studies were published concerning the induction of oxidative 
stress by DON and T-2. A recent study reported that T-2 is a moderate oxidant mycotoxin, 
while DON is a non-oxidant mycotoxin (El Golli-Bennour and Bacha, 2011). T-2 can generate 
higher reactive oxygen species (ROS) levels which lead to DNA damage, activation of p53 and 
final apoptosis in human cervical cancer cells (Chaudhari et al., 2009). This DNA damage 
occurs as early as 10 min after exposure to the toxin, a time point much earlier than the 
protein synthesis inhibition. However, the mechanism responsible for the DNA damage has 
still to be elucidated. DNA fragmentation of leukocytes in broilers was observed after 
exposure to T-2 at a concentration of 13.5 mg/kg feed for 17 days (Rezar et al., 2007). The 
same effects were seen in broilers even at a lower concentration of 10 mg/kg T-2 after 
exposure for 17 days (Frankic et al., 2006). Awad et al. (2012) demonstrated that the 
genotoxic effects of DON in broilers are not correlated with the induction of oxidative stress 
in the liver. In contrast, diets contaminated with DON and ZEA induced oxidative stress in the 
liver of broilers, but no effect was seen in the duodenal mucosa of the animals (Borutova et 
al., 2008). Besides the p53 pathway, ROS can also activate MAPK’s and thus also lead to 
apoptosis by this pathway (Martindale and Holbrook, 2002). 
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Figure 5. Trichothecene-mediated signal transduction and downstream processes in 
mammalian cells (adapted from Rocha et al., 2005). 
 
Trichothecenes appear to have an impact on the cell cycle depending on the cell type. A cell 
cycle arrest in the G2/M-phase was observed in intestinal porcine epithelial cells from the 
mid-jejunum (IPEC-J2 cells) after incubation with 2000 ng/ml DON for 48h. In contrast, in 
intestinal porcine epithelial cells from the jejunum and ileum (IPEC-1 cells) a significant 
increase in PreG1 phase was observed under the same circumstances (Hegewald et al., 
2010). Another study also demonstrated an arrest in G2/M-phase of the cell cycle after 
exposure to DON in a concentration range of 250 ng/ml and 1000 ng/ml in human HCT-116 
and intestinal-407 epithelial cells (Yang et al., 2008). Prudence is however in order when 
extrapolating these in vitro results to in vivo situations. 
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3.1.1 Gut wall morphology 
The intestinal mucosa functions as a kind of barrier which regulates the uptake of nutrients 
and water, but excludes potential pathogens and toxicants (Oswald, 2006). The epithelial 
surface of the intestine is characterized by a large contact area for absorption. The surface 
consists of a simple columnar epithelium, which is increased by the presence of depressions 
(crypts) and villi (DeSesso and Jacobson, 2001). This monolayer is also called the mucosa of 
the intestinal monolayer. Mature cells migrate along the crypt-villus axis towards the villus-
top, underway these cells become differentiated cells (Booth and Potten, 2000; Simon and 
Gordon, 1995). Especially in chicks, cell proliferation not only occurs in the crypts but also 
along the villi (Uni et al., 2000). In poultry the flattened leaf-shaped villi become shorter and 
broader throughout the length of the small intestines. In mammals, normally a submucosal 
layer is found under the mucosa. However, in poultry the non-existence of a tela submucosa 
is a histological particularity. Furthermore, poultry also possess a thick lamina muscularis 
mucosae which is frequently in continuity with the underlying circular muscle (Hodges, 
1974).  
 
Histological alterations have been described after ingestion of different concentrations of 
trichothecenes. More precisely, cells on the tips of the villi are destroyed and crypt 
epithelium is injured (Hoerr, 1998). Shorter and thinner villi were observed in the duodenum 
and the jejunum of broiler chickens after exposure to 10 mg/kg DON in the feed for 6 weeks 
(Awad et al., 2006a). These authors related the histological changes to the irritant effect of 
DON. No effect on the jejunum villi, but only decreased height and width of villi in 
duodenum was found after 3 weeks exposure of broiler chickens to 5 mg/kg DON in the feed 
(Böhm et al., 2006). The same authors reported also that even concentrations of 1 mg/kg 
DON fed during 5 weeks resulted in a decreased villus height, decreased villus surface area 
and a reduced muscular thickness in the jejunum of broilers (Awad et al., 2011). Recently, a 
study could demonstrate that the increasing levels of DON linearly decreased the villus 
height in both the mid-duodenum and mid-jejunum of broiler chickens (Yunus et al., 2012b). 
T-2 exposure at a concentration of 0.982 mg/kg for 32 days resulted in shorter villi in the 
duodenum and shorter and thinner villi in the jejunum of turkey poults (Sklan et al., 2003). 
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The decrease in enterocyte height is highly indicative that these mycotoxins can alter the 
digestive and absorption function. Besides a direct irritant effect of the toxin, the inhibition 
of the protein synthesis by DON, which results in death of the epithelial cells, was also 
pointed out as explanation for the morphological changes.  
The mitotic index in crypt epithelia was decreased after inoculation with T-2 in mice (Li et al., 
1997). Reduced enterocyte migration was observed in the jejunum of turkey poults fed T-2 
(Sklan et al., 2003). DON is also known to inhibit the intestinal cell proliferation (Sergent et 
al., 2006). Trichothecenes can cause apoptosis via different pathways and can influence the 
cell cycle, which can be an explanation for the reduced proliferation. 
 
3.1.2 The intestinal functional barrier 
Intestinal absorption can be described as the way molecules navigate across the 
enterocytes. The transport through the enterocyte barrier can be divided in active, passive 
and specialized transport; and into a paracellular and a transcellular route. Passive diffusion 
can be defined as the movement of molecules across the lipid bilayer without the need of 
energy. The driving force for this process is the concentration gradient (Park and Chang, 
2011). Active transport is an energy-consuming system, mostly acting against the 
concentration gradient. An example of specialized transport is endocytosis, whereby 
macromolecules are taken up into the cells by vesicles. From the literature, trichothecenes 
are known to interact with the intestinal barrier function, interrupting both paracellular and 
transcellular routes. 
3.1.2.1 Trichothecenes interact with the paracellular pathway 
The epithelial barrier is formed by a lipid bilayer of enterocytes. The enterocytes are adhered 
to each other through complexes that form junctions between the cells, called tight 
junctions. These tight junctions regulate the traffic between the epithelial cells or the 
paracellular pathway. The intestinal barrier is a dynamic barrier, which is characterized by 
the fact that the tight junctions are able to open and close at any time in a response to a 
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variety of stimuli (Forster, 2008). Besides adhesive functions, these intercellular junctions are 
also involved in different signaling pathways that regulate the proliferation and the 
differentiation of the epithelial cells (Matter and Balda, 2003). 
Tight junctions are constituted of different proteins as illustrated in Figure 6. Three different 
types of transmembrane proteins can be distinguished: occludins, claudins and junctional 
adhesion molecules (JAMs) (Matter and Balda, 2003). Occludin was the first identified 
integral membrane protein in chicken (Furuse et al., 1993). However, different studies 
demonstrated that occludin is not indispensable for the formation of tight junction strands 
(Furuse et al., 1996; Saitou et al., 1998), but more supports the role of claudins (Forster, 
2008). The members of the claudin family on the other hand, really form the backbone of 
the tight junctions (Matter and Balda, 2003). So far, at least 24 members of the claudin 
family have been identified in different animal species and these proteins also seem to be 
expressed in a tissue-specific manner (Forster, 2008). Expression studies revealed that 
claudin 1 and 5 are specific for the mediation of transepithelial resistance in poultry and thus 
are important subtypes for the intestinal barrier function (Amasheh et al., 2005; Inai et al., 
1999; Markov et al., 2010). The third group consists of the junction-associated adhesion 
molecules. Three different members have been characterized until know, but only the 
function of JAM-1 is well defined. JAM-1 is involved in the immune cell migration or cell 
adhesion (Bazzoni et al., 2000). Besides these transmembrane proteins, the tight junctions 
also possess a cytoplasmatic plaque responsible for the organization of different processes 
such as morphogenesis, cell polarity, cell proliferation and differentiation. This plaque 
consists of two different categories of proteins: the peripherally associated scaffolding 
proteins (ZO-1, ZO-2, ZO-3 and cingulin) and the signaling proteins (ZONAB, Rhoa and Raf-1) 
(Forster, 2008).  Of special interest are the zona occludens proteins as they act as a kind of 
adaptors, which are connected to the transmembrane proteins and to other cytosolic 
components (Paris et al., 2008).  
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Figure 6. Molecular composition of tight junctions (adapted from Forster, 2008).  
 
To measure the permeability of membranes, probe drugs are frequently used. However, the 
selection of a useful probe drug is not easy. Movement across the paracellular pathway 
depends on 5 different parameters, namely the concentration gradient, the surface area of 
the epithelium, the thickness of the epithelium, the time available for permeation and the 
intrinsic permeability properties of the barrier. To evaluate this last factor, a probe drug has 
to be selected with the guarantee that the four first factors are not changed. In addition, the 
probe drug may not be degraded or transformed by the gut flora (Arrieta et al., 2006).  
Another frequently used method in both in vitro and ex vivo studies is the measurement of 
the trans-epithelial electrical resistance (TEER) across the intestinal membrane. This 
technique is a useful approach in combination with other techniques, since the TEER 
measurements can be influenced by different factors that are difficult to take into account 
(Madara, 1998). For example, a decrease in TEER does not always equate with an altered 
paracellular pathway as migration of neutrophils across the intestinal epithelia may cause 
the same effects. Another example is edge damage of tissue which can occur due to 
manipulation of the epithelial explants when using Ussing chambers for the measurements 
of intestinal TEER. Edge damage consists of a loss of integrity of the tissue, resulting in a 
decreased TEER (Clarke, 2009).  
The application of 2000 ng/ml DON for 48h on IPEC-1 and IPEC-J2 cells led to a 
desintegration of ZO-1 as observed by  immunofluorescence, reinforced by a decreased 
protein expression of ZO-1 as shown by western blot analysis (Diesing et al., 2011; Hegewald 
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et al., 2010). In contrast, another study reported that ZO-1 and occludin staining and 
localization were not affected by DON treatment. However, a reduced intensity for the 
staining of claudin 3 was observed in Caco-2 cells and for both claudin 3 and 4 in IPEC-1 cells 
(Pinton et al., 2009). The overall morphology of the cells remained unchanged during this 
trial, suggesting a direct or specific effect on claudins rather than general cell damage. The 
authors suggested that the tight junction complex structure and function was regulated 
through the activation of the MAPK pathway by DON (see Figure 5). A concentration-
dependent reduction of the expression of claudin 4 was demonstrated by western blot 
analysis in human Caco-2 cells which were exposed to 50, 500 or 5000 ng/ml DON for 24h 
(Van de Walle et al., 2010). The authors reported that this effect was due to the ability of 
DON to inhibit protein synthesis. There is a lack of literature on the effects of trichothecenes 
on the tight junctions after in vivo exposure. One study reported a reduced claudin 4 protein 
expression in pigs after 4 weeks treatment with DON at a concentration of 2.85 mg/kg feed 
for 5 weeks (Pinton et al., 2009). However, no data are available on the effects in broiler 
chickens. 
Barrier disruption is an important etiologic factor of intestinal inflammation because it can 
lead to an increased permeability to luminal antigens with subsequent contact with toll-like 
receptors and potential activation of underlying immune cells (Forster, 2008; Maresca et al., 
2008). TLRs play a key role in microbial recognition, control of adaptive immune responses, 
and induction of antimicrobial effectors pathways, leading to efficient elimination of host-
threatening pathogens (Takeuchi et al., 1999).  
 
3.1.2.2. Trichothecenes interact with efflux transporters involved in the 
transcellular pathway 
Along the entire length of the gastro-intestinal tract, different drug transporters can be 
localized in the apical membrane of the enterocytes. These transporters are able to remove 
xenobiotics from the enterocyte linings and return them into the gastro-intestinal lumen. 
This secretion process is also called efflux transport (Chang et al., 2011). After their return 
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into the gut lumen, drugs continue to move along the GI tract and afterwards the molecules 
can re-enter the enterocytes or they can be eliminated with the faeces. It is generally 
accepted that members of ATP-binding cassette (ABC) are widely involved in the active 
process of efflux transport. The ABC family needs cellular energy for active transport of 
substrates against the concentration gradient (Higgins and Linton, 2004). Another 
requirement is that the transporter protein needs to recognize the specific drug as a 
substrate. Afterwards, the protein undergoes a conformational change which allows the 
substrate to be transported. 
A study of the evolution of the ABC gene family showed that chickens only have 41 ABC 
genes which is lesser than any other higher vertebrates (Annilo et al., 2006). Several efflux 
transporters have already been identified in chickens such as P-glycoprotein (P-gp or MDR1) 
and multidrug resistance-associated protein2 (MRP2). In turkeys another efflux transporter 
has been described, namely breast cancer resistance protein (BCRP) (Haritova et al., 2008b). 
P-gp is highly conserved and is known to be expressed in tumor cells and thus to lead to 
multidrug resistance (Goldstein et al., 1989). However, this protein is also expressed in 
healthy intestines and in other organs such as e.g. the liver of animals (Haritova et al., 2010). 
Another protein which is also found at this level is MRP2. A difference in expression between 
these two efflux transporters has been observed in both mammals and chickens. P-gp 
expression pattern in chickens shows an increasing trend from proximal to distal in the 
intestinal tract. MRP2 on the other hand, is characterized by a decreasing trend along the 
entire length of the GI tract of poultry. Due to their apical localization in the different organs, 
efflux transporters are well positioned to function as a barrier for xenobiotics (Chang et al., 
2011; Schrickx and Fink-Gremmels, 2008). Both induction and inhibition of these transporter 
proteins can occur, which respectively results in a decreased and increased bioavailability of 
a drug (Zhou, 2008). Different factors including disease, diet, endogenous or exogenous 
compounds can be responsible for the up- or down-regulation of the efflux pumps (Fardel et 
al., 2005). Numerous xenobiotics have been found to be good substrates for these 
transporters and can be responsible for the modulation of their expression (Green et al., 
2005). Two fluoroquinolone antibiotics, namely danofloxacin mesylate and enrofloxacin 
have been demonstrated to restore partially the mRNA down-regulation of MDR1 due to E. 
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coli infection in broiler chickens. The antibiotics were, however, not able to restore MRP2 
down-regulation in these infected animals (Haritova et al., 2008a). The same trend was 
observed for danofloxacin mesylate in turkeys (Haritova et al., 2008b). 
Differences in drug bioavailability as described above can be a factor responsible for 
resistance to antibiotics. On the other hand, micro-organisms, such as bacteria, also possess 
ABC transporters to adapt to the environment and to develop resistance to the actions of 
toxic compounds (Chen et al., 2010; Sabri et al., 2006). However, the effects of mycotoxins 
on ABC transporters of micro-organisms have, to our knowledge, not been investigated in 
poultry until now. 
It is suggested that P-gp is strongly involved in the protection of animals against different 
mycotoxins which are substrates of P-gp (De Angelis et al., 2005). The toxin nivalenol has 
been characterized as a substrate for both P-gp and MRP2 in Caco-2 cells (Tep et al., 2007). 
Also DON was demonstrated to be a substrate for both MDR1 and MRP2 in Caco-2 cells 
(Videmann et al., 2007). Immunohistochemical analysis showed a reduced expression of P-
gp at the brush border of the small intestines in pigs receiving 1 mg DON/kg of feed. A higher 
dose of 3 mg/kg DON even resulted in a complete disappearance of P-gp (Van der Heyden et 
al., 2009). A study conducted with laying hens reported the use of the paracellular pathway 
by DON, however, the same authors did not exclude the transcellular pathway (Awad et al., 
2007a).  
 
3.1.2.3 Trichothecenes interact with drug metabolism in the GI tract 
 
The bioavailability of drugs can be limited due to their limited absorption or extensive 
metabolism. Older literature stated that the liver is the main organ for metabolism of drugs. 
However, recent publications reported that the small intestines also play a major role (Paine 
et al., 1996; Thummel et al., 1996). It is important to mention that the intestines are the first 
site of exposure for xenobiotics and in addition, intestinal cells are exposed to higher 
concentrations of drugs compared to the liver cells as the intestine is the place where drugs 
are released from their dosage form (Hu and Singh, 2011). Some studies even reported that 
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the intestinal metabolism may be of greater importance than the hepatic metabolism 
(Fromm et al., 1996; Wu et al., 1995). The principal biotransformation enzymes in the gut 
wall include the phase I cytochrome P-450 (CYP450) subfamily, but also phase II reactions 
can occur. Phase I reactions are usually oxidation, hydrolysis and reduction, while phase II 
reactions are the conjugation of the parent compound and phase I metabolites.  
The most important family of enzymes involved in phase I metabolism is the CYP450 
superfamily of hemeproteins. The CYP superfamily is subdivided into families and 
subfamilies based on the amino acid sequence homology. Enzyme families 1 to 4 are 
primarily responsible for the biotransformation of drugs (Fink-Gremmels, 2008). In humans, 
the predominant CYP isoform in the small intestines is CYP3A4 (Zhang et al., 1999).  An avian 
CYP450 of the CYP3A family has been cloned, namely CYP3A37. A homology of 
approximately 60% with human CYP3A4 and of 62% with pig CYP3A29 was found (Ourlin et 
al., 2000). However, relatively little is known about expression and activity of CYP3A enzyme 
in birds (Vermeulen et al., 2002).  
 
An important remark is that P-gp and CYP3A may be functionally linked due to their co-
localization in the intestinal tract and to their similar substrates, but also because they can 
be co-induced as a response to some xenobiotics (Watkins, 1997). Although some 
information is available about the influence of trichothecenes on intestinal P-gp, little data 
is, to our knowledge, available about the effects of these toxins on intestinal CYP enzymes in 
animals. One study reported that CYP1A1 was induced in Caco-2 cells after exposure to 0.03 
µg/ml T-2 (Kruber et al., 2011). However, in vitro cell response to mycotoxins is not always a 
good predictor for the in vivo situation (Rocha et al., 2005).  
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3.2  Effects at the hepatic level 
 
The liver is responsible for energy homeostasis, cholesterol metabolism, blood filtration, bile 
production and processing of nutrients and hemoglobin. Additionally, an important function 
of the liver is detoxification of toxic substances both from endogenous and exogenous origin 
(Wang and Tompkins, 2011). The liver receives blood directly from the gut, via the portal 
vein, and thus the liver can be directly exposed to intestinal absorbed compounds (Figure 7). 
To accomplish the role of detoxifier, the liver also disposes of metabolizing enzymes of 
phase I and II, as described earlier. The biotransformation of drugs before entering the 
systemic circulation is referred to as first-pass metabolism and the liver CYP enzymes are 
considered to be the major protagonists for this process. 
 
Figure 7. First-pass effect (adapted from van Herwaarden et al., 2009). 
 
The effect of trichothecenes on hepatic CYP enzymes has been investigated in vitro. Hepatic 
CYP3A22 mRNA expression in primary hepatocyte cultures of piglets was induced after T-2 
exposure (0.1 µg/ml) for 48h (Ge et al., 2010; Wang et al., 2011), while CYP1A expression 
was not affected under the same conditions (Wang et al., 2011).  
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Some in vivo studies have already been performed in other animal species than chickens to 
study the effects of chronic exposure to T-2. The concerned literature is summarized in Table 
8. 
 
Table 8. Summary of performed in vivo studies concerning the effects of dietary exposure to 
trichothecenes on hepatic CYP proteins. 
 
Mycotoxin  Exposure 
time 
Species Target 
CYP 
Effect in the liver Reference 
T-2 toxin and 
diacetoxyscirpenol: 
1.0 mg/kg feed 
1, 4 or 8 
days 
Rat CYP450 Dose-dependent 
decrease in protein 
expression 
Galtier et al., 
1989 
T-2 toxin: 
0.5, 0.25, 0.1 mg/kg 
feed 
5 days Rabbit CYP1A1 
CYP1A2 
CYP2A1 
CYP2B4 
Dose-dependent 
decrease in protein 
expression 
Guerre et al.. 
2000 
T-2 toxin:  
2.102 mg/kg feed 
28 days Pig CYP1A 
CYP2B 
CYP2C 
CYP3A 
Significant lower 
protein expression. 
Decreasing trend for 
the protein 
expression was 
observed, but no 
significant 
differences 
Meissonnier 
et al., 2008 
T-2 toxin: 0.903 
mg/kg feed 
14 days Pig CYP3A Significant lower 
protein activity 
Goossens et 
al., 2013 
 
In the liver, the efflux pumps MDR1 and MRP2 as described earlier, are also present. The 
mRNA expression of MDR1 is lower in the chicken liver compared to the intestinal 
expression, while for MRP2 the opposite is seen (Haritova et al., 2010). These hepatic efflux 
pumps could possibly be altered due to mycotoxin exposure. However, at the start of this 
research no data was available about this subject. 
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The European Union has established the most comprehensive regulations for mycotoxins in 
food and feed. However, these regulations do not comprise all the mycotoxins. In addition, 
mycotoxins rarely occur as a single contaminant which questions the applicability of the 
proposed individual safety levels. From economical point of view Fusarium mycotoxins are 
the most important in our temperate climate regions. Deoxynivalenol is considered the most 
prevalent Fusarium toxin, whereas T-2 toxin the most acute toxic one. Different studies 
already reported the effects of these mycotoxins on production parameters in poultry, but 
action at mRNA and protein level in target organs may be underestimated. Therefore, the 
general aim of this thesis was to investigate the effects of the Fusarium toxins 
deoxynivalenol and T-2 toxin on the intestinal barrier and hepatic function in broiler 
chickens. 
In general, poultry are claimed to be relative resistant to mycotoxicosis. However, nor clear 
dose-response relationship can be found in this species, nor information on their disposition 
and toxicokinetic characteristics in the body. In practice, there is a need for suitable 
biomarkers to assess mycotoxin exposure in vivo.  
It is generally accepted that the presence of mycotoxins can be reduced, but not completely 
avoided. Therefore, mycotoxin detoxifiers are frequently used as feed additives to prevent 
mycotoxicosis. Mycotoxin detoxifying agents can be divided in two different groups 
according to their mode of action, namely adsorbing and biotransforming agents. However, 
little is known about the safety and efficacy of these feed additives. 
 
The scientific aims of part I of this thesis therefore are: 
1. To perform toxicokinetic studies for deoxynivalenol, T-2 toxin and zearalenone in 
order to evaluate the oral bioavailability and toxicokinetic parameters of these 
different mycotoxins in broiler chickens (Chapter 1) 
2. To evaluate different biomarkers to assess deoxynivalenol exposure after chronic 
feeding in broiler chickens, and to test the efficacy and safety of two types of 
mycotoxin detoxifiers, i.e. an adsorbing agent and a biotransforming agent 
(Chapter 2) 
Being an interface between the outside world and the inside body, the gastro-intestinal tract 
is especially equipped for the absorption of essential nutrients, ions and vitamins. At the 
same time it must function as a first line of defense against exogenous toxins and harmful 
micro-organisms. In addition, the oral bioavailability of xenobiotics may be limited by 
biotransformation and/or efflux in the gut and liver. The principal enzymes responsible for 
biotransformation belong to the cytochrome P450 family, with the CYP3A subfamily being 
important. However, the expression and activity of CYP3A have not been studied in poultry. 
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CYP450 enzymes are also known to interact with efflux transporter proteins such as P-
glycoprotein and other multidrug resistance-associated proteins. The transporter systems 
and biotransformation enzymes are present in both small intestines and liver. These organs 
consist of continuously proliferating and differentiating cells, and are thus important target 
organs of trichothecenes. Moreover, as mycotoxin adsorbing agents pass through the whole 
digestive tract, their influence on the intestinal barrier function may also be questioned. 
Effects of deoxynivalenol are mainly observed at the intestinal level in several animal 
species. On the other hand, significant effects of T-2 on biotransformation enzymes have 
already been reported in other animal species. Therefore, besides deoxynivalenol, also a 
study with T-2 was included in this thesis. 
 
The scientific aims of part II of this thesis are thus: 
1. To evaluate the influence of deoxynivalenol and an adsorbing agent on the intestinal 
barrier and liver function in broiler chickens (Chapter 3) 
2. To evaluate the gene expression and activity of CYP3A in liver and small intestines of 
broiler chickens (Chapter 4) 
3. To investigate the effects of T-2 toxin on the gene expression of CYP450 enzymes and 
drug efflux transporters and on the activity of CYP3A, both in liver and small 
intestines of broiler chickens (Chapter 5) 
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Chapter 1. 
 
Toxicokinetic studies of three important Fusarium mycotoxins: 
deoxynivalenol, T-2 toxin and zearalenone 
 
 
 
 
 
 
 
 
 
 
Adapted from: Osselaere, A., Devreese, M., Goossens, J., Vandenbroucke, V., De Baere, S., 
De Backer, P., Croubels, S. (2013). Toxicokinetic study and absolute oral bioavailability of 
deoxynivalenol, T-2 toxin and zearalenone in broiler chickens. Food and Chemical Toxicology 
51, 350-355. 
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ABSTRACT 
Mycotoxins lead to economic losses in animal production. A way to counteract 
mycotoxicosis is the use of detoxifiers. The European Food Safety Authority stated that the 
efficacy of detoxifiers should be investigated based on toxicokinetic studies. Little 
information is available on the absolute oral bioavailability and the toxicokinetic parameters 
of deoxynivalenol, T-2 and zearalenone in broilers. Toxins were administered intravenously 
and orally in a two-way cross-over design. For deoxynivalenol a bolus of 0.75 mg/kg BW was 
administered, for T-2 toxin 0.02 mg/kg BW and for zearalenone 0.3 mg/kg BW. Blood was 
collected at several time points. Plasma levels of the mycotoxins and their metabolite(s) 
were quantified using LC-MS/MS methods and toxicokinetic parameters were analyzed. 
Deoxynivalenol has a low absolute oral bioavailability (19.3%). For zearalenone and T-2 no 
plasma levels above the limit of quantification were observed after an oral bolus. Volumes of 
distribution were recorded, i.e. 4.99 L/kg, 0.14 L/kg and 22.26 L/kg for deoxynivalenol, T-2 
toxin and zearalenone, respectively. Total body clearance was 0.12 L/min.kg, 0.03 L/min.kg 
and 0.48 L/min.kg for deoxynivalenol, T-2 toxin and zearalenone, respectively. After IV 
administration, T-2 toxin had the shortest elimination half-life (3.9 min), followed by 
deoxynivalenol (27.9 min) and zearalenone (31.8 min). 
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INTRODUCTION 
Many fungi species are able to produce and secrete low-molecular-weight compounds, 
called mycotoxins. The occurrence of mycotoxin-producing moulds is a worldwide problem, 
but the nature and the quantity of produced mycotoxins depend on the interaction of 
several factors (Bhat et al., 2010). Moulds belonging to the Fusarium genus are commonly 
present in moderate climate zones (Edwards, 2011). These fungi are responsible for the 
production of trichothecenes, which are divided in four groups. Type A (e.g. T-2 toxin) and 
type B (e.g. deoxynivalenol) are the most important. Other mycotoxins like zearalenone are 
also produced by these Fusarium moulds (Devegowda and Murthy, 2005).  
Due to the threat for the animal health, the occurrence of these mycotoxins in animal feed 
can lead to important economic losses. Especially the poultry industry is confronted with this 
problem, as cereal grains form the major part of the animals diet (Anonymous, 2011). 
Deoxynivalenol (DON), known colloquially as “vomitoxin”, causes decreased weight gain, 
anorexia and emesis in animals (Pestka, 2007). T-2 toxin (T-2) mostly induces cutaneous 
lesions of the oral cavity and intestinal membrane in poultry (Weber et al., 2010). A decrease 
in egg production has also been reported after chronic exposure to T-2 (Diaz et al., 1994). On 
the other hand, zearalenone (ZEN) induces reproductive disorders (Devegowda and Murthy, 
2005). 
Recommended maximum levels in poultry feed were stated by the European Union for DON 
in complete feed (5 mg/kg). For ZEN, maximum levels were set for cereals and cereal 
products at 2 mg/kg and for maize by-products at 3 mg/kg. For T-2 toxin on the other hand, 
no maximum levels for the feed were pointed out until now (Anonymous, 2006, 2011). 
Although these maximum levels are a good starting-point, other actions have to be 
undertaken to reduce the risk for mycotoxicosis. The use of mycotoxin detoxifying agents is 
a common way to prevent the negative impacts of mycotoxins (Diaz et al., 2005; Döll et al., 
2004). These feed additives can be divided in two different classes, depending on their mode 
of action: adsorbing and biotransforming agents. The first group is able to bind the 
mycotoxin in the intestinal tract of the animal; the second group reduces the mycotoxin to 
(a) less toxic metabolite(s).  
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Evidently, the efficacy of these feed additives has to be proven. The European Food Safety 
Authority (EFSA) states that toxicokinetic studies have to be performed for the investigation 
of the bioavailability and the absorption/excretion of mycotoxins in combination with 
detoxifying agents. Trials have to be performed with respect to the recommended maximum 
levels for the toxins in animal feed. For each mycotoxin different end-points have been 
proposed to test the efficacy of mycotoxin detoxifying agents, except for the emerging toxin 
T-2. For DON and ZEN for example, the blood serum or plasma concentration levels of the 
main toxin and its metabolite(s) have to be determined (Anonymous, 2009). For DON, this is 
deepoxy-deoxynivalenol (DOM-1) as main metabolite, and for ZEN these are α-zearalenol (α-
ZEL) and β-zearalenol (β-ZEL). 
However, little or no information is available on the absolute oral bioavailability and the 
toxicokinetic parameters of mycotoxins in animals, especially for poultry. To the best of our 
knowledge there are only two reported studies: one on the excretion of 14C-labeled DON in 
white leghorns chickens after a single oral bolus (Prelusky et al., 1986) and another study 
about the excretion and tissue distribution of tritium-labeled T-2 toxin in chicks (Chi et al., 
1978). These studies only observed the presence of radio-labeled mycotoxins in function of 
the time, but no toxicokinetic parameters were calculated and thus no data are available 
concerning the absolute oral bioavailability of DON, T-2 and ZEN in broiler chickens. For this 
reason, toxicokinetic trials for DON, T-2 and ZEN were performed with broilers in a two-way 
cross-over design. The mycotoxins were administered by oral and intravenous bolus, in order 
to calculate the absolute oral bioavailability of the mycotoxins. The calculated toxicokinetic 
parameters can be used in further research to investigate the efficacy of mycotoxin 
detoxifying agents, e.g. to study their effect on the absorption and bioavailability of 
mycotoxins. Moreover, knowledge on the kinetic parameters of toxins is essential to 
understand their mode of action and to evaluate animal and human health risks.  In addition, 
we also quantified the plasma levels of the metabolites DOM-1, α-ZEL and β-ZEL as proposed 
by EFSA, after administration of the recommended maximum levels for mycotoxins in animal 
feed. 
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MATERIALS AND METHODS  
Animals  
Twenty-four 3-week-old broiler chickens (Ross 308, local commercial poultry farm) were 
housed according to the requirements of the European Union (Anonymous, 2007). The 
animals were kept in three groups, each consisting of 8 animals (4 ♂ and 4 ♀), in floor pens 
with wood shavings. The applied light cycle was the same as on the commercial farm (20 
hours light/ 4 hours dark). The experiments started after 1 week of acclimatization allowing 
the animals to adapt to the environment. During the whole experiment the animals were fed 
with blank feed ad libitum. This feed was commercially available broiler feed (Bromix Plus®) 
obtained from Versele-Laga (Deinze, Belgium). It was considered as blank feed after analysis 
for the presence of mycotoxins by a validated multi-mycotoxin liquid chromatography-
tandem mass spectrometry (LC-MS/MS) method (Fytolab, Zwijnaarde, Belgium). Following 
mycotoxins were analyzed in the feed with their respective limit of detection: aflatoxin B1 (1 
µg/kg), aflatoxin B2 (1 µg/kg), aflatoxin G1 (1 µg/kg), aflatoxin G2 (1 µg/kg), cytohalasin E (2 
µg/kg), DON (100 µg/kg), 3-acetyl-DON (100 µg/kg), fumonisin B1 (50 µg/kg), fumonisin B2 
(50 µg/kg), HT-2 (50 µg/kg), T-2 (20 µg/kg), nivalenol (100 µg/kg), ochratoxin A (0.5 µg/kg), 
ZEN (10 µg/kg), α-zearalenol (20 µg/kg), β-zearalenol (20 µg/kg). None of the mentioned 
toxins were detected above the limit of detection. The animal experiments were approved 
by the Ethical Committee of the Faculty of Veterinary Medicine, Ghent University (EC 
2010/176). After the experiment, the animals were humanely euthanized with an 
intravenous injection of T61® containing embutramide, mebenzonium iodide and tetracain 
hydrochloride (Intervet, Brussels, Belgium).  
Mycotoxins  
The mycotoxins DON, T-2 and ZEN used for the toxicokinetic studies were purchased in 
powder form from Fermentek LTD (Jerusalem, Israel). Mycotoxins were dissolved in ethanol 
pro analysis and afterwards diluted in water of HPLC quality (1/8 for DON; 1/20 for T-2; 1/2 
for ZEN, v/v) in order to obtain stock solutions (DON: 1 mg/ml, T-2: 50 µg/ml, ZEN: 0.5 
mg/ml), which were used for dosing the broiler chickens.  
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The administered dose of DON was based on the recommended maximum concentrations in 
poultry feed (5 mg/kg feed) (Anonymous, 2006). A dose of 2 mg/kg was applied for ZEN, 
according to the maximum level for cereals and cereal products with the exception of maize 
by-products (Anonymous, 2006). For T-2, the results of the analysis of 67 contaminated feed 
samples by Monbaliu et al. (2010) were taken into account. During this trial the highest 
reported level of T-2 was 112 µg/kg (Monbaliu et al., 2010). Based on these results, the dose 
for T-2 toxin was set at 0.1 mg/kg feed. In addition, the daily feed intake of broilers was 
taken into account (150 g/kg BW). Thus, the administered doses for DON, T-2 and ZEN were 
respectively, 0.75 mg/kg BW, 0.02 mg/kg BW and 0.3 mg/kg BW (Table 1). 
All standards used for the analytical experiments (DON, deepoxy-deoxynivalenol (DOM-1), T-
2 toxin (T-2), HT-2 toxin (HT-2), ZEN, α-zearalenol (α-ZEL), β-zearalenol (β-ZEL), α-zearalanol 
(α-ZAL), β-zearalanol (β-ZAL) and zearalanone (ZAN)) were obtained from Sigma-Aldrich 
(Bornem, Belgium) and stored at ≤ -15°C. The internal standards (IS) 13C15-DON, 13C24-T-2 
and 13C18-ZEN were purchased as 25 µg/ml solutions in acetonitrile (ACN) from Biopure 
(Tulln, Austria) and stored at ≤ -15°C. Stock solutions of 1 mg/ml were prepared for each 
compound in methanol, except for T-2 (0.5 mg/ml in methanol) and for DON (1 mg/ml in 
acetonitrile). The standard of DOM-1 was purchased as a solution of 50 µg/ml in acetonitrile. 
Per group of compounds (i.e. DON and DOM-1, T-2 and HT-2, ZEN and its metabolites), 
combined working solutions were prepared by diluting appropriate volumes of the stock 
solutions with ACN/water (50/50, v/v). These working solutions were used to prepare 
matrix-matched calibrators and quality control samples in plasma. For the internal 
standards, working solutions of 1 µg/ml in ACN/water (50/50, v/v) were prepared. 
 
Experimental protocol 
The twenty-four animals were divided into three groups of eight animals, one group for each 
mycotoxin. The animal experiments were performed in a two-way cross-over design and 
mycotoxins were administered intravenously (IV) or orally (PO). In brief, for each mycotoxin, 
four animals received an oral bolus and four animals received the mycotoxin intravenously. 
After a wash-out period was applied (Table 1), the animals that previously received an oral 
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bolus, received at that time an intravenous bolus and vice versa. For the intravenous 
injection in the wing vein a 25G needle (0.5 x 16 mm, Becton Dickinson, Temse, Belgium) was 
used. The mycotoxin was administered orally using a crop tube. Due to the high 
concentration of lipids in chicken plasma after feeding (Ferlazzo et al., 2011), the obtained 
plasma is more viscous resulting in lower workability. Therefore, feed was withdrawn from 6 
hours before, until 4 hours post-administration (p.a.) of the toxins. Following the toxin 
administration, blood samples were taken from the leg vein at different time points: at 0 
(just before administration) and at several time points post-administration depending on the 
administered mycotoxin (Table 1). Blood was collected in heparinized tubes. Samples were 
centrifuged at 2851 g and 4°C for 10 minutes and plasma was stored at ≤ -15°C until further 
analysis. 
 
Table 1. Design of the animal experiment. 
 
Mycotoxin     Dose 
 (mg/kg BW) 
Wash-out 
period (days) 
Time points of blood sampling  
Deoxynivalenol 0.75 2 0, 10, 20, 30, 40 and 50 min, 1, 1.5, 
2, 3, 4, 6 and 8h 
T-2 toxin 0.02 2 0, 2, 5, 10, 15, 20, 30, 40 and 50 
min, 1h 
Zearalenone  
 
 
0.30 7 0, 10, 20, 30, 40 and 50 min, 1, 1.5, 
2, 3, 4, 6, 8, 10, 12, 24, 30, 36, 48 
and 72h 
 
Plasma analysis 
Quantification of the plasma levels of DON and its major metabolite DOM-1 was performed 
using an in-house developed and validated LC-MS/MS method (De Baere et al., 2011), while 
little modifications were applied for the sample preparation. Briefly, 250 µl of plasma were 
spiked with 12.5 µl of the IS working solution (13C15-DON, 1 µg/ml), followed by the addition 
of 750 µl of acetonitrile. Afterwards, the samples were vortexed (15 sec) and centrifuged (10 
min, 7826 g, 4°C). The supernatant was evaporated using a gentle nitrogen stream (40 ± 
5°C). The dry residue was reconstituted in 200 µl of a 95/5 (v/v) mixture of mobile phase 
A/B. The mobile phase A consisted of 0.1 % glacial acetic acid (VWR, Leuven, Belgium) in 
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water of UPLC quality. Mobile phase B consisted of methanol of UPLC quality. After vortex 
mixing and filtering through a Millex® GV-PVDF filter (0.22 µm), the sample was transferred 
to an autosampler vial, and an aliquot (10 µl) was injected onto the LC-MS/MS instrument.  
The same sample preparation procedure was applied for the analysis of T-2 and its 
metabolite HT-2. 13C24-T-2 was used as the IS. After the evaporation of the supernatant, the 
dry residue was reconstituted in 200 µl of a 70/30 (v/v) mixture of mobile phase A/B with 
mobile phase A consisting of 5 mM ammonium acetate (VWR, Leuven, Belgium) in 
water/methanol/acetic acid (94/5/1, v/v/v) and mobile phase B of 5 mM ammonium acetate 
in methanol/water/acetic acid (97/2/1, v/v/v). A 10-µl aliquot was injected onto the LC-
MS/MS instrument (De Baere et al., 2011). 
The plasma concentrations of ZEN and its metabolites α-ZEL, β-ZEL, α-ZAL, β-ZAL and ZAN 
were determined using an in-house validated LC-MS/MS method. To 250 µl of plasma were 
added 12.5 µl of the IS working solution (13C18-ZEN, 1 µg/ml) and 750 µl of acetonitrile, as for 
DON and T-2 analysis. The dry residue was then reconstituted in 200 µl of a mixture of 
water/methanol (85/15, v/v). After vortex mixing, the sample was passed through a Millex® 
GV-PVDF filter and transferred to an autosampler vial. An aliquot (10 µl) was injected onto 
the LC-MS/MS instrument.  
The LC-MS/MS instrument consisted of a Surveyor® type MS pump Plus and Autosampler 
Plus HPLC in combination with a TSQ® Quantum UltraTM mass spectrometer (Thermo Fisher 
Scientific, Breda, The Netherlands). Chromatographic separation of the analytes of interest 
was achieved on a Hypersil Gold column (50 mm x 2.1 mm i.d., dp: 1.9 μm) using 0.01 % 
acetic acid in water (A) and acetonitrile (B) as mobile phase. A gradient elution was 
performed at a flow rate of 300 μl/min and a column temperature of 45°C. The mass 
spectrometer was operated in the selected reaction monitoring (SRM) mode and for each 
compound the two most intense precursor ion > product ion transitions were selected for 
quantification and qualification, respectively. The following transitions were used: DON: m/z 
355.1 > 265.2 and 355.1 > 295.1, DOM-1: m/z 339.0 > 249.0 and 339.0 > 59.1 and 13C15-DON: 
m/z 370.1 > 279.2 and 370.1 > 310.1; T-2: m/z 484.1 > 215.1 and 484.1 > 185.1, HT-2: m/z  
442.0 > 263.1 and 442.0 > 215.1 and 13C24-T-2: m/z 508.2 > 229.1 and 508.2 > 198.1; ZEN: 
m/z 317.3 > 131.0 and 317.3 > 175.0, α-ZEL: m/z 319.2 > 275.1 and 319.2 > 301.1,  β-ZEL: 
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m/z 319.2 > 301.1 and 319.2 > 275.1, ZAN: m/z 319.2 > 205.0 and 319.2 > 275.1, α-ZAL: 
321.2 > 277.1 and 321.2 > 303.1, β-ZAL: m/z 321.2 > 277.1 and 321.2 > 303.1 and for 13C18-
ZEN: 335.3 > 185.1 and 335.3 > 169.1.  
The limit of quantification (LOQ) of DON, DOM-1, T-2 and HT-2  ranged from 1 to 2.5 ng/ml 
(De Baere et al., 2011), while for ZEN and its metabolites LOQ values between 1 to 5 ng/ml 
were obtained. All values below the LOQ were not included in the plasma concentration-
time curves and the toxicokinetic analysis. Limits of detection (LOD) ranged from 0.01 to 
0.63 ng/ml for DON, T-2 and their metabolites (De Baere et al., 2011) and for ZEN and its 
metabolites from 0.005 to 0.07 ng/ml.  
Toxicokinetic analysis 
The toxicokinetic parameters were analyzed using the software program WinNonlin, Version 
6.2.0 (Phoenix, Pharsight corp., USA). A non-compartmental model was used to determine 
the area under the plasma concentration-time curve (AUC0→∞), elimination rate constant 
(kel), half-life of elimination (t1/2el), volume of distribution (Vd), clearance (Cl), maximum 
plasma concentration (Cmax) and time to maximum plasma concentration (Tmax). The 
absolute oral bioavailability (F) was calculated from the following equation: 
 x 100.  
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RESULTS 
Toxicokinetic study of deoxynivalenol 
The plasma concentration-time profiles of DON, after a single oral or intravenous bolus, are 
shown in Figure 1. No plasma concentrations of the main metabolite of DON, DOM-1, could 
be detected above the LOQ.  Moreover, from 2 hours p.a. no levels above LOQ could be 
detected for DON. Main toxicokinetic parameters of DON are summarized in Table 2.  The 
AUC after IV administration was much higher than after oral administration, which correlates 
with a low absolute oral bioavailability (F). F was determined to be 19.3 ± 7.42%.  
 
Figure 1. Plasma concentration-time profile of DON after a single oral or intravenous 
administration of DON (0.75 mg/kg BW) to eight broiler chickens. Results are presented as 
mean values + SD. 
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Toxicokinetic study of T-2 toxin 
After a single oral bolus of T-2, no plasma levels above the LOQ could be observed for T-2 
and its metabolite HT-2. The plots of the plasma concentration-time curve after an 
intravenous bolus of T-2 are depicted in Figure 2. Plasma concentrations of T-2 were only 
detected until 20 min and of the main metabolite HT-2 only 2 min post intravenous 
administration with a mean concentration of 3.9 ± 0.06 ng/ml. Five minutes post-
administration only half of the animals showed plasma levels of HT-2 above the LOQ (LOQ = 
2.5 ng/ml). Mean plasma concentrations of these four animals were 1.3 ± 0.28 ng/ml. 
Thereafter, no plasma concentrations of HT-2 above the limit of quantification could be 
observed (data not shown). Toxicokinetic parameters of T-2 are shown in Table 2.  
 
Figure 2. Plasma concentration-time profile of T-2 after a single intravenous administration 
of T-2 (0.02 mg/kg BW) to eight broiler chickens. Results are presented as mean values + SD. 
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Toxicokinetic study of zearalenone 
After a single oral bolus of zearalenone (0.3 mg/kg BW) no plasma concentrations above the 
LOQ could be detected for ZEN and its metabolites. The plasma concentration-time profile 
after a single bolus of ZEN given intravenously is shown in Figure 3. No plasma levels of the 
metabolites could be detected (<LOD), except for α-ZEL. However, the detected 
concentrations of α-ZEL were below the limit of quantification of 5 ng/ml. 
 
Figure 3. Plasma concentration-time profile of ZEN after a single intravenous administration 
of ZEN (0.3 mg/kg BW) to eight broiler chickens. Results are presented as mean values + SD.        
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Table 2. Main toxicokinetic parameters of DON, T-2 and ZEN after oral or intravenous 
administration of the toxin in broiler chickens (n=8). Results are presented as mean values ± 
SD. 
 
Toxicokinetic parameters DON (PO) DON (IV) T-2 (IV) ZEN (IV) 
AUC0-inf (ng.min/ml) 1281 ± 481.7 6198 ± 983.4 889 ± 363.2 626 ± 60.0 
Cmax (ng/ml) 26.1 ± 14.64 167.9 ± 56.76 185.4 ± 79.79 32.1 ± 9.91 
Tmax (min) 35.0 ± 8.37 - - - 
Cl/F (PO) or Cl (IV) (L/min.kg) 0.65 ± 0.217 0.12 ± 0.024 0.03 ± 0.008 0.48 ± 0.050 
Vd/F (PO) or Vd (IV) (L/kg) 35.72 ± 15.563 4.99 ± 1.168 0.14 ± 0.045 22.26 ± 15.148 
kel (1/min) 0.02 ± 0.008 0.03 ± 0.006 0.19 ± 0.061 0.03 ± 0.021 
T 1/2el (min) 38.2 ± 11.19 27.9 ± 6.89 3.9 ± 0.98 31.8 ± 20.60 
F (%) 19.3 ± 7.42 - - - 
(AUC, area under the curve; Cmax, maximum plasma concentration; Tmax, time to maximum plasma 
concentration; Cl, clearance; F, bioavailability; Vd, volume of distribution; kel, elimination rate constant; T1/2el, 
half-life of elimination) 
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DISCUSSION 
Recently, new bolus models have been developed at our department for the in vivo efficacy 
testing of mycotoxin detoxifying agents (Devreese et al., 2012).  The bolus models have been 
applied for the mycotoxin DON in broilers, but not for other mycotoxins such as T-2 toxin 
and ZEN. Little or no information is available to this day about the absolute oral 
bioavailability and toxicokinetic parameters of DON, T-2 and ZEN in broilers. This information 
could also be helpful for the evaluation of the health risk caused by the different toxins in 
chickens compared to other animal species.  
To the best of our knowledge, only Prelusky et al. (1986) reported plasma levels of DON in 
chickens 2-2.5 hours after administration of a single oral bolus of 14C-labeled DON to White 
Leghorns hens. Tissue distribution and excretion of tritium-labeled T-2 toxin in chicks was 
reported earlier (Chi et al., 1978). However, these studies did not analyze the parent toxins 
and their possible metabolites separately, but only the disappearance of the radioactivity in 
plasma.  
Toxicokinetic studies were already performed for several mycotoxins in other animal species 
(Goyarts and Dänicke, 2006; Shin et al., 2009). Extrapolation of these results to chickens is 
however not possible, as poultry possess different physiology and biotransformation of 
xenobiotics, and chickens revealed to be less sensitive to the risk of mycotoxicosis compared 
to other animal species (Devegowda and Murthy, 2005).  For these reasons three separate 
toxicokinetic studies were performed for the mycotoxins DON, T-2 and ZEN in broiler 
chickens. Plasma concentrations of the toxins and their main metabolites were analyzed 
using validated LC-MS/MS methods. Mass spectrometry has the important advantage to be 
sensitive and to present an unambiguous identification of specific compounds.  All the 
mycotoxins were administered as a standard solution, thus interaction with other 
mycotoxins was avoided. Moreover, animals received blank feed during one week before the 
start of the study which excludes the presence of baseline levels of the toxins before the 
start of the experiments. 
The toxicokinetic study of DON revealed a low absolute oral bioavailability of 19.3 ± 7.42%. 
Prelusky et al. (1986) already reported a rapid transport of DON-derived radioactivity 
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through the alimentary tract of chickens, contributing to the poor absorption of the toxin.  In 
sheep even a lower F has been reported (7.5%) (Prelusky et al., 1985), but in pigs the 
bioavailability is higher after a single oral bolus (54%) and even much higher (89%) after 
chronic exposure to DON (Goyarts and Dänicke, 2006). These results are in accordance with 
the rank order of susceptibility to the harmful effects of DON; i.e. pigs > poultry and 
ruminants. In the present study, no clinical signs of intoxication were observed following 
administration of DON in broilers. A high plasma clearance (0.12 ± 0.024 L/min.kg) might 
also explain the relative tolerance of poultry to DON. In pigs, after a single intravenous 
administration of DON, the observed clearance was 0.00381 L/min.kg, which is indeed 
significantly lower compared to chickens (Goyarts and Dänicke, 2006).  DOM-1 is known to 
be produced via intestinal microbial activity rather than by the liver or other organs.  
However, no plasma levels of DOM-1 above the LOQ could be detected in this study, maybe 
due to a low absorption. The conjugated forms of DON and its metabolites were not 
analyzed, as the main goal of this study was to evaluate the absolute oral bioavailability of 
the parent toxin. Moreover, the analysis of DON alone without DON-glucuronide was 
reported to be a suitable biomarker for DON exposure and toxicity (Wu et al., 2007).  
The results of the toxicokinetic study of T-2 revealed that no plasma levels of T-2 and HT-2 
could be detected after a single oral bolus of the mycotoxin. Retention of radioactivity in 
liver and bile after oral administration of tritium-labeled T-2 in chickens, indicate elimination 
of the absorbed toxin and its metabolites in the intestinal tract through the biliary excretion 
system (Chi et al., 1978). However, after one intravenous bolus of the toxin, plasma levels 
could be observed for T-2 and its main metabolite HT-2.  Twenty minutes after the single 
bolus IV administration, no plasma levels could be observed for T-2 anymore, which can be 
explained by the limited volume of distribution (0.14 ± 0.045 L/kg) and the rather high 
clearance of this toxin (0.03 ± 0.008 L/min.kg). This results in a rapid elimination half-life (3.9 
± 0.98 min). On the other hand, T-2 toxin is known to be rapidly metabolized to different 
metabolites, which are more polar (Yoshizawa et al., 1980). This is in accordance with our 
results: HT-2 was detected already 2 minutes after administration of T-2. No other 
toxicokinetic studies with T-2 in broilers are available to compare our results with.   
Concentrations of the glucuronide-forms of T-2 and HT-2 were not investigated during our 
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study, as glucuronidation of these compounds was only reported in rats and pigs until now 
(Wu et al., 2009). 
The toxicokinetic parameters of ZEN have already been studied in different animal species, 
especially in pigs due to the high sensitivity to ZEN of this animal species (Malekinejad et al., 
2006).  In the present study, no adverse effects were observed following the administration 
of ZEN or its solvent (ethanol) in broilers. During our study, no plasma levels could be 
observed for ZEN and its metabolites after one oral bolus of 0.3 mg/kg BW in broilers. ZEN is 
known to be rapidly absorbed after oral administration.  However, the degree of absorption 
is difficult to determine in animals due to its extensive biliary excretion (Zinedine et al., 
2007). After administration of a single bolus of 5.8 µg ZEN/kg BW in naturally contaminated 
wheat to broilers, ZEN and α-ZEL could be detected, but only in 6 of the 32 plasma samples 
and values were around the detection limits (10 ng/ml for ZEN and 5 ng/ml for α-ZEL) 
(Dänicke et al., 2001). A likely explanation could be the low oral bioavailability of ZEN, as 
reported in rats where F equals 2.7 % after oral administration of ZEN at a dose of 8 mg/kg 
BW (Shin et al., 2009). In our study, the maximum recommended level of 2 mg/kg for ZEN in 
cereals and cereal products was respected (Anonymous, 2006). Although this concentration 
was probably too low to obtain plasma concentrations after a single oral bolus,it has to be 
noticed that no levels above 1.8 mg/kg feed were reported for ZEN in Europe in cereal grains 
and animal feeds (Gromadzka et al., 2008). Moreover, in the study of Monbaliu et al. (2010), 
where European feed samples were analyzed with LC-MS/MS, the minimum and maximum 
level ranged between 0.058 and 0.387 mg/kg of ZEN.  
However, after one intravenous bolus of ZEN, plasma levels were observed for ZEN and α-
ZEL. In broilers and pigs, α-ZEL has been reported to be the main metabolite of ZEN (Dänicke 
et al., 2005; Dänicke et al., 2001).  These findings are in contrast with the results of an in 
vitro study performed to investigate the hepatic transformation of ZEN. In both the hepatic 
microsomes and the post-mitochondrial fraction ZEN was mainly transformed to β-ZEL in 
chickens (Malekinejad et al., 2006). In turkeys α-ZEL was also reported to be the only 
detectable metabolite of ZEN after 2-weeks of feeding of 800 mg ZEN/kg diet (Olsen et al., 
1986). However, in ruminants β-ZEL is known to be the major metabolite of ZEN (Dong et al., 
2010), which can be a possible determinant of the species differences in susceptibility for 
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ZEN (Malekinejad et al., 2006). Compared to other animals, chickens revealed to have a 
lower glucuronidation capacity for ZEN (Malekinejad et al., 2006), for this reason 
glucuronide-forms of ZEN and its metabolites were not analyzed.  
Compared to other animals, such as pigs (Cl= 0.048 L/min.kg; Vd= 10.48 L/kg) and goats (Cl= 
0.003 L/min.kg; Vd= 7.32 L/kg), broilers seem to have the highest clearance (0.48 ± 0.050 
L/min.kg) and also a high volume of distribution (22.26 ± 15.148 L/kg) for ZEN (Dong et al., 
2010; Dänicke et al., 2005). These results confirm the statement that the susceptibility to the 
estrogenic effects of ZEN cannot be explained by circulating ZEN and its metabolites (Dong et 
al., 2010).  
From our findings, we can conclude that oral bolus models respecting the maximum 
recommended levels in feed to test the efficacy of mycotoxin detoxifying agents in vivo 
cannot be applied for the mycotoxins T-2 and ZEN, due to their low absolute oral 
bioavailability in broilers. Administration of higher doses can offer a possibility, but can lead 
to higher risks for acute mycotoxicosis. On the other hand, it is also clear that plasma or 
blood concentrations of the tested parent toxins and their main reported metabolites as 
stated by the EFSA cannot be used as biomarkers to test the efficacy of mycotoxin 
detoxifiers in broilers, when maximum recommended levels in feed are respected.  
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Chapter 2. 
 
Evaluation of different biomarkers to assess deoxynivalenol exposure and 
efficacy and safety testing of mycotoxin detoxifiers 
 
 
 
 
 
 
 
 
 
 
Adapted from: Osselaere, A., Devreese, M., Watteyn, A., Vandenbroucke, V., Goossens, J., 
Hautekiet, V., Eeckhout, M., De Saeger, S., De Baere, S., De Backer, P., Croubels, S. (2012). 
Efficacy and safety testing of mycotoxin-detoxifying agents in broilers following the 
European Food Safety Authority guidelines. Poultry Science 91, 2046-2054. 
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ABSTRACT 
Contamination of feeds with mycotoxins is a worldwide problem and mycotoxin detoxifying 
agents are used to decrease their negative impact. The European Food Safety Authority 
(EFSA) recently stated guidelines and end-points for the efficacy testing of detoxifiers. Our 
study revealed that plasma concentrations of deoxynivalenol and deepoxy-deoxynivalenol 
were too low to assess efficacy of two commercially available mycotoxin detoxifying agents 
against deoxynivalenol after 3 weeks continuous feeding this mycotoxin at concentrations of 
2.44±0.70 mg/kg feed and 7.54±2.20 mg/kg feed in broilers. This correlates with the poor 
absorption of deoxynivalenol in poultry. A safety study with two commercially available 
detoxifying agents and veterinary drugs showed innovative results with regard to the 
pharmacokinetics of two antibiotics after oral dosing in the drinking water. The plasma and 
kidney tissue concentrations of oxytetracycline were significantly higher in broilers receiving 
a biotransforming agent in the feed compared to control birds. For amoxicillin the plasma 
concentrations were significantly higher for broilers receiving an adsorbing agent in 
comparison to birds receiving the biotransforming agent, but not to the control group. 
Mycotoxin detoxifying agents can thus interact with the oral bioavailability of antibiotics 
depending on the antibiotic and detoxifying agent, with possible implications for practical 
use of these agents. 
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INTRODUCTION 
Food safety is an important issue receiving a lot of scientific attention worldwide. The 
presence of mycotoxins, produced as secondary metabolites of toxigenic moulds, in food 
and feed is one of the most important concerns. Also climate changes, characterized by an 
increase of temperature and relative humidity have a great impact on plants and their 
pathogens (Ingram, 1999; Miraglia et al., 2009). Both parameters, in combination with the 
rising level of CO2 in the atmosphere have an influence on the mycotoxin production. The 
changed production of mycotoxins is correlated mainly to the predominance of Fusarium 
graminearum, a fungus responsible for the production of zearalenone and of mycotoxins 
belonging to the class of trichothecenes (Paterson and Lima, 2010).  
Consequences of climate changes for the food system comprise all the stages from ‘farm to 
fork’ and thus not only the pre-harvest conditions, but also other parameters are important 
such as quality and temperature of the grain storage facilities. Poor management can lead to 
microbial activity and loss of quality, for this reason Good Agricultural Practice (GAP) is 
essential to minimize mycotoxin development (Magan and Aldred, 2007). Mycotoxins are 
very resistant to all kinds of production steps, even brewing, malting and extrusion-
processes are not a threat for these contaminants (Scudamore et al., 2008).  
Mycotoxins exert several direct adverse effects on human and animal health, while the 
excretion of some mycotoxins in animal products such as milk can also contribute to the 
consumers’ exposure (Fink-Gremmels, 2008). Apart from the health problem, mycotoxins 
can cause important economic losses. Their toxic properties depend on the particular 
mycotoxin and its dose. Deoxynivalenol (DON) for example, which is one of the most 
prevalent mycotoxins (Monbaliu et al., 2010), causes vomiting and diarrhea when ingested in 
high doses, especially in pigs.  In lower concentrations it induces weight loss and feed refusal 
(Miller et al., 2001). Poultry on the other hand are very resistant to DON, for example 
concentrations above 5 mg per kg diet are necessary to cause detrimental effects (Awad et 
al., 2006).  
One of the most recent methods to counteract mycotoxicosis in animals is the use of 
mycotoxin detoxifying agents in feed. These detoxifiers are added to animal feed and act in  
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the digestive tract of the animal. The additives can consist of different components and 
depending on their mode of action they are ‘adsorbing’ or ‘biotransforming’ agents. The first 
class is able to bind mycotoxins and to reduce their gastro-intestinal absorption, the second 
one degrades mycotoxins to less or non-toxic metabolite(s) (Anonymous, 2010).  Research 
has already been performed on the efficacy of these feed additives using both in vitro and in 
vivo assays (Avantaggiato et al., 2004; Avantaggiato et al., 2005; Galvano et al., 2001). 
Testing under laboratory circumstances is difficult since the intestinal conditions are almost 
impossible to reproduce. Adsorption isotherms and different models like intestinal cell lines 
and Ussing chambers using intestinal tissues, can be used to study these detoxifiers in vitro 
(Clarke, 2009; Lemke et al., 1998). Although in vitro trials are a rapid screening method to 
choose which agents can be further tested in vivo, animal trials remain essential.  
The set up of in vivo trials is an important point of discussion. The European Food Safety 
Authority (EFSA) has recently published a scientific opinion about the efficacy and safety 
testing of mycotoxin detoxifying agents and focusing on the experimental design of in vivo 
studies (Anonymous, 2010). The EFSA has also pointed out several relevant end-points for 
the different mycotoxins. For DON the analysis of this mycotoxin and its metabolite 
deepoxy-deoxynivalenol (DOM-1) in blood has been indicated as the most relevant end-
point. On the other hand EFSA also pays importance to the safety testing of mycotoxin 
detoxifying agents. Possible interactions with respect to nutrients and/or veterinary drugs 
absorption should also be investigated (Anonymous, 2010). 
The first aim of this present study was to test whether the guidelines published by EFSA can 
be applied for the in vivo efficacy testing of two commercially available mycotoxin 
detoxifying agents with respect to DON in broilers.  We performed an in vivo trial with 
broilers according to these guidelines and tested the most relevant endpoints for the 
mycotoxin DON as stated by EFSA. A second aim of this study was to test if the two selected 
mycotoxin detoxifying agents can have an influence on the pharmacokinetics and tissue 
residues of commonly used antibiotics in poultry medicine. 
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MATERIALS AND METHODS 
Materials 
DON, used for artificial contamination of the feed, was produced with a reference strain 
obtained from the MUCL (Mycothèque de l’Université Catholique de Louvain, Belgium). Both 
antibiotics, oxytetracycline (Oxytetracycline 80%®) and amoxicillin (Amoxicilline 70%®), were 
obtained from Kela Veterinaria (Sint-Niklaas, Belgium). Blood was collected in heparinized 
tubes (Venoject®) obtained from Terumo Corp. (Tokyo, Japan). Standards used for analytical 
experiments (DON and DOM-1) were obtained from Sigma-Aldrich (Bornem, Belgium) and 
stored at ≤-15°C. The internal standard 13C15-DON was purchased as a 25 µg/ml solution in 
acetonitrile from Biopure (Tulln, Austria).  Water, methanol and acetonitrile were of HPLC 
grade, while ammonium acetate, ethyl acetate and glacial acetic acid were of analytical 
grade. All these reagents were obtained from VWR (Leuven, Belgium). Oasis® HLB solid-
phase extraction (SPE) columns (60mg/3cc) were obtained from Waters (Zellik, Belgium). 
Millex®-GV PVDF filter units (0.22 µm) were obtained from Millipore (Brussels, Belgium). 
 
Experimental design for Animals and Diets 
Efficacy testing. Sixty-four one-day-old Ross broiler chicks, in an equal number of both sexes, 
were obtained from a commercial hatchery. During an acclimatization period of ten days, 
the animals were fed blank feed. Males and females were housed separately. Afterwards the 
chickens were randomly assigned to 1 of 8 dietary groups, each consisting of 8 animals (4♀ 
and 4♂). The animals were housed in 8 cages with a floor area of at least 1m2. The concrete 
floor was covered with wood shavings. During the 3 weeks of experimental feeding the 
animals received different diets as illustrated in Table 1. The concentrations of the different 
mycotoxins as shown in Table 1 were determined by a multi-mycotoxin LC-MS/MS method 
(Monbaliu et al., 2010). The feed of group 3, 4 and 5 was the same feed as group 1 (blank 
feed) but it was artificially contaminated with DON in the laboratory. DON was produced 
with the reference strain MUCL 6131. This strain was grown in liquid GCY medium (glucose 
10 g/L, yeast extract 1 g/L, peptone 1 g/L) together with 50 µM hydrogen peroxide (H2O2) 
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which induces an oxidative stress in the fungus that stimulates the production of DON 
(Audenaert et al., 2010). After 14 days of cultivation, with supplementation of H2O2 every 2 
days, the culture was filtered and freeze-dried and mixed into the blank feed to have a final 
DON concentration of 2.44±0.70 mg/kg feed, thus below the maximum level of 5 mg/kg as 
recommended by the EFSA (Anonymous, 2006). For the last three groups (6, 7 and 8) a 
naturally contaminated feed was prepared out of contaminated maize. The concentration of 
DON in this feed (7.54±2.20 mg/kg feed) was higher than the recommended maximum level 
(Anonymous, 2006).  
Two different kinds of commercially available mycotoxin detoxifying agents were 
supplemented to the diets. The adsorbing agent was a smectite type clay mineral (illite-
ambrosite). The biotransforming agent, as classified by the EFSA (2010), was a bentonite-
montmorillonite upgraded with a yeast. The yeast is claimed to be able to detoxify DON in 
vitro by opening the C-12,13 epoxide ring. Group 2 received blank feed supplemented with 
the adsorbing agent to test possible effects of the detoxifier. Water and feed were given ad 
libitum to all broilers. A light regime of 20 hours light and 4 hours darkness was applied. The 
experimental procedures conducted with the chickens were in accordance with the 
European guidelines for the care and use of animals for research purposes. The protocol was 
approved by the Ethical Committee of the Faculty of Veterinary Medicine (Ghent University) 
(EC 2010/064 and EC 2010/076). 
Safety testing. Forty-eight one-day-old Ross broiler chicks, in an equal number of both sexes, 
were obtained from a commercial strain. During an acclimatization period of 7 days, the 
animals were fed blank feed. Males and females were housed separately. Afterwards the 
chickens were randomly assigned to 1 of 6 dietary groups, each consisting of 8 animals (4♀ 
and 4♂) and received experimental diets for 3 weeks. The animals were housed in 6 cages 
with a floor area of at least 1m2 covered with wood shavings. The composition of the dietary 
groups is shown in Table 2 and 3. The blank feed did not contain any mycotoxin above the 
limit of detection of a multi-mycotoxin LC-MS/MS method analyzing 23 mycotoxins 
(Monbaliu et al., 2010). This uncontaminated feed was useful for this study as an interaction 
with natural occurring mycotoxins had to be avoided. Both mycotoxin detoxifying agents, 
the same as used during the efficacy study, were added in a dosage of 1.5 kg/tonne feed. 
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Water and feed were given ad libitum to the broilers. A light regime of 20 hours light and 4 
hours darkness was applied. From day 28 onwards, two different antibiotics, frequently used 
in poultry industry against bacterial diseases, were administered. Oxytetracycline is a broad-
spectrum antibiotic that interacts with the ability of bacteria to produce proteins. On the 
other hand amoxicillin, a moderate-spectrum antibiotic with a bacteriolytic function, was 
tested. The antibiotics were administered to the animals as stated in Table 2 for 
oxytracycline and in Table 3 for amoxicillin. For the oral bolus study on day 28, the 
antibiotics were dissolved in tap water and administered directly in the crop with a tube, in 
order to conduct a pharmacokinetic study. Therefore blood was collected from the leg vein 
in heparinized tubes   at following time points: 0’ (before administration) and 20’, 40’, 60’, 
90’, 2h, 2.5h, 3h, 5h, 8h, 12h p.a. for oxytetracycline and 0’ (before administration), 5’, 10’, 
20’, 30’, 40’, 50’, 1h, 1h15’, 1h30’, 1h45’, 2h p.a. for amoxicillin. The blood samples were 
immediately centrifuged at 3000 rpm for 10 minutes at 4°C and plasma was stored at -70°C 
until analysis. Next, the antibiotics were added to the drinking water during 5 days for 
amoxicillin and 7 days for oxytetracycline, as stated by the leaflet. To be sure that every 
animal received the required dose, an extra oral bolus at half the dosage was administered 
every morning. On day 35 of the experiment with oxytetracycline, the animals were 
euthanized 16 hours after withdrawal of the antibiotic by cervical dislocation and liver and 
kidneys were collected. For amoxicillin, the animals were euthanized on day 33, 12 hours 
after the last antibiotic administration and the same organs as described for oxytetracycline 
were collected. The concentration of both antibiotics in plasma and tissues was determined 
by validated LC-MS/MS methods (based on Reyns et al., 2006; Reyns et al., 2008 for 
amoxicillin, based on Cherlet et al., 2003; Cherlet et al., 2006 for oxytetracycline). Plasma 
pharmacokinetic parameters such as area under the plasma concentration-time curve (AUC0-
>∞ and AUC0->t), maximum plasma concentration (Cmax), time to reach maximum plasma 
concentration (Tmax) and elimination half-life (T1/2el) were calculated using WinNonlin 6.2.0® 
(Pharsight Corporation, Mountain View, Ca, USA). The protocol was approved by the Ethical 
Committee of the Faculty of Veterinary Medicine (Ghent University) (EC 2010/063 and EC 
2011/002).
  
Table 1. Composition of 8 dietary groups for the efficacy testing1. 
 
 
              
 
 
 
 
1 Mycotoxin levels (mg/kg feed) in the diets fed to the broilers for three weeks after the acclimatization period. 
2 Group 3 to 5 received artificially DON-contaminated feed. Group 6 to 8 received naturally contaminated feed 
3 DON=deoxynivalenol (LOD = 11.09 μg/kg) , NIV= nivalenol (LOD = 66.26 μg/kg), 3-aDON= 3-acetyldeoxynivalenol (LOD = 8.96 μg/kg), 15-aDON= 15-acetyldeoxynivalenol (LOD = 5.62 μg/kg), FB1= fumonisin 
B1 (LOD = 58.24 μg/kg), FB2= fumonisin B2 (LOD = 44.57 μg/kg), FB3= fumonisin B3 (LOD = 42.40 μg/kg) 
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
 
Group2 DON3 NIV3  3-aDON3 15-aDON3 FB13 FB23 FB33 Detoxifying agent  
1 <LOD <LOD <LOD <LOD <LOD <LOD <LOD No 
2 <LOD <LOD <LOD <LOD <LOD <LOD <LOD adsorbing (1.5 kg/tonne) 
3 2.439±0.70 0.086±0.030 0.571±0.22 2.051±0.80 <LOD <LOD <LOD No 
4 2.439±0.70 0.086±0.030 0.571±0.22 2.051±0.80 <LOD <LOD <LOD adsorbing (1.5 kg/tonne) 
5 2.439±0.70 0.086±0.030 0.571±0.22 2.051±0.80 <LOD <LOD <LOD biotransforming (1.5 kg/tonne) 
6 7.540±2.20 <LOD 1.481±0.57 <LOD 0.700±0.08 0.201±0.02 0.207±0.08 No 
7 7.540±2.20 <LOD 1.481±0.57 <LOD 0.700±0.08 0.201±0.02 0.207±0.08 adsorbing (1.5 kg/tonne) 
8 7.540±2.20 <LOD 1.481±0.57 <LOD 0.700±0.08 0.201±0.02 0.207±0.08 biotransforming (1.5 kg/tonne) 
  
Table 2. Timetable of the critical events of the bird experiment with oxytetracycline. 
 
 
Time d 8 – d 35  d 28                                     d 29-d 33 d 34 d 35 
8 a.m. 
Administration of the feed 
to 3 different dietary 
groups: 
- Blank feed (n=8) 
- Blank feed supplemented 
with an adsorbing agent 
(n=8) 
- Blank feed supplemented 
with a biotransforming 
agent (n=8) 
Oral bolus (100 mg/kg 
BW) followed by a 
kinetic study during 24 
h 
Oral bolus (50 mg/kg BW) 
Oxytetracycline in water 
(100 mg/kg BW) 
Oral bolus (50 mg/kg 
BW) 
Refreshing of the 
medicated water (100 
mg/kg BW) 
Euthanasia 16 hours 
after withdrawal of 
medicated water 
8 p.m. 
 
 
Refreshing of the medicated 
water (100 mg/kg BW) 
Unmedicated water 
 
BW= body weight; d= day
  
Table 3.  Timetable of the critical events of the bird experiment with amoxicillin. 
 
 
Time d 8-d 33 d 28 d 29-d 31 d 32 d 33 
8 a.m. Administration of the 
feed to 3 different 
dietary groups: 
-Blank feed (n=8) 
-Blank feed 
supplemented with an 
adsorbing agent (n=8) 
-Blank feed 
supplemented with a 
biotransforming agent 
(n=8) 
Oral bolus                                
(20 mg/kg BW) 
followed by a kinetic 
study during 2 hours 
Oral bolus                                
(10 mg/kg BW) 
Refreshing of the 
medicated water (20 
mg/kg BW) 
Oral bolus                               
(10 mg/kg BW) 
Refreshing of the 
medicated water (20 
mg/kg BW) 
Euthanasia 12 hours 
after withdrawal of 
medicated water 
8 p.m.  Amoxicillin in water                  
(20 mg/kg BW) 
Refreshing of the 
medicated water (20 
mg/kg BW) 
Unmedicated water  
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Experimental Parameters measured during the Efficacy Testing Study 
Body weight (BW), Feed Consumption and Live Weight Gain. The chickens were weighed 
individually three times a week and feed consumption for each group was measured daily 
during the whole experiment. Live weight gain was calculated according to the formula: (BW 
d32-BW d11)/n, with n equal to the number of days of feeding the experimental diet.  
Analysis of Mycotoxins in Plasma, Bile and Tissues. After the first week (day 18) of feeding 
the experimental diets, blood was taken from the leg vein in heparinized tubes. For animal 
welfare, it was not appropriate to take enough blood of all the birds to perform the LC-
MS/MS analysis for DON and DOM-1 for this particular time point, so the blood of 2 times 4 
birds was pooled to analyze plasma concentrations of DON and DOM-1 for each group. The 
second week (day 25) blood was taken from the leg vein of all the birds, and plasma was 
separated after centrifugation at 2,095 x g at 4°C for 10 minutes. The birds were euthanized 
after the third week (day 32). Blood, liver and kidneys were collected.  The bile fluid was 
collected from each bird and pooled per group. All samples were frozen at ≤ -20°C until 
assayed. Prior to analysis, the tissue samples were minced and homogenized using a 
Moulinette mixer (Moulinex, Paris, France). The concentration of DON and deepoxy-
deoxynivalenol (DOM-1) was determined in plasma and bile by a validated LC-MS/MS 
method (De Baere et al., 2011).  
For the quantitative determination of DON and DOM-1 in liver and kidney samples the 
method of De Baere et al. (2011) was used with minor modifications:  112.5 µL of the 
internal standard working solution (13C15-DON, 1 µg/mL) was added to 2.0 g of tissue 
sample. After vortex mixing, the sample was left at room temperature for 5 min. Thereafter, 
5 mL of a water/acetonitrile mixture (10/90, v/v) was added, followed by a vortex mixing 
step (15 sec). The sample was extracted on a homemade rotary apparatus for 20 min, 
followed by a centrifugation step (10 min, 2,095 x g). The supernatant was transferred to 
another extraction tube and 8 mL of a solution of 7 % acetic acid in ethyl acetate was added. 
After vortex mixing, the sample was extracted for 20 min, followed by a 10-min 
centrifugation step (2,095 x g). The organic phase was transferred to another extraction tube 
and evaporated using a gentle stream of N2 ( ~ 45°C). The dry residue was reconstituted in 1 
mL of a water/methanol (90/10, v/v) solution and vortex mixed for 15 sec. The sample was 
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further purified using an Oasis® HLB column (same procedure as for plasma and bile 
analysis). The dry residue was reconstituted in 150 µL of a 70/30 (v/v) mixture of mobile 
phase A/B (A: 5 mM ammonium acetate in water/methanol/acetic acid (94/5/1, v/v/v); B: 
5mM ammonium acetate in methanol/water/acetic acid (97/2/1, v/v/v)) and filtered 
through a Millex®-GV PVDF filter unit (0.22 µm) (Millipore, Brussels, Belgium). An aliquot (10 
µL) was injected onto the LC-MS/MS instrument. The HPLC settings were as followed: 
gradient elution: 0-2 min (70% A, 30% B), 6 min (linear gradient to 30% A), 6-14 min (30% A, 
70% B), 15 min (linear gradient to 70% A), 15-20 min (70% A, 30% B), flow-rate: 200 µL/min, 
column temperature: 35°C, column oven temperature: 5°C. The LC-MS/MS instrument and 
the MS/MS conditions were the same as for plasma and bile analysis (De Baere et al., 2011).  
Statistical Analysis 
The data were analysed using ANOVA (SPSS® 17.0 software for Windows, IBM, USA) to 
address the significance of difference between the mean values, with significance level set at 
p<0.05. 
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RESULTS 
Efficacy Testing 
Zootechnical parameters: Body Weight, Feed Consumption and Live Weight Gain. Diets 
with(out) different concentrations of DON, with or without the supplementation of 
detoxifying agents, had no significant effect on the body weight and live weight gain of 
broilers after three weeks of feeding (p>0.05). The feed intake was also not affected 
(p>0.05).  
EFSA end-points: DON and DOM-1 in Plasma. Plasma levels were measured above the limit 
of quantification (LOQ = 1.25 ng/mL) in the three groups which received feed naturally 
contaminated at a level of 7.54±2.20 mg DON/kg feed. This means that plasma 
concentrations could not be detected during feeding a contamination level of 2.44±0.70 mg 
DON/kg feed. The plasma levels of the animals that received naturally contaminated feed 
with or without supplementation of detoxifying agents are shown in Figure 1. For group 6 
(naturally contaminated feed without supplementation) a trend was observed: the plasma 
concentrations were higher after one week of feeding than after two weeks. At the end of 
the experiment, after 3 weeks of feeding, even no plasma concentrations were detected for 
this group. For group 7, which received the same feed but with an adsorbing agent, the 
plasma concentrations were much higher than in group 6, but the same decreasing trend 
was observed and also after three weeks of feeding no plasma levels could be detected. The 
group supplemented with a biotransforming agent (group 8) also reached higher plasma 
concentrations than group 6, but the decreasing trend was not so obvious for this group 
within the first two weeks of feeding. After three weeks of feeding also for group 8 no 
plasma concentrations could be detected. The metabolite DOM-1 was also analyzed in the 
plasma samples, but no levels above the LOQ (LOQ = 1.25 ng/mL) could be measured in any 
of the groups. 
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Figure 1. Plasma concentrations of deoxynivalenol (DON) in broilers after 1, 2 and 3 weeks of 
feeding naturally contaminated feed with DON in a concentration higher than the maximum 
guidance level of 5 ppm. The effect of the supplementation of an adsorbing or a 
biotransforming agent was evaluated. Results are presented as mean values + SD. 
 
DON and DOM-1 in Tissues and Bile Fluid. No residues above the LOQ (LOQ=1.25 ng/g) 
could be detected in the liver and kidneys of the animals of the 8 different groups. The 
results of the analyses of bile fluid are shown in Table 4. DON was only detected in the bile 
fluid of the three groups that received naturally contaminated feed containing 7.54±2.20 mg 
DON/ kg feed. The metabolite DOM-1 was detected in all the groups that received 
contaminated feed. However, the concentration of DOM-1 in the groups that received 
artificially contaminated feed (group 3, 4 and 5) was significantly lower than the three 
groups fed naturally contaminated feed (group 6, 7 and 8) (p<0.05). Supplementation of a 
detoxifying agent did not have a significant influence on the concentration in the bile fluid of 
any measured analytes (p>0.05).  
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Table 4. Concentration of DON and DOM-1 in the pooled bile fluid of broilers (n= 8/ group) 
after three weeks of feeding (un)contaminated feed with DON. 
 
 DON (ng/mL) 
DOM-1 
(ng/mL) 
Group 1 (control) ND ND 
Group 2 (control + adsorbing agent) ND ND 
Group 3 (artificial DON contaminated) ND 10.0 
Group 4 (artificial DON contaminated + adsorbing agent) ND 12.0 
Group 5 (artificial DON contaminated + biotransforming agent) ND 11.5 
Group 6 (naturally contaminated) 7.5 51.6 
Group 7 (naturally contaminated + adsorbing agent) 8.6 57.4 
Group 8 (naturally contaminated + biotransforming agent) 5.7 52.7 
(ND= not detected, LOQ DON= 1 ng/mL, LOQ DOM-1= 2.5 ng/mL)  
 
Safety Testing 
Influence of two different Detoxifying Agents on the Pharmacokinetics of oxytetracycline 
and amoxicillin. The plasma concentration-time profiles for oxytetracycline in the control 
and two detoxifying agents groups are shown in Figure 2. Remarkably, the area under the 
curve (AUC0→12h) is significantly higher for the group fed a diet with a biotransforming agent 
(32.70 h.µg/mL) compared to the group without detoxifying agent (18.12 h.µg/mL) and the 
group fed an adsorbing agent (24.72 h.µg/mL) (p<0.05). The Cmax of the group with the 
biotransforming agent (5.49 µg/mL) was also significantly higher than for the adsorbing 
agent and the control group (2.37 µg/mL and 3.04 µg/mL, respectively). No significant 
differences in Tmax (p=0.114) and T1/2el (p=0.305) were noticed between the groups. 
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Figure 2.  Effects of 3 weeks feeding of detoxifying agents on the plasma concentration 
versus time profile of oxytetracycline, administered as a single oral bolus of 100 mg/kg BW in 
broilers (n=8, mean + SD).  
 
Results for the antibiotic amoxicillin are presented in Figure 3. For this antibiotic, the group 
that received the adsorbing agent reached higher plasma concentrations compared to the 
other groups. The area under the curve (AUC0→2h) for the group with the adsorbing agent 
(608.26 min.µg/mL) was significantly different from the one with the biotransforming agent 
(414.26 min.µg/mL) (p<0.05), but not with the control group (507.52 min.µg/mL). The Cmax of 
the group receiving the adsorbing agent (7.00 µg/mL) was significantly higher than for the 
group with the biotransforming agent (4.19 µg/mL), but no significant differences were 
noticed with the control group (5.20 µg/mL). No significant differences in Tmax (p=0.597) and 
T1/2el (p=0.915) were observed between the groups. 
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Figure 3.  Influence of 3 weeks of feeding detoxifying agents on the plasma profile of 
amoxicillin,  administered as a single oral bolus of 20 mg/kg BW in broilers (n=8, mean + SD). 
 
Influence of two different Detoxifying Agents on the Tissue Residues of Oxytetracycline and 
Amoxicillin.The results of the analysis of oxytetracycline in liver and kidney tissues are 
shown in Figure 4. The residues of oxytetracycline in the liver were not significantly different 
between groups. For the kidneys, the concentration of oxytetracycline was much higher in 
the group that received feed supplemented with a biotransforming agent compared to the 
control group (p<0.05). This is in agreement with the results obtained in plasma (Fig. 2). For 
amoxicillin on the other hand, the residue levels in kidneys and liver were lower than the 
limit of quantification for all the animals (LOQ = 12.5 ng/g) (data not shown). 
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Figure 4.  Influence of 3 weeks of feeding of detoxifying agents on residues of 
oxytetracycline in broiler tissues, obtained 16h after withdrawal medicated drinking water 
(n=8, mean + SD, * = significant difference). 
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DISCUSSION 
This study is, to our knowledge, the first one which fully complies with recent EFSA 
guidelines for in vivo efficacy testing of mycotoxin detoxifying agents in broilers. 
Zootechnical parameters such as feed intake and live weight gain could not be used to 
demonstrate efficacy of the tested detoxifiers for DON in broilers since no significant 
differences were seen between groups. Nevertheless, the same biotransforming agent 
showed potential in diminishing deleterious effects of DON on growth performance and 
other non-specific parameters in pigs (Plank et al., 2009), and of T-2 toxin in broiler chickens 
(Diaz et al., 2005). Moreover, Dänicke et al. (2003) stated that this detoxifying agent even 
decreased the performance of broilers independently of the dietary mycotoxin 
concentration. Negative effects on the performance of the broilers however were not 
noticed during this trial.  
Analysis of DON in plasma only resulted in quantifiable levels in those birds that received 
DON in a concentration of 7.54±2.20 mg/kg feed, which is higher than the guidance level of 5 
mg/kg in feed, during a 3-week feeding period (Anonymous, 2006). It was remarkable that 
supplementation of the naturally contaminated feed with mycotoxin detoxifying agents even 
slightly increased the plasma levels of DON within the first two weeks of feeding. Devreese 
et al. (2012) performed in vivo efficacy testing of detoxifying agents in broilers with different 
oral bolus models. A single oral bolus of DON with or without a detoxifying agent in broilers 
also revealed a significant higher AUC0→∞, Cmax and relative oral bioavailability in the group 
with a detoxifying agent compared to the control group. Possible hypotheses for the 
increased oral bioavailability of DON include unspecific effects such as an increased ratio of 
villus height-crypt depth due to feeding detoxifying agents (de los Santos et al., 2007; 
Baurhoo et al., 2009; Star et al., 2009), but further investigations are needed to confirm this. 
Other  nonspecific effects, such as increased protein digestibility, were also attributed to 
detoxifying agents and should be investigated, as they can have an influence on the 
bioavailability of essential feed constituents (Döll and Dänicke, 2004). Surprisingly, after 
three weeks of feeding, no plasma levels above the LOQ were observed in any of the 
experimental groups. After three weeks of feeding, the birds may have developed a kind of 
tolerance to the negative impact of deoxynivalenol. This resistance may be attributed to the 
Experimental studies: Chapter 2 
 
  
104  
 
age of the animals or to a kind of adaptation process through a variety of metabolic and 
hormonal compensatory mechanisms (Moon et al., 2008; Kobayashi-Hattori et al, 2011). 
Very low plasma concentrations of DON were measured during this trial, which correspond 
with the literature, where 14C-labeled DON was described to be poorly absorbed from the 
gastrointestinal tract of hens since peak plasma levels occurring 2-2.5h post-administration 
accounted for only 0.64% of the administered dose (Prelusky et al., 1986). Our group also 
demonstrated an absolute oral bioavailability of only 19.3% for DON in broilers after a single 
oral bolus of DON (0.75 mg/kg BW) (A. Osselaere, unpublished data).  Other researchers 
reported concentrations of DON and its de-epoxidized metabolite DOM-1 below the LOQ of 
2 ng/mL in plasma after 5 weeks of feeding DON in a concentration of 2.5 mg/kg (Dänicke et 
al., 2007). Because continuous feeding trials with plasma analysis do not seem to be 
promising to test detoxifiers for DON in poultry, bolus models to test the efficacy of 
detoxifying agents were developed at our department. Higher plasma concentrations were 
observed after a single oral administration of DON (0.75 mg/kg BW), which was more 
appropriate to test the efficacy of the detoxifiers compared with continuous feeding trials 
(Devreese et al. 2012). In an effort to look for other possible end-points, the concentrations 
of DON and DOM-1 were determined in liver, kidneys and bile fluid after three weeks of 
feeding. Prelusky et al. (1986) described the important role of biliary excretion in the 
elimination of DON from the body. Again, no residues above the LOQ were detected in the 
collected organs. On the other hand, DON was detectable in the bile fluid, but only for these 
groups which received a diet with an amount of DON higher than 5 mg/kg feed. DOM-1 was 
even found in the bile fluid of all the groups that received DON contaminated feed. This is in 
contrast with the results reported by Dänicke et al. (2007) where no concentrations of DOM-
1 were detected in the bile fluid (LOQ = 4 ng/mL) of chickens after three weeks of feeding. 
Supplementation of the diets with an adsorbing or a biotransforming agent did not have 
significant effects on the concentration of DON and DOM-1 in the bile fluid.  
The safety of mycotoxin detoxifying agents is an important issue that did not receive much 
attention until now (Phillips et al., 2009). Detoxifying agents are able to modify the chemical 
structure of mycotoxins or to exert their activity by binding mycotoxins in the gastro-
intestinal tract. However, interactions with nutrients, feed additives or veterinary drugs, can 
possibly occur. Therefore we also investigated the possible interaction of detoxifying agents 
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with the pharmacokinetic profiles and tissue residues of the antibiotics oxytetracycline and 
amoxicillin, which are frequently used in poultry practice (Abo El-Sooud et al., 2004; Ismail 
and El-Kattan, 2004). To our knowledge, only the recent EFSA scientific opinion (Anonymous, 
2011) and a report of The Bureau of Veterinary Drugs of Canada (Anonymous, 1992) discuss 
a possible interaction between bentonite and tylosin or with coccidiostats. After three weeks 
of feeding diets supplemented with a detoxifier, significant different plasma profiles 
depending on the type of antibiotic were observed. For oxytetracycline, the birds receiving 
feed supplemented with a biotransforming agent had a significantly higher Cmax and AUC 
than the other birds (p<0.05). The results of the residue depletion study of oxytetracycline in 
tissues also showed higher concentrations of oxytetracycline in the kidneys of these birds 
compared to the control group. Kidneys play an important role in the elimination of 
oxytetracycline in poultry (Ismail and El-Kattan, 2004). In contrast, for amoxicillin, the group 
with the adsorbing agent reached significantly higher plasma concentrations and AUC, only 
when compared to the group with the biotransforming agent. For this antibiotic, no tissue 
residue levels above the limit of quantification were observed twelve hours after the last 
administration, which can be explained by the rapid elimination of amoxicillin in poultry 
(Anadon et al., 1996). In this study clay-based detoxifiers were used, which have a non-
specific binding capacity. Moshtaghian et al. (1991) noted that clays can absorb 
micronutrients and thus can have a negative impact on the bioavailability of minerals and 
trace elements. Clays consist of a porous structure with electric elementary charges which 
can trap particles with a particular size and electric charge (Jouany, 2007). Surprisingly, we 
observed an enhancement in bioavailability for these antibiotics rather than a reduction. 
Although the mechanism is still unclear, the possible consequences of these findings are very 
important. Adaptation of the dosage of the antibiotic can be necessary; otherwise the higher 
plasma concentrations of the antibiotic can possibly lead to toxicity and to higher tissue 
residue levels. An advantage could be that the dosage of the antibiotic can be reduced and 
thus could lead to a reduced use of antibiotics. Influence of detoxifying agents on the 
pharmacokinetics of doxycycline has also been demonstrated in pigs by co-authors. 
Significantly higher plasma concentrations were observed in piglets that received T-2 toxin 
contaminated feed supplemented with a mycotoxin-detoxifying agent (Goossens et al., 
2012).  
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In conclusion, we have shown that the analysis of DON and its metabolite in vivo is not a 
relevant end-point for the efficacy testing of mycotoxin detoxifying agents in plasma of 
broilers when fed in a continuous design. The safety testing of two commercially available 
detoxifiers revealed possible interactions with veterinary drugs, which can have important 
consequences and warrants further investigations to elucidate underlying mechanisms. 
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Chapter 3. 
 
The effects of deoxynivalenol and an adsorbing agent on the intestinal barrier 
and liver function 
 
 
 
 
 
 
 
 
 
 
Adapted from: Osselaere, A., Santos, R., Hautekiet, V., De Backer, P., Chiers, K., Ducatelle, R., 
Croubels, S. (2013). Deoxynivalenol impairs hepatic and proximal intestinal gene expression 
of selected oxidative stress, tight junction and inflammation proteins in broiler chickens, but 
addition of an adsorbing agent shifts the effects to more distal parts of the small intestine. 
Submitted to PLOS One. 
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ABSTRACT 
Broiler chickens are rather resistant to deoxynivalenol and thus, clinical signs are rarely seen. 
However, effects of subclinical concentrations of deoxynivalenol on both the intestine and 
the liver are less frequently studied at the molecular level. During our study, we investigated 
the effects of three weeks of feeding deoxynivalenol on the gut wall morphology, intestinal 
barrier function and inflammation in broiler chickens. In addition, oxidative stress was 
evaluated in both the liver and intestine. Besides, the effect of a clay-based mycotoxin 
adsorbing agent on these different aspects was also studied. Our results show that feeding 
deoxynivalenol affects the gut wall morphology both in duodenum and jejenum of broiler 
chickens. A qRT-PCR analysis revealed that deoxynivalenol acts in a very specific way on the 
intestinal barrier, since only an up-regulation in mRNA expression of claudin 5 in jejunum 
was observed, while no effects were seen on claudin 1, zona occludens 1 and 2. Addition of 
an adsorbing agent resulted in an up-regulation of all the investigated genes coding for the 
intestinal barrier in the ileum. Up-regulation of Toll-like receptor 4 and two markers of 
oxidative stress (heme-oxigenase or HMOX and xanthine oxidoreductase or XOR) were 
mainly seen in the jejunum and to a lesser extent in the ileum in response to deoxynivalenol, 
while in combination with an adsorbing agent main effect was seen in the ileum. These 
results suggest that an adsorbing agent may lead to higher concentrations of deoxynivalenol 
in the more distal parts of the small intestine. In the liver, XOR was up-regulated due to DON 
exposure. HMOX and HIF-1α (hypoxia-inducible factor 1α) were down-regulated due to 
feeding DON but also due to feeding the adsorbing agent alone or in combination with DON. 
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INTRODUCTION 
Mycotoxin contamination can occur in all agricultural commodities in the field and/or during 
storage, if the conditions are favorable for fungi growth (CAST, 2003). Deoxynivalenol (DON), 
also called vomitoxin, is a trichothecene mycotoxin which is highly prevalent in Europe 
(Binder et al., 2007; Monbaliu et al., 2010; Streit et al., 2012). In poultry, DON rarely causes 
acute mycotoxicosis. However, chronic exposure to the toxin can lead to reduced production 
and an altered immune function (Awad et al., 2011). As poultry seems to be less susceptible 
to DON-mycotoxicosis compared to other animals, infected cereal batches are sometimes 
diverted to the poultry feed production (Awad et al., 2008). Mycotoxin detoxifying agents 
are frequently used feed additives to reduce the adverse effects of mycotoxins. Detoxifiers 
based on clay minerals are classified by the European Food Safety Authority (EFSA) as 
adsorbing agents (Anonymous, 2009).  
Mycotoxins are food and feed contaminants and thus after ingestion the intestine can be 
exposed to high concentrations of the toxins (Maresca et al., 2002; Sergent et al., 2006). The 
epithelial surface of the intestine is characterized by a large contact area for absorption of 
nutrients and xenobiotics. This surface consists of a simple columnar epithelium, which is 
increased by the presence of villi (DeSesso and Jacobson, 2001). Both toxins and mycotoxin 
detoxifiers can interact with this surface area, resulting in altered extent and rate of 
absorption of xenobiotics such as drugs and mycotoxins. For example, we found in a 
previous study higher plasma concentrations of DON in animals fed contaminated feed in 
combination with a clay-based adsorbing agent compared to animals fed DON contaminated 
feed only (Goossens et al., 2012; Osselaere et al., 2012). 
The absorbing epithelial cells (enterocytes) are connected strongly by tight junction proteins. 
These tight junctions seal off the luminal end of the intercellular space and so transport by 
this paracellular route is very limited (Arrieta et al., 2006). Claudins are transmembrane 
proteins which form the backbone of the tight junction strands. Claudin 1 and 5 are known 
to interact and are important to guarantee the intestinal barrier function. Both claudins have 
already been characterized in chickens (Furuse et al., 1998; Krause et al., 2008; Ozden et al., 
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2010). The family of zona occludens, including zona occludens 1 (ZO 1) and zona occludens 2 
(ZO 2), is a group of scaffolding proteins which is part of the cytoplasmic plaque of the tight 
junctions.  
The intestinal epithelial cells also contribute to the regulation of inflammatory conditions 
and create a kind of barrier against invading pathogens. Toll-like receptors (TLR) in the 
intestinal epithelium, particularly TLR4, serve as rapid pathogen sensors. 
After intestinal absorption of mycotoxins these compounds reach the liver as the gateway of 
the portal blood draining the gastrointestinal tract. Both intestine and liver consist of rapidly 
proliferating cells and have a high protein turnover rate. Therefore, we may suppose that 
these organs are more sensitive for the action of DON (Ueno, 1984).  
The toxicity of DON is mediated by various mechanisms. Trichothecenes are potent 
inhibitors of the RNA, DNA and protein synthesis (Eriksen and Petterson, 2004). In addition, 
DON may induce the production of free radicals and cellular oxidative stress. It has been 
shown that oxidative stress causes up-regulation of hypoxia-inducible factor 1, subunit alpha 
(HIF-1α) (Wenger, 2000), a transcription factor which regulates genes involved in 
inflammation and cell death (Lee et al., 2007). Heme-oxigenase (HMOX) is another sensitive 
marker of oxidative injury, which affords protection against hepatocyte death (Carchman et 
al., 2011). Both HIF-1α and HMOX have already been characterized in chickens (Giusti and 
Fiszer de Plazas, 2012; Shan et al., 2004). Xanthine oxidoreductase (XOR) is an enzyme 
associated with the synthesis of reactive oxygen species and is part of the cellular defense 
enzyme systems (Harrison, 2002). In broilers, this enzyme is mainly expressed in the liver, 
but also in the intestine (60% of the amount in the liver) and other organs but in a lower 
amount (Carro et al., 2009). The intestine requires an efficient immune defense at the 
epithelial surface, and among other factors, XOR is secreted by the enterocytes of the small 
intestine (Van Den Munckhof et al., 1995).  
The aim of our study was to assess the effects of three weeks dietary exposure to DON on 
the small intestine and liver in broiler chickens. To this end qRT-PCR analyses were 
conducted to study if genes coding for oxidative stress and inflammation response are 
influenced by DON, both in the liver and the small intestine. In addition, the effects of DON 
Experimental studies: Chapter 3 
 
  
115  
 
on the intestinal morphology and intestinal barrier function were investigated with 
histopathology and qRT-PCR analysis, respectively. To our knowledge, this is the first in vivo 
study which observes these parameters in broiler chickens. Finally, the effects of a clay-
based mycotoxin-detoxifying agent were also investigated during our trial.  
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MATERIALS AND METHODS 
Ethics statement 
The protocol was approved by the Ethical Committee of the Faculty of Veterinary Medicine 
(Ghent University) (EC 2010/064 and EC 2010/076). All husbandry practices and euthanasia 
were performed with full consideration of animal welfare. 
Animals and diets 
The animals and the experimental design have been described elsewhere (Osselaere et al., 
2012). In brief, 32 1-day-old broiler chickens were fed uncontaminated feed during an 
acclimatization period of ten days. Afterwards, the animals were divided into four different 
dietary groups of 8 animals each: a control group receiving uncontaminated feed, a group 
receiving uncontaminated feed + adsorbing agent, a third group receiving naturally DON 
contaminated feed and a group fed naturally DON contaminated feed + adsorbing agent. 
Analyses of the feed were performed by a multi-mycotoxin LC-MS/MS method (Monbaliu et 
al., 2010). The naturally contaminated feed was contaminated as follows: DON (7.540 ± 2.20 
mg/kg), 3-acetylDON (1.481 ± 0.57 mg/kg), fumonisin B1 (0.700 ± 0.08 mg/kg), fumonisin B2 
(0.201 ± 0.02 mg/kg) and fumonisin B3 (0.207 ± 0.08 mg/kg). The adsorbing agent (illite-
ambrosite clay) was added in a concentration of 1.5 kg/ton feed. After three weeks of 
feeding, the animals were euthanized and liver and intestinal samples were immediately 
collected. From the small intestine, samples were taken at three different locations: 2 cm 
after the gizzard (duodenum), just before Meckel’s diverticulum (jejunum) and two cm 
before the ileo-cecal transition (ileum). Intestinal and liver samples were rinsed in phosphate 
buffered saline (PBS). Afterwards, the samples for qRT-PCR analysis were immediately frozen 
in liquid nitrogen and stored at -80 °C until analysis. Samples for morphological examination 
were also rinsed in PBS and then fixed in 4% (v/v) phosphate buffered formalin.  
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Quantitative RT-PCR method to analyze the intestinal barrier function, inflammation and 
oxidative stress 
RNA from samples of liver and intestine (duodenum, jejunum and ileum) were isolated using 
the SV Total RNA Isolation System (Promega, Madison, WI, USA) according to the 
manufacturer’s instructions, and total RNA was quantified by spectrophotometry (Nanodrop 
ND-1000, Thermo Scientific, Wilmington, NC, USA). Subsequently, 1 μg of extracted total 
RNA was reverse transcribed with the iScriptTM cDNA Synthesis kit (Biorad, Hercules, CA, 
USA). The obtained cDNA was diluted to a final concentration of 30 ng/µL. Primers were 
commercially produced (Eurogentec, Nijmegen, the Netherlands) (Table 1). The primers used 
were selected based on specificity and efficiency by qPCR analysis of a dilution series of 
pooled cDNA at a temperature gradient (55oC to 65oC) for primer-annealing and subsequent 
melting curve analysis. The reaction mixture for the qPCR containing 10 μL of the diluted 
cDNA was mixed with 15 μL iQSYBR Green Supermix (Biorad), forward and reverse primers 
(final concentration of 0.4 pmol/μL for each primer) and sterile water according to the 
manufacturer's instructions. qPCR was performed using the MyiQ single-colour real-time 
PCR detection system (Biorad) and MyiQ System Software Version 1.0.410 (Biorad). 
Amplification efficiency was determined per plate using linregPCR. Data were analyzed using 
the efficiency corrected Delta-Delta-Ct method (Pfaffl, 2001). Housekeeping genes were 
tested for all the test conditions after which most stable housekeeping genes for liver and 
intestinal samples were selected using the geNorm software (data not shown). The most 
stable housekeeping genes had a M-value between 0.2 and 0.5. To determine if the inclusion 
of an additional housekeeping gene was required, the cut-off value for variation was set at 
0.2. The fold-change values of the genes of interest (GOIs) were normalized using two 
housekeeping genes: hypoxanthine-guanine phosphoribosyl transferase (HPRT) and hexose-
6-phosphate dehydrogenase (H6PD). The mRNA expression of proteins involved in oxidative 
stress i.e. HMOX, HIF-1α and XOR were evaluated in the liver and intestine. Furthermore, 
mRNA expression of the tight junctions proteins claudin 1 and 5 (CLDN1 and CLDN5) and 
zona occludens 1 and 2 (ZO1 and ZO2) in sections from the duodenum, jejunum and ileum 
were measured. Two compounds of the immune system, namely Toll-like receptors (TLR) 2 
and 4 were also investigated during our study. For the validation of the qPCR assays 
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following criteria were applied:  slope between -3.6 and -3.1, efficiency between 90 and 110 
%, R2 > 0.99. 
Morphological examination of the gut wall 
Formalin-fixed intestinal samples were dehydrated in xylene and embedded in paraffin. With 
a microtome (Microm, Prosan, Merelbeke, Belgium), sections of 4 μm thickness were cut 
and mounted in glass slides. Afterwards, deparaffination occurred in xylene (2 times 5 min) 
and then rehydratation occurred in isopropylene (5 min), 95 % alcohol (5 min) and 50 % 
alcohol (5 min). Sections were stained with haematoxylin and eosin. Using light microscopy, 
villus height and crypt depth (10 villi per intestinal segment) from each of 8 chickens per 
treatment, were measured. For this, a Leica Camera DFC320 (Leica Microsystems Ltd, 
Wetzlar, Germany) coupled to a computer-based image analysis system LAS v.3.8. (Leica 
Microsystems Ltd) was used. Only intact villi were measured. Measurements were done on 
cross-sections of ring-shaped intestinal segments.   
Data analysis 
Results were compared by ANOVA after determination of normality and variance 
homogeneity. Multiple comparisons were performed using a LSD post-hoc test. Not normally 
distributed data were analyzed using the non-parametric Kruskal-Wallis analysis, followed by 
a Mann-Whitney test using SPSS 19.0 Software (SPSS Inc., Chicago, IL, USA). A P-value of 
<0.05 was considered statistically significant.  
  
Table 1. Primers used for the quantification of housekeeping genes (HKG) and genes of interest (GOI). 1 
 2 
Gene Accession N° Primer Sequence Product size (pb)  Annealing T° 
HKG      
HPRT  NM_204848.1 Forward  5' CGTTGCTGTCTCTACTTAAGCAG 3' 90 65 
  Reverse 5' GATATCCCACACTTCGAGGAG 3'   
H6PD XM_425746.2 Forward 5' GGAGAACCAGCACTTCTTAGAC 3' 84 64 
  Reverse 5' GGGTTCAGCAATTCCACTG 3'   
GOI      
CLDN1 NM_001013611 Forward 5’ CTGATTGCTTCCAACCAG 3’ 140 57-59 
  Reverse 5’ CAGGTCAAACAGAGGTACAAG 3’     
CLDN5 NM_204201 Forward 5’ CATCACTTCTCCTTCGTCAGC 3' 111 56-65 
  Reverse 5’ GCACAAAGATCTCCCAGGTC 3’   
HIF-1α NM_204297 Forward 5’ CACCATTACCATACTTCAGCAG 3' 88 65 
  Reverse 5’ CTTCACATCATCCACACGTTC 3’   
HMOX NM_205344 Forward  5' CTTGGCACAAGGAGTGTTAAC 3' 78 61-63 
  Reverse 5' CATCCTGCTTGTCCTCTCAC 3'   
TLR2 NM_204278 Forward  5' CCTGCAACGGTCATCTCAG 3' 135 59 
  Reverse 5' GTCTCAGGGCTTGTTCTTCAG 3'   
TLR4 NM_001030693 Forward  5' CTGACCTACCCATCGGACAC 3' 111 59 
  Reverse 5' GCCTGAGAGAGGTCAGGTTG 3'   
XOR NM_205127 Forward  5' GTGTCGGTGTACAGGATACAGAC 3' 110 61 
  Reverse 5' CCTTACTATGACAGCATCCAGTG 3'   
ZO1 XM_413773 Forward  5' CTTCAGGTGTTTCTCTTCCTCCTC 3' 131 59 
  Reverse 5' CTGTGGTTTCATGGCTGGATC 3'   
ZO2 NM_204918 Forward  5' CGGCAGCTATCAGACCACTC 3' 87 64-65 
  Reverse 5' CACAGACCAGCAAGCCTACAG 3'   
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RESULTS 
Not only DON but also the adsorbing agent alters mRNA expression of oxidative stress 
markers in liver of broiler chickens 
 
In the liver, both HIF-1α and HMOX mRNA were significantly down-regulated for all the 
broiler chickens receiving either DON, an adsorbing agent or DON and the adsorbing agent, 
when compared to the control group. Differently, XOR was significantly up-regulated in the 
group receiving DON. The group receiving an adsorbing agent, whether or not in 
combination with DON was not affect ed. Data are shown in Figure 1. 
 
Figure 1. Effects of DON and an adsorbent on oxidative stress in the liver of broiler chickens. 
Results are presented as mean (± SEM) mRNA expression. Fold change in gene expression 
levels of the chicken liver relative to control group, which is considered 1. * Indicates 
significant differences between treated and control animals.  
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DON leads to oxidative stress in the jejunum and in the ileum of broiler chickens in 
combination with an adsorbing agent  
For the small intestine, the expression of HIF-1α, HMOX and XOR mRNA was investigated in 
the duodenum, jejunum and ileum. Expression of HIF-1α was unaltered in the intestine, 
independently on the treatment or intestinal section. On the other hand, HMOX and XOR 
were significantly up-regulated in the jejunum of animals fed the DON contaminated feed, 
independently on the supplementation of an adsorbing agent.  For the last part of the small 
intestine, the ileum, only XOR was up-regulated when animals were fed with feed containing 
DON and the adsorbing agent (Figure 2).  
DON and adsorbent do not affect duodenal barrier function, but do so in jejunum and 
ileum 
As observed for oxidative stress markers, barrier function of duodenum was unaffected by 
both DON and adsorbing agent, while jejunum presented a significant up-regulation of 
CLDN5 mRNA when animals were fed with DON contaminated feed. Feed supplementation 
with the adsorbing agent did significantly reduce the CLDN5 mRNA expression when 
compared to DON, but its expression remained significant higher than that observed in the 
control. The strongest effect on tight junctions was observed in the ileum when animals 
were fed with feed contaminated with DON and supplemented with the adsorbing agent, 
with a significant up-regulation of CLDN1, CLDN5, ZO1 and ZO2 mRNA (Figure 2).  
DON leads to inflammatory reaction in duodenum and jejunum, but its negative effect in 
the ileum depends on the feed supplementation with an adsorbing agent  
A significant up-regulation of TLR4 mRNA was observed in the duodenum and jejunum of 
animals fed with DON contaminated feed. Although feed supplementation with an adsorbing 
agent was efficient to decrease the TLR4 expression, it was efficient to recover control levels 
only in the duodenum and not in the jejunum. Finally, as observed with tight junctions’ 
analysis, ileum exposure to DON and adsorbing agent resulted in the significant up-
regulation of TLR4 mRNA (Figure 2). 
 
 Figure 2. Effects of DON and an adsorbent on intestinal barrier in broiler chickens. Results are presented as mean (± SEM) mRNA expression. 
Fold change in gene expression levels of the chicken intestines relative to control group, which is considered 1. a-c Different lower-case letters 
indicate significant differences between groups. 
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DON alters the gut wall morphology in duodenum and jejunum of broiler chickens, but 
addition of an adsorbing agent counteracts these effects 
Feeding DON contaminated feed resulted in a decreased villus length and crypt depth both 
in duodenum and jejunum of the broiler chickens. Addition of an adsorbing agent resulted in 
longer villi, even in combination with DON and this over the entire length of the small 
intestine. The crypt depth however, was not influenced by the addition of an adsorbing 
agent to control feed in the duodenum and jejunum, when compared to the control group. 
On the other hand, the adsorbing agent had a positive effect on the crypt depth in these 
intestinal parts, when added to DON contaminated feed. In the ileum, no effect of feeding 
DON contaminated feed without an adsorbing agent was observed. In this part of the small 
intestine, it was the adsorbing agent in combination with DON or not which resulted in 
higher villi and deeper crypts (Table 2). 
Table 2. Length of villi (μm) and crypt depth (μm) in duodenum, jejunum and ileum after 3 
weeks feeding a control diet or feed contaminated with DON, either or not supplemented 
with an adsorbing agent. Results are presented as mean values and standard deviations of 
fifteen villi or crypts measured from 8 chickens per treatment group. 
 
 Control Adsorbing agent DON DON + adsorbing 
agent 
Duodenum 
Villus height 
Crypt depth 
 
1734 ± 26 a 
131 ± 7 a 
1773 ± 43 c 
134 ± 7 a 
1449 ± 31 b 
114 ± 9 b 
 
1789 ± 39 c 
128 ± 8 a 
 
Jejunum 
Villus height 
Crypt depth 
1343 ± 37 a 
120 ± 8 a 
1521 ± 39 c 
116 ± 10 a 
1184 ± 48 b 
101 ± 8 b 
1509 ± 43 c 
109 ± 7 c 
Ileum  
Villus height 
Crypt depth 
596 ± 30 a 
113 ± 6 a 
773 ± 63 b 
124 ± 17 b 
616 ± 38 a 
110 ± 15 a 
744 ± 63 b 
119 ± 18 ab 
a,b mean values within a row with unlike superscript letters are significantly different 
(p≤0.05)  
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DISCUSSION 
Being an interface between the outside world and the inside body, the gastro-intestinal tract 
(GIT) is a dynamic barrier (Oswald, 2006). This barrier is responsible for two major processes, 
which are on the one hand uptake of nutrients and fluids and on the other hand defense 
mechanism against xenobiotics. We performed a study with broiler chickens fed with 
naturally contaminated feed to investigate the effects of DON on the intestinal barrier and 
hepatic function. Co-contamination of different mycotoxins in naturally contaminated feed is 
common and this was also the case for the experimental feed used in this study. DON was 
the most prevalent mycotoxin and was even present in a concentration higher than the 
European recommended maximum level of 5 mg/kg (Anonymous et al., 2006). The other 
contaminant present, 3-acetylDON, is considered a masked mycotoxin, i.e. a conjugated 
form of DON also produced by Fusarium fungi. It is hypothesized that this conjugated form 
may be hydrolysed and release DON in vivo, but the question remains whether this occurs in 
every animal species and if this occurs already in the GIT and/or liver and/or systemic 
circulation. The sum of the concentration of the co-contaminants fumonisin B1 and B2 of 
0.901 mg/kg was much lower than the European guidance value of 20 mg/kg in poultry feed 
(Anonymous et al., 2006). Thus, the co-contamination with fumonisins can be considered as 
negligible. In our study, three weeks feeding DON at 7.54 mg/kg feed reduced the villus 
height and the crypt depth both in the duodenum and the jejunum. Reduced villi in the 
duodenal and jejunal segment of the small intestine were also observed in broiler chickens 
after 6 weeks feeding a diet of 10 mg/kg DON (Awad et al., 2006). Yunus et al. (2012) 
observed a linear correlation between increasing levels of DON and the decrease in villus 
height in both the mid-duodenum and mid-jejunum (Yunus et al., 2012). Possible 
explanation for these histological changes can be a direct irritant effect of the mycotoxin or 
suppression of mitosis or protein synthesis (Eriksen and Petterson, 2004; Yunus et al., 2012). 
In order to maintain an effective barrier function, the intestinal epithelium needs to 
regenerate continuously. Mature cells migrate along the crypt-villus axis towards the villus-
top, in the mean time these cells become differentiated cells (Booth and Potten, 2000). DON 
can be responsible for a reduced cell proliferation (Bensassi et al., 2009; Kasuga et al., 1998; 
Yang et al., 2008). This can be an explanation for the reduced crypt depth observed during 
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our trial. A decreased crypt depth in the mid-duodenum in broiler after chronic exposure to 
DON (12 mg/kg) has been reported earlier (Yunus et al., 2012). Interestingly, the adsorbing 
agent resulted in longer villi over the entire length of the small intestine. These longer villi 
seen in our study in the chickens receiving the adsorbing agent can be responsible for the 
higher oral bioavailabilities of xenobiotics as observed in our previous study (Osselaere et al., 
2012).  
Several studies both in vitro and in vivo already reported that DON is able to alter intestinal 
permeability. Intestinal physiology can even be affected by DON in the absence of clinical 
signs (Awad et al., 2004). The function of the tight junctions can be evaluated by 
measurements of the trans-epithelial electrical resistance (TEER) and of the paracellular 
efflux of macromolecules (Madara, 1998). These techniques, however, do not give 
information which specific protein of the tight junctions is affected (Van Itallie et al., 2009). 
Therefore, a qRT-PCR method was applied in our study to evaluate the effects of DON on the 
different specific proteins of the tight junctions, namely CLDN1, CLDN5, ZO1 and ZO2. An 
important advantage of this technique is the generation of quantitative results, which makes 
it possible to detect small differences which could otherwise be missed when using 
immunofluorescence. Moreover, due to the lack of suitable commercial avian antibodies, no 
effects at the protein level could be studied. This general lack in anti-chicken antibodies for 
use in Western blot and immunofluorescence is well known in poultry research.  
Major effects of feeding DON without an adsorbing agent on the intestinal barrier were 
observed in the jejunum. A significant up-regulation of CLDN5 was observed in the jejunum 
of the groups fed contaminated feed with or without an adsorbing agent. No significant 
differences were noticed in the jejunum for the mRNA expression of the other genes coding 
for the intestinal barrier function. The ileum on the other hand, is less susceptible to DON 
due to the fact that the majority of ingested DON is absorbed in the proximal parts of the 
small intestine (Awad et al., 2007). However, in the group receiving DON in combination with 
an adsorbing agent, detrimental effects were seen in the ileum. This indicates that addition 
of the adsorbing agent results in a sustained presence of DON in the intestine. 
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The results of our study suggest that DON selectively acts on the different parts of the tight 
junction complex as only an up-regulation of CLDN5 was observed. A selective effect of DON 
has been observed in vitro in intestinal porcine epithelial cells and human Caco-2 cells. After 
48h exposure to DON at a concentration of 9000 ng/mL both claudin 3 and 4 showed 
reduced protein expression, but ZO1 and occludin were not affected (Pinton et al., 2009). 
The same authors also described a reduced claudin 4 expression in growing pigs after in vivo 
exposure to DON (2.85 mg DON/kg feed) for 5 weeks, using Western blot analysis and 
immunohistochemistry. Immunohistochemistry results showing no changes in the overall 
morphology of the cells, but only a decreased staining for the claudins strengthens our 
hypothesis of a selective action of DON (Pinton et al., 2009). Selective action of DON on 
claudin-isoforms was confirmed in other more recent in vitro studies (Diesing et al., 2011; 
Van de Walle et al., 2010). Our study is, to our knowledge, the first one showing the effects 
of DON on the intestinal barrier in poultry after in vivo exposure to DON.  
Different authors also suggest that trichothecenes may be responsible for the production of 
free radicals, causing damage to DNA and membranes and thus suggesting that oxidative 
stress may play an important role in their toxicity (Atroshi et al., 1997; Leal et al., 1999; 
Minervini et al., 2005; Rizzo et al., 1994; Vila et al., 2002). Up-regulation of HIF-1α often 
occurs in the first hours of hypoxia and, thereafter, returns to basal levels. This can be an 
explanation for the basal levels of HIF-1α found in the small intestine during this study. 
However, instead of basal expression of HIF-1α, we have observed its down-regulation in the 
liver of chicken, after exposure to DON or the adsorbing agent alone or in combination. As 
shown recently by Sparkenbaugh et al. (2011), HIF-1α is up-regulated during liver injury in 
the initial phase of inflammation and oxidative stress, and should guarantee cell protection 
when the stress becomes chronic, which was not observed in our study. Furthermore, 
protection against hepatocyte death is related to the up-regulation of HMOX (Carchman et 
al., 2011). In our present study, however, hepatic HMOX was also significantly down-
regulated in animals fed with adsorbent supplemented feed, contaminated with DON, or 
with a combination of both. In contrast, in the jejunum a significant up-regulation of HMOX 
was observed in the animals receiving DON contaminated feed with or without the 
adsorbing agent. XOR, which responds more in the chronic phase, was significantly up-
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regulated in the jejunum in all the animals receiving DON, but in the liver an up-regulation 
was observed only in the group receiving DON without an adsorbing agent. In summary, 
DON caused oxidative stress in the small intestine. This has previously been reported in 
Caco-2 cells, where DON caused a significantly increased production of malondialdehyde, a 
biomarker of lipid peroxidation (Kouadio et al., 2005). The hepatic effects of in vivo exposure 
to 10 mg/kg DON in broiler chickens have previously been reported by Frankic et al. (2006). 
They observed no differences in liver content of malondialdehyde, glutathione peroxidase 
and total antioxidant status, which are all markers for lipid peroxidation (Frankic et al., 
2006). These findings suggest a more direct genotoxic effect of DON, rather than via the 
oxidative pathway (Awad et al., 2012; El Golli-Bennour and Bacha, 2011).  
Due to the damage to the intestinal barrier, an increased passage of non-invasive 
commensal bacteria may occur (Maresca et al., 2008). Both in duodenum and jejunum a 
significant up-regulation of TLR4 was observed during our study, which suggests 
inflammation, more specific due to the presence of Gram-negative bacteria (Reynolds et al., 
2012). In contrast, no effects on TLR2 were observed. TLR2 is more affected by the presence 
of Gram-positive bacteria (Takeuchi et al., 1999).  
In the last part of the small intestine, the ileum, inflammation was caused by the presence of 
DON in combination with the adsorbing agent. In addition, in this group all the genes coding 
for the tight junction complex were also up-regulated and the same trend was observed for 
the gene XOR, coding for oxidative stress. Along the entire length of the small intestine 
administration of the adsorbing agent resulted in longer villi. From our qRT-PCR results, we 
can conclude that it is not the adsorbing agent that causes damage as no significant 
differences in gene expression were seen in the group receiving control feed in combination 
with the adsorbing agent. The adsorbing agent is a mineral clay and seems to protect DON 
from degradation by the gastric fluids and intestinal enzymes in the proximal part. This may 
result in a higher concentration of the mycotoxin in the distal part of the small intestine 
when an adsorbing agent is used. Thus the binding or interaction of DON with the adsorbing 
agent results in a longer exposure time of the intestine to DON. 
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From our in vivo study, we can conclude that DON acts in a very specific way on the 
intestinal barrier in broiler chickens. Increased intestinal barrier permeability after chronic 
exposure to DON may lead to intestinal inflammation. The mechanism of action of DON can 
be different depending on the investigated target organ. The investigated mycotoxin 
adsorbing agent does not cause direct damage or irritation. However, feeding this clay 
mineral in combination with DON may result in higher concentrations of the mycotoxin in 
more distal parts of the small intestine, resulting in damage of the intestinal barrier there.   
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CYP3A in the liver and the small intestine of healthy broiler chickens 
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Boussery, K., Croubels, S. (2013). Hepatic and intestinal CYP3A expression and activity in 
broilers. Journal of Veterinary Pharmacology and Therapeutics, doi:10.1111/jvp.12034. 
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ABSTRACT 
Cytochrome P450 is involved in drug metabolism. Subfamily CYP3A shows a degree of 
similarity across different animal species. However, little information is available about its 
expression and activity in broiler chickens. A RT-PCR method was developed for the 
quantification of CYP3A37 expression in the liver and small intestine of broilers. A higher 
expression in the jejunum was observed compared with that in the ileum. In the liver, a 
significantly lower expression compared witht that in the jejunum was noticed. Thus, the 
role of the small bowel in drug metabolism cannot be neglected in broilers. CYP3A activity 
was studied in vitro using midazolam as a substrate. Two protocols for the preparation of 
intestinal microsomes were compared. Mincing of the tissues before ultracentrifugation 
seemed to be more appropriate than a protocol based on ethylenediaminetetra-acetic acid 
separation. CYP3A activity revealed to be the highest in the duodenum with a decreasing 
trend towards the ileum. Activity in liver was comparable to duodenal activity.  
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INTRODUCTION 
Cytochrome P450 (CYP450) enzymes play a dominant role in the process of oxidative 
biotransformation (Hollenberg, 1992). These heam proteins are classified in different 
families, with CYP1 to CYP4 being the most important ones. Members of the CYP1, CYP2 and 
CYP3 group are responsible for phase I metabolism of xenobiotics. On the other hand, the 
CYP4 family is responsible for the catalytic functions in the metabolism of fatty acids and 
prostaglandins (Bains et al., 1985) and also for the oxidation of many drugs with an acidic 
function (Moody, 1992).  
The CYP enzymes have mainly been studied in humans and laboratory animals, but little is 
known about hepatic and especially intestinal CYP-enzymes in domestic animals (Antonovic 
& Martinez, 2011). To date, several subtypes of CYP enzymes have already been 
characterized and some have even been cloned in chicken. For the CYP1A subfamily, 
homology between mammalian CYP1A1 and CYP 1A2 and avian CYP1A4 and CYP 1A5, 
respectively, has been described (Kubota et al., 2006). Both CYP1A4 and CYP1A5 have also 
been cloned in chickens (Gilday et al., 1996). CYP1B is another member of the CYP1 family in 
chicken with a homology of 72% with the human CYP1B1 (Antonovic & Martinez, 2011). For 
the CYP2 family, many iso-enzymes have already been described in chickens. In chickens, 
CYP2G is a homologue of human CYP2G (Antonovic & Martinez, 2011). The chicken CYP2C45 
has a homology of 56% with human CYP2H1 (Baader et al., 2002). Similarity was proven 
between human CYP2C and chicken CYP2H1 and CYP2H2 and between human CYP2J2 and 
chicken CYP2J19 (Antonovic & Martinez, 2011). The CYP3A subfamily is the last family 
important for phase I metabolism. In humans, approximately 50% of the therapeutic drugs 
are metabolized by the CYP3A subfamily. CYP3A4 has even been proven to be the most 
dominant CYP3A isoenzyme in the human intestine (Koch et al., 2002). The presence of 
CYP3A has been confirmed in chickens as an isoform, designated as CYP3A37, which is 60% 
homologous to human CYP3A4 (Ourlin et al., 2000). On the other hand, the existence of 
other CYP3A isoforms cannot be excluded (Antonovic and Martinez, 2011; Cortright and 
Craigmill, 2006; Murcia et al., 2011; Ourlin et al., 2000). In the evolutionary history of CYP3A 
gene family, it is described that the CYP3A80-like genes were lost, except in reptiles and 
aves. In all Eutheria CYP3A genes are the descendants of the CYP3A37 gene (Qiu et al., 
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2008).  The presence of CYP3A80 has already been described in turkeys, but some authors 
suggest that it may be a pseudo-gene without activity. For example, for the metabolisation 
of aflatoxin B1 in turkeys, CYP3A37 was the only investigated CYP3A isoform (Rawal and 
Coulombe, 2011). 
Midazolam (MDZ) is known to be a marker substrate in humans and rats for CYP3A4 
(Kobayashi et al., 2002; Kronbach et al., 1989; Watkins, 1994). This drug belongs to the group 
of the benzodiazepines and is metabolized via CYP4503A members in the liver to 1-hydroxy, 
4-hydroxy or 1,4-dihydroxy metabolites. Chickens form 1-hydroxy (1-OH)-midazolam as the 
major metabolite, which is also reported for humans (Cortright and Craigmill, 2006).  
In our study, we investigated the hepatic and intestinal gene expression of CYP3A37 in 
broilers using RT-PCR. A comparative study was performed between two different 
microsomal preparation methods for chicken small intestines. In addition, we also evaluated 
the CYP3A activity using midazolam as a substrate.  
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MATERIALS AND METHODS 
Chemicals 
Gibco® Dulbecco’s phosphate buffered saline (PBS) was obtained from Life Technologies 
(Ghent, Belgium). Potassium chloride, potassium dihydrogenphosphate, sodium chloride, 
disodium hydrogenphosphate, dipotassium hydrogenphosphate, glycerol and 
ethylenediaminetetra-acetic acid (EDTA) were purchased from VWR (Leuven, Belgium). 
Chlorpropamide, trisodium citrate dihydrate, dithiothreitol, histidine and sucrose were 
purchased from Sigma-Aldrich (St-Louis, MO, USA).   Nicotinamide adenine dinucleotide 
phosphate (NADPH) was obtained at Biopredic International (Rennes, France). Midazolam 
and 1-OH-midazolam were kindly donated by Roche (Basel, Switzerland). Protease Inhibitor 
Cocktail Tablets Complete Mini were obtained from Roche (Vilvoorde, Belgium). These 
Protease Inhibitor Cocktail Tablets consist of pancreatic extract (0.02 mg/ml), pronase (0.005 
mg/ml), thermolysin (0.0005 mg/ml), chymotrypsin (0.0015 mg/ml) and papain (0.33 
mg/ml).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
Animals and sample collection 
The experimental procedures conducted with the broiler chickens were in accordance with 
the European guidelines for the care and use of animals for research purposes. 
Sampling for intestinal microsome preparation. Healthy broiler Ross chicks (n=6, 3 ♀ and 3 
♂) aged 4 weeks used in this study were of a commercial strain. After cervical dislocation, 
various parts of 12 cm of the small intestines were collected. The different sampling sites 
along the digestive tract of the broilers were as follows: 2 cm posterior to the gizzard 
(intestine 1), immediately anterior to the Meckel’s diverticulum (intestine 2) and 2 cm 
anterior to the ileo-caecal transition (intestine 3). Parts were divided in three different parts 
of 4 cm each and were opened longitudinally with a pair of scissors. The tissues were rinsed 
with PBS to remove partially digested feed residues and put in separate vials. No scraping of 
the mucosa was performed. After snap-freezing, the tissues were kept at -80°C until analysis. 
To try to reduce variability, random combinations of samples were used to test the 
protocols. Samples were pooled as follows: 1 tissue set consisted of 3 pieces of 4 cm from 
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the same intestinal part but from three random chickens. Consequently, every intestinal 
tissue sample had a total length of 12 cm. Three tissue sets per region were tested for each 
protocol.  
 
Sampling for CYP3A37 gene expression. Fourteen broiler chickens (7 ♀ and 7 ♂) ages 4 
weeks were euthanized by cervical dislocation. Samples of the liver (100 mg) and various 
parts of 1 to 2 cm of the small intestines were collected. The sampling sites along the 
digestive tract were as described above. The samples were rinsed in PBS, immediately frozen 
in liquid nitrogen and kept at -80°C until analysis. 
 
Sampling for CYP3A activity measurements. The same number of animals as described for 
gene expression, were euthanized. A segment of 4 cm was taken from each intestinal part 
(intestine 1, 2 and 3 as described previously). The segments were opened and rinsed with 
PBS. Liver samples of 8 g were also washed carefully with PBS. All the samples were 
collected in separate cryovials, immediately frozen in liquid nitrogen and stored at -80°C 
until analysis. 
Microsomal preparation for CYP3A activity measurements 
Hepatic microsomes were prepared using a process of differential ultracentrifugation 
(Wilson et al., 2003). All processing of tissue was performed on a bed of ice. Liver tissue was 
minced and homogenized in 4 ml homogenization buffer (pH 7.25, 0.25 M phosphate buffer, 
1.15% KCl) per g tissue. After centrifugation at 10,000 x g (15 minutes, 4°C), the resulting 
supernatant was centrifuged at 100,000 x g for 75 minutes (4°C). In order to wash the 
formed microsomal pellet, it was resuspended in homogenization buffer (4 ml/g tissue) and 
centrifuged again following the last conditions. The final microsomal pellet was resuspended 
in 1 ml/g tissue of resuspension buffer (pH 7.25, 0.25 M phosphate buffer, 1.15% KCl, 30% 
glycerol). The resuspended microsomes were immediately frozen in liquid nitrogen and 
stored at  -80°C until activity measurements. 
Intestinal microsomes were prepared using two different methods, described by Mohri and 
Uesawa (2001) for rat small intestinal epithelial cells. The first method was based on mincing 
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in a Potter system, the other method also used the Potter system but was preceded by an 
EDTA-based separation of the enterocytes.  
To start both methods, samples were immersed in Solution A (pH 7.3, 1.5 mM KCl, 96 mM 
NaCl, 27 mM sodium citrate, 8 mM KH2PO4 and 1 tablet protease inhibitor cocktail/10 ml) 
while thawing for approximately 3 minutes at 41°C in an incubation oven, which corresponds 
with the avian body temperature. The thawed sample was blot dried and weighed. 
Mincing method. The thawed sample was minced with scissors and homogenized using an 
automated Potter-Elvehjem system (500 rpm, 7 up and down movements) in 4 ml 
homogenization buffer (pH 7.4, 50 mM KH2PO4, 50 mM K2HPO4, 1 mM EDTA and 1 tablet 
protease inhibitor cocktail/ 10 ml) per g sample. The homogenate was centrifuged at 
18,000xg for 15 minutes (4°C), and the resulting supernatant was centrifuged at 100,000 x g 
for 60 minutes (4°C). The resulting microsomal pellet was washed with resuspension buffer 
(pH 7.5, 125 mM KH2PO4, 125 mM K2HPO4, 1.25 mM EDTA, 20% glycerol and 1 tablet 
protease inhibitor cocktail/10 ml), centrifuged again at 100,000 x g for 60 minutes (4°C) and 
resuspended in 1 ml resuspension buffer per g tissue. 
 
EDTA-separation method. The thawed sample was immersed in 4 ml Solution B for 2 
minutes (pH 7.4, 2.7 mM KCl, 137 mM NaCl, 1.5 mM KH2PO4, 8 mM Na2HPO4, 1.5 mM EDTA, 
0.5 mM dithiothreitol and 1 tablet protease inhibitor cocktail/10 ml) while gently squeezing 
the tissue and swirling the dish. The separated enterocytes were collected, and the 
immersion in Solution B was repeated 3 times in total. The cells were rinsed with 12 ml 
Solution C (pH 7.0, 5 mM histidine, 0.25 mM sucrose, 0.5 mM EDTA and 1 tablet protease 
inhibitor cocktail/10 ml) and centrifuged at 800xg for 15 minutes (4°C). Subsequently, the 
cells were homogenized with Solution C (Potter-Elvehjem at 500 rpm) and centrifuged at 
15,000 x g for 15 minutes (4°C).  The supernatant was then centrifuged at 100,000 x g for 45 
minutes (4°C), and the microsomal pellet was resuspended as described above in the 
mincing method. 
The obtained microsomal suspensions, after applying one of the 2 above mentioned 
methods, were snap frozen in liquid nitrogen and stored at -80°C. Protein concentration of 
all microsomes was measured using the method described by Bradford (1976). 
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Sample processing 
CYP3A37 gene expression. According to the manufacturer’s instructions, total RNA was 
isolated from the liver and intestinal samples using RNAzol®RT (MRC Inc., Cincinnati, USA). 
An Experion RNA StdSens Analysis kit (Biorad Laboratories, Hercules, CA, USA) was used to 
check the purity of the RNA samples. RNA concentrations were measured using a Nanodrop 
spectrophotometer (Thermo Scientific, Wilmington, USA) at an absorbance of 260 nm. 
Reverse transcription was carried out in a 20 µl final volume that included 4 µl of 5 x iScript 
Reaction Mix, 1 µl of iScript Reverse Transcriptase, 1 µl of RNA template (1 µg) and nuclease-
free water to complete the final volume. Different components described above are part of 
the iScript cDNA Synthesis Kit (Biorad Laboratories). The mix was incubated at 25°C for 5 
min, heated to 42°C for 30 min and inactivated at 85°C for 5 min. The obtained cDNA was 
stored at -20°C until analysis. Absolute quantification was carried out using the Applied 
Biosystems 7500 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA). The 
primers used for CYP3A37 amplification were adopted from Zhang et al. and were as follows: 
CYP3A37 forward, 5’-CGAATCCCAGAAATCAGA–3’; CYP3A37 reverse, 5’-
AGCCAGGTAACCAAGTGT-3’ (GenBank ID: NM 001001751.1) (Zhang et al., 2010).  The 
annealing temperature was set at 60°C for the primers. The quantitative RT-PCR reaction 
was carried out in 96-well plates with 500nM of the forward and reverse primers, 5 µl iQTM 
SYBR®Green Supermix (Biorad) and 1 µl of the fivefold diluted cDNA template, in a total 
reaction volume of 10µl. The thermal cycler conditions were 15 min at 95°C, followed by 40 
cycles of 20s at 95°C, 30s at 60°C, 30s at 72°C. The melt curve analysis showed that the RT-
PCR generated PCR-products had identical melt-points for all tissues, indicating that the PCR-
products amplified are the same in the various tissues. For construction of the standard 
curve, a PCR product of 396 bp was generated using DNA from chicken liver and the 
following primers: forward, 5’-CCCCAGTGATGCTGTAGATT-3’; reverse, 5’-
TAGAGCCGGAGGGTTTCATT-3’. After purification with an Invitek kit (Germany) and 
measuring the DNA concentration with a Nanodrop ND 1000 spectrophotometer (NanoDrop 
Technologies), the volume of the linear dsDNA standard was adjusted to 1 x 108 copies/µl. 
This stock solution was serially diluted to obtain a standard series with each step differing by 
10-fold. The copy numbers of samples were determined by reading off the standard series 
with the Ct values of the samples. Three amplifications were performed for each CYP mRNA 
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and the standard curve was repeated on each plate in duplicate. For the validation of the 
qPCR assays following criteria were applied:  slope between -3.6 and -3.1, efficiency between 
90 and 110 %, R2 > 0.99. 
 
CYP3A activity measurements. Microsomal incubations were performed at 41°C in a shaking 
heat block. For each broiler and tissue two separate incubations were run in duplicate. 
Mixtures of 1.15% KCl, 0.05 M phosphate buffer (pH 7.4) and midazolam (final concentration 
of 25 µM according to the study of Cortright and Craigmill (2006) our chosen concentration 
corresponds with Vmax) were pre-heated. After addition of NADPH (final concentration in 
incubation medium of 1 mM), the mixture was pre-incubated for 3 minutes, after which the 
incubation reaction was initiated by the addition of the microsomal dilution. Incubations 
contained 0.275 mg protein/ml. After exactly 20 minutes, the enzymatic reactions were 
terminated through the addition of the stop reagent (water/acetonitrile/formic acid 
(42/55/3, (v/v/v)) containing the internal standard (IS) chlorpropamide (final concentration 
in terminated incubation mixture of 0.072 µM). The terminated samples were vortex mixed 
and cooled on ice, after which they were centrifuged at 20,000 x g for 10 minutes (4°C). The 
supernatants were collected and frozen at -20°C until analysis.  
The amounts of 1-OH-midazolam that were formed during the incubations were quantified 
using a validated UPLC-MS/MS method published elsewhere (De Bock et al., 2012).  In short, 
20 µl of the supernatant was injected onto a Waters Acquity UPLC BEH C18 column (50 mm x 
2.1mm, 1.7 µm particle size) with a VanGuard pre-column (5 mm x 2.1 mm, 1.7 µm particle 
size). 1-OH-MDZ eluted at 2.08 min, and the IS at 2.75 min, after gradient elution, using 
water with 0.1% formic acid and acetonitrile with 0.1% formic acid at a flow rate of 400 
µl/min. Detection was performed using a quadrupole mass spectrometer in the multiple 
reaction monitoring mode (m/z 1-OH-MDZ 342.04> 323.70, m/z IS 276.86> 174.69). A linear 
calibration curve with weighting factor 1/x2 was calculated within 4.29-1929.60 nM range. 
The method accuracy was 93.52 – 102.61%, and the between-day and within-day precision 
were <4.82% RSD and <4.61% RSD, respectively. Data were analysed with MassLynx software 
(v 4.1). 
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Data analysis 
Results from the expression and activity measurements were compared between the 
different sections by ANOVA after determination of normality and variance homogeneity. 
Multiple comparisons were performed using a LSD post-hoc test. Not normally distributed 
data were analyzed using the non-parametric Kruskal-Wallis analysis, followed by a Mann-
Whitney test using SPSS 19.0 Software (SPSS Inc., Chicago, IL, USA). A P-value of <0.05 was 
considered statistically significant.  
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RESULTS 
MINCING preparation method results in higher CYP3A activity per gram of intestinal tissue 
compared to the EDTA protocol 
Mean total protein content of the microsomes prepared using the mincing method was 
higher (mean= 7.063 mg/ml; SD= 1.61 mg/ml) than with the EDTA-separation method 
(mean= 2.196 mg/ml; SD= 0.56 mg/ml).  Normalization of the CYP3A activity to gram tissue 
confirmed that the mincing protocol had a higher yield than the EDTA-based method (data 
not shown).  The EDTA preparation resulted in a lower protein content, which makes it more 
difficult to evaluate the activity of CYP3A in the small intestines of broiler chickens. 
Therefore, the mincing protocol was applied to test intestinal CYP3A activity in the group 
with 14 animals (see results presented below). 
 
Quantification of CYP3A37 mRNA expression in liver and along the entire length of small 
intestines of broiler chickens 
Analysis of the data shown in Figure 1 indicates that the CYP3A37 gene expression in the 
intestines is substantially higher immediately anterior to the Meckel’s diverticulum (intestine 
2), even significantly higher than in the ileum (intestine 3) (P<0.05). The expression in the 
proximal part (intestine 1) is comparable to the most distal part of the small intestine 
(intestine 3). Remarkably, the expression level is the lowest in the liver of the broilers with a 
significant difference with intestine 2 (P<0.001). A similar trend was observed for both male 
and female animals. 
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Figure 1. Expression of CYP3A37 mRNA in the small intestines and liver of broilers (n= 14, 7 
♂ and 7 ♀). Each expression level represents the mean + standard deviation of the seven 
broilers based on three independent amplifications. (*: P<0.05; *** : P<0.001).  
 
CYP3A activity decreases from proximal to distal in the chicken small intestine 
Figure 2 shows the CYP3A activity after applying the mincing method for the preparation of 
intestinal microsomes. The highest metabolic activity was observed in the proximal part, 
with a clearly decreasing trend towards the distal part of the small intestines (P<0.001). The 
mean hepatic midazolam biotransformation activity is similar as the level observed in the 
proximal part of the small intestines. Again, a similar trend was observed for both male and 
female birds. 
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Figure 2. CYP3A subfamily activity in the small intestines and liver of broilers (n= 14, 7 ♂ 
and 7 ♀). For each broiler and tissue, two separate incubations were run in duplicate. Data 
are represented as mean activity + standard deviation. 
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DISCUSSION 
In this study, we analyzed the CYP3A expression and activity in liver and small intestines of 
broilers. Discordant regulation of these enzymes in liver and small intestine has been 
observed in man (Lown et al., 1994) and rats (Hakkak et al., 1993). 
A newly developed RT-PCR method showed that CYP3A37 mRNA in broilers is expressed in a 
much higher extent immediately anterior to Meckel’s diverticulum. From these results, it can 
be concluded that the CYP3A37 expression in the jejunum of broilers is substantially higher 
than in the duodenum or ileum of these animals. In cynomolgus monkeys, mRNA of CYP3A4 
was abundantly expressed in the distal part of the duodenum and the upper jejunum. Again 
a decreasing trend was observed towards the distal ileum (Nakanishi et al., 2010). A similar 
trend was also observed in rats (Mitschke et al., 2008).  However, our results are in contrast 
with the findings in horses, where the CYP3A4 expression was noticed to be the highest in 
the proximal intestine with a decreasing trend towards the distal parts (Tyden et al., 2004). 
Unfortunately, there is no further literature available to compare with, especially not for 
poultry species. Our study also showed that the expression of CYP3A37 mRNA in the livers of 
broilers is lower in comparison to the intestines of these animals. Previous studies in horses 
and humans also resulted in a higher CYP3A4 mRNA expression in the proximal intestine 
compared to the liver (Kolars et al., 1992; Tyden et al., 2004).  
In addition, the expression of CYP3A37 mRNA showed high inter-individual differences, in 
both liver and intestines. Interpatient CYP3A4 heterogeneity in humans was previously 
described by Lown et al. (1994). Moreover, existence of large inter-breed differences in 
CYP450 expression patterns has been reported by Fink-Gremmels (2008). Ozdemir et al. 
reported that at least 60% or more of the variability in CYP3A4 activity is under genetic 
control (Ozdemir et al., 2000). It is known that CYP450 isoforms are also influenced by many 
other factors including physiological and environmental ones (Watkins, 1994; Antonovic & 
Martinez, 2011). However, gender differences in CYP3A37 mRNA expression were not seen 
in our study, both sexes revealed similar variation in expression. CYP3A activity, on the other 
hand, was observed using midazolam as substrate. The protocols that were evaluated in this 
study to prepare intestinal microsomes, were based on the paper of Mohri and Uesawa 
(2001). These authors compared different preparation methods of rat intestine, based on 
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either scraping or EDTA-separation of the enterocytes, followed by Ca-aggregation or 
ultracentrifugation in order to obtain the microsomal fraction. Other useful information was 
obtained from the study by Tyden et al. (2004), which describes a procedure for the 
preparation of horse intestinal microsomes after scraping of the mucosal cells with a scalpel, 
as also done by Paine et al. (1997) for human intestinal microsomes. The subsequent 
procedure was similar to the ultracentrifugation procedure described by Mohri and Uesawa. 
Results of our study revealed that the protocol based on mincing of the tissues leads to a 
higher total protein content compared to the method with EDTA-separation. Different 
preparation procedures can indeed result in different enzymatic activities. Mohri and 
Uesawa (2001) concluded that the separation of enterocytes with EDTA-treatment is more 
appropriate than a method that involves scraping of the enterocytes with a microscope 
slide. In our study, the EDTA-separation seemed to be difficult to standardize with a lower 
reproducibility as consequence. This method also did not provide a guarantee about the 
quantity of enterocytes that is separated in the supernatant, which is further used for 
homogenization. In the mincing protocol, the whole tissue is homogenized after mincing. For 
the investigation of the in vitro biotransformation of drugs, high enzymatic activities are 
necessary to guarantee accurate and representative measurements, and therefore the 
mincing method is considered superior. Moreover, high protein levels are necessary for 
chickens, due to the low hepatic CYP content reported in these animals compared to other 
species, such as mice, rats, horse and ruminants (Khalil et al., 2001).  
Watkins (1994) described different substrates to test CYP3A enzymes such as erythromycin, 
midazolam, cortisol, nifedipine, dapsone and lignocaine. From all these substrates 
midazolam seemed to be the most appropriate as substrate for CYP3A (Watkins, 1994). In 
addition, MDZ has already been used in different avian species as a substrate for CYP3A 
(Cortright and Craigmill, 2006). In chicken the production of MDZ metabolites in liver 
microsomes demonstrated Michaelis-Menten kinetics with Km equal to 2.1±0.8 μM for 1-OH-
MDZ (Cortright and Craigmill, 2006). Therefore, MDZ was also used in our study to evaluate 
the CYP3A activity in liver and intestines of the broilers. Both liver and duodenum are 
involved in the first pass metabolism, which explains the high CYP3A activity in the 
duodenum and the liver.  
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The discordance between the CYP3A mRNA expression and the activity of these enzymes 
may suggest that transcriptional or posttranscriptional factors may be involved in the 
regulation of CYP3A in the small intestines of chickens. A poor correlation between CYP3A 
mRNA expression and protein activity has also been seen in humans. However, the protein 
concentration and activity were in accordance and thus, posttranscriptional regulation of 
CYP was supposed. (Lown et al., 1994). On the other hand, it can’t be excluded that the 
results for CYP3A activity may be influenced by the presence of other CYP3A isoforms for 
which midazolam can be a substrate in chickens (Murcia et al., 2011). 
From our findings, we can conclude that the cytochrome P450 enzymes in the mucosal villi 
of the small intestine in broilers can have an equal or even a higher importance for the first-
pass metabolism of some drugs and xenobiotics than the liver. The inter-species variations 
can lead to large differences in oral bioavailability of drugs which are subject to first-pass 
metabolism. A variable susceptibility to diseases and environmental factors of the animals 
can also be explained. From the differences between the various intestinal sections, we can 
conclude that the sample sites have to be carefully described and selected for the 
measurement of the CYP mRNA expression levels and activity.  
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Chapter 5. 
 
Effects of T-2 toxin on intestinal and hepatic biotransformation mechanisms 
and transporter systems 
 
 
 
 
 
 
 
 
 
 
Adapted from: Osselaere, A., Li, S.J., De Bock, L., Devreese, M., Goossens, J., 
Vandenbroucke, V., Van Bocxlaer, J., Boussery, K., Pasmans, F., Martel, A., De Backer, P., 
Croubels, S. (2013). Toxic effects of dietary exposure to T-2 toxin on intestinal and hepatic 
biotransformation enzymes and drug transporter systems in broiler chickens. Food and 
Chemical Toxicology 55, 150-155.. 
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ABSTRACT 
The effects of the mycotoxin T-2 on hepatic and intestinal drug-metabolizing enzymes 
(cytochrome P450) and drug transporter systems (MDR1 and MRP2) in poultry were 
investigated during this study. Broiler chickens received either uncontaminated feed, feed 
contaminated with 68 µg/kg or 752 µg/kg T-2 toxin. After three weeks, the animals were 
euthanized and MDR1, MRP2, CYP1A4, CYP1A5 and CYP3A37 mRNA expression were 
analyzed using qRT-PCR. Along the entire length of the small intestine no significant 
differences were observed. In the liver, genes coding for CYP1A4, CYP1A5 and CYP3A37 were 
significantly down-regulated in the group exposed to 752 µg/kg T-2. For CYP1A4, even a 
contamination level of 68 µg/kg T-2 caused a significant decrease in mRNA expression. 
Expression of MDR1 was not significantly decreased in the liver. In contrast, hepatic MRP2 
expression was significantly down-regulated after exposure to 752 µg/kg T-2. Hepatic and 
intestinal microsomes were prepared to test the enzymatic activity of CYP3A. In the ileum 
and liver CYP3A activity was significantly increased in the group receiving 752 µg/kg T-2 
compared to the control group. The results of this study show that drug metabolizing 
enzymes and drug transporter mechanisms can be influenced due to prolonged exposure to 
relevant doses of T-2. 
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INTRODUCTION 
Mycotoxins are widely distributed contaminants of different crops intended for human and 
animal consumption (Fink-Gremmels, 1999; Placinta et al., 1999). T-2 toxin (T-2) is a 
trichothecene mycotoxin, produced by fungi belonging to the Fusarium species. Among the 
trichothecenes, T-2 is the most acutely toxic (Hussein and Brasel, 2001). In broiler chickens, 
T-2 causes reduced feed intake and body weight gain, but also severe oral lesions and 
immunological dysfunction (Devegowda and Murthy, 2005). Clinical signs depend on the 
exposure time and on the dose of the toxin. In addition, T-2 is a potent inhibitor of the 
protein synthesis and tissues with a high cell division rate, like the intestinal mucosa and the 
liver, are the most susceptible (Sokolovic et al., 2008). Moreover, this toxin causes oxidative 
stress that alters the cell cycle and induces apoptosis in vitro and in vivo (Chen et al., 2008; 
Islam et al., 1998). Although T-2 is known to cause important economic losses, no maximum 
guidance limits for T-2 in food and feedstuff have been pointed out by the European Union 
until now (Anonymous, 2011). However, T-2 can be considered as an emerging contaminant 
since concentrations up to 1810 µg T-2 toxin per kg wheat have been reported in Germany 
(Schollenberger et al., 2006). In poultry the generally accepted no observed adverse effect 
level (NOAEL) value is set at 0.5 mg T-2 /kg feed (Eriksen and Pettersson, 2004). 
Drugs and feed contaminants are both xenobiotics. Being considered foreign products, they 
are both eliminated from the animal body by comparable processes. Before their excretion 
in the urine or faeces, biotransformation of these compounds can take place. 
Biotransformation is also possible before absorption of the compound into the systemic 
circulation. Both liver and intestine are involved in this first pass metabolism of orally 
ingested xenobiotics. Cytochrome P450 (CYP450) enzymes play a dominant role in the 
process of oxidative biotransformation (Hollenberg, 1992). In humans, most drugs are 
metabolized by the CYP3A4 isoform (Hardman, 2001). Presence of CYP3A subfamily has been 
confirmed in chickens, as an isoform CYP3A37 has been found with a homology of 60% to 
human CYP3A4 (Ourlin et al., 2000).  
Beside the superfamily of cytochrome P450, active transport-systems also play a role in the 
protection against xenobiotics. These transporters are called adenosine-tri-phosphate (ATP)-
binding cassette (ABC) carrier proteins and are able to remove xenobiotics from cells using 
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ATP hydrolysis as energy source. Multiple drug resistance 1-gene (MDR1, which encodes P-
glycoprotein (P-gp)) and multidrug resistance-associated protein 2 (MRP2) gene are genes 
coding for membrane proteins belonging to the ABC superfamily (Cherrington et al., 2002; 
Tusnady et al., 1997).   
Drug-food interactions often occur through effects on gastro-intestinal motility or by drug 
binding. On the other hand, drug metabolism and drug transporter can also be influenced by 
food or feed and their contaminants. Grapefruit for example, is a very well-known inhibitor 
of CYP3A4 in humans and is responsible for increased drug levels (Ameer and Weintraub, 
1997). Grapefruit compounds such as flavonoids, furocoumarins and furanocoumarins have 
been identified as inhibitors of the intestinal CYP3A4 in different in vitro studies (Fukuda et 
al., 1997; Ho et al., 2001). These grapefruit compounds bind irreversibly to CYP3A4 and 
permanently inactivate the isoenzyme. The mode of action is called mechanism-based 
inhibition and the duration of this inhibition may be longer than competitive inhibition since 
new CYP3A4 isoenzymes must be synthesized for activity to be restored. Inhibition of 
intestinal CYP3A4 enzymes leads to an increased maximum plasma concentration and total 
amount of the drug (Bressler, 2006). Different studies already reported the negative 
influence of T-2 on the normal metabolism of xenobiotics in the liver (Kravchenko et al., 
1986; Suneja et al., 1989). Negative effects of short-term exposure to high doses of T-2 on 
CYP1A expression have been reported in rats and rabbits (Galtier et al., 1989; Guerre et al., 
2000). One study reports the impact of chronic exposure to T-2 on CYP1A protein expression 
in pigs (Meissonnier et al., 2008). Studies mentioned above mainly focused on the CYP1A 
subfamily expression and only in the liver. We focused on the effects of long-term exposure 
to T-2 on CYP1A4, CYP1A5 but also on CYP3A-expression in broilers. In addition, the 
influence of prolonged exposure to T-2 on the enzymatic activity of CYP3A was studied, using 
midazolam as substrate. Both liver and small intestines were included in our study, since 
both organs play a dominant role in the first pass effect. The last aim of our study was to 
investigate the possible impact of prolonged T-2 exposure on the mRNA expression of MDR1 
and MRP2 transporter-mechanisms in broilers.   
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MATERIALS AND METHODS 
Chemicals 
Dulbecco’s phosphate buffered saline (PBS) was obtained from Gibco® Life Technologies 
(Ghent, Belgium). Potassium chloride, potassium dihydrogenphosphate, sodium chloride, 
disodium hydrogenphosphate, dipotassium hydrogenphosphate, glycerol and 
ethylenediaminetetra-acetic acid (EDTA) were purchased from VWR (Leuven, Belgium). 
Chlorpropamide and trisodium citrate dihydrate were purchased from Sigma-Aldrich (St-
Louis, MO, USA).   Nicotinamide adenine dinucleotide phosphate (NADPH) was obtained at 
Biopredic International (Rennes, France). Midazolam and 1-OH-midazolam were kindly 
donated by Roche (Basel, Switzerland). Protease inhibitor Cocktail Tablets Complete Mini 
were obtained from Roche (Vilvoorde, Belgium).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
Animal experiments 
Animals and tissue sampling. Twenty-four one-day old broiler chickens (12 ♀ and 12 ♂) 
were obtained from a commercial strain (Belgabroed, Hoogstraten, Belgium) and housed 
together according to the requirements of the European Union (Anonymous, 2007). The 
experiments started after 10 days of acclimatization, allowing the animals to adapt to the 
environment. For the study, the animals were divided in three experimental groups, each 
consisting of 8 animals. Three different experimental diets were fed during three weeks: the 
first group received control feed, the second and third group received feed contaminated at 
68 and 752 µg/kg T-2, respectively. Feed and water were given ad libitum. The applied light 
cycle was the same as on the commercial farm (20 hours light/ 4 hours dark). Animals were 
weighed before feeding the different diets and at the end of the experiment, in order to 
calculate the body weight (BW) gain over the experimental period (BW d 33 – BW d 11). 
After three weeks of feeding, the animals were killed by cervical dislocation. Organs (liver, 
heart, kidneys, proventriculus and ventriculus) were weighed and the lengths of the 
duodenum, jejunum and ileum were measured. Afterwards, tissue samples were collected. 
Intestinal sections, 1 cm long, were collected for the mRNA expression measurements (qRT-
PCR analysis). The different sampling sites along the digestive tract of the broilers were as 
follows: 2 cm posterior to the gizzard (duodenum), immediately anterior to the Meckel’s 
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diverticulum (jejunum) and 2 cm anterior to the ileo-cecal transition (ileum). After rinsing in 
PBS and freezing in liquid nitrogen, the tissues were kept at -80°C until analysis. For the 
investigation of CYP activity the same sampling sites were applied, but parts of 2 cm were 
taken. From the liver, samples of approximately 1 cm3 (qRT-PCR analysis) and 2 cm3 (activity 
measurements) were taken and rinsed in PBS. The samples were immediately frozen in 
liquid nitrogen and kept at -80°C until analysis. All animal experiments were approved by the 
ethics committee of the Faculty of Veterinary Medicine, Ghent University (EC 2011/033). 
Feed preparation and experimental diets. Conventional broiler feed (Bromix Plus®) was 
purchased from Versele-Laga (Deinze, Belgium). It was considered as uncontaminated feed 
after analysis for the presence of mycotoxins by a validated multi-mycotoxin liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) method (Fytolab, Zwijnaarde, 
Belgium). This feed is further referred to as control feed and was used to feed the animals 
during the acclimatization period as well as to prepare the T-2 contaminated feeds needed 
for the experiment.  
To produce feed of a contamination level of approximately 100 µg T-2/kg feed, a stock 
solution of 0.55 mg/mL was prepared by dissolving 55 mg T-2 (Fermentek, Jerusalem, Israel) 
in 100 mL ethanol (Merck, Darmstadt, Germany). The contaminated feed was produced by 
adding 9.1 mL of the stock solution to 500 g of control feed. This premix was then mixed 
with 5 kg control feed to assure homogeneous distribution of the toxin. The premix was 
finally mixed for 15 min in the total amount of feed (50 kg) needed for the experiment. To 
test T-2 homogeneity in the feed, a sample was taken at three different locations in the 
batch and analysed with LC-MS/MS to determine the concentration of T-2. A mean 
concentration of 68 µg/kg feed was found in this T-2 contaminated feed. To produce feed 
with a contamination level of approximately 1000 µg T-2/kg feed, a similar procedure as 
described above was applied but 90.9 mL of the stock solution was used instead of 9.1 mL. 
After the production of the contaminated feed, again analysis of the presence of T-2 was 
investigated at three different sampling sites. The analysis resulted in a mean contamination 
level of 752 µg/kg feed.  
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Analysis of CYP1A4, CYP1A5, CYP3A37, MDR1 and MRP2 mRNA expression using qRT-PCR  
Samples of the liver and different intestinal segments were collected as described above. 
Total RNA from the tissue samples was isolated using RNAzol®RT (MRC Inc., Cincinnati, USA) 
according to the manufacturer’s instructions. The RNA concentration was measured by 
absorbance at 260 nm with a Nanodrop spectrophotometer (Thermo Scientific, Wilmington, 
USA). An Experion RNA StdSens Analysis kit (Biorad Laboratories, Hercules, CA, USA) was 
applied to test the purity of the RNA samples. Reverse transcription was carried out using 
the iScript cDNA Synthesis kit of Biorad Laboratories. This reaction was carried out in a 20 µL 
final volume that included 4 µL of 5x iScript Reaction Mix, 1 µL of iScript Reverse 
Transcriptase, 1 µL of RNA template (1 µg), and nuclease-free water to complete the final 
volume. The reverse transcription mix was incubated at 25°C for 5 min, heated to 42°C for 30 
min, and inactivated at 85°C for 5 min. The obtained cDNA was stored (-20°C) until further 
analysis. The primers for CYP1A4, CYP1A5 and CYP3A37 were adopted from Zhang et al. 
(Zhang et al., 2010) and for the transporter carriers MDR1 and MRP2 from Haritova et al. 
(Haritova et al., 2010). The specificity of the primers was tested by performing a BLAST 
search against the genomic NCBI database. A list of the genes and their sequences used for 
quantitative PCR analysis is given in Table 1. Housekeeping genes were tested for all the test 
conditions and all the samples after which most stable housekeeping genes for liver and 
intestinal samples were selected using the geNorm software (data not shown). The most 
stable housekeeping genes had a M-value between 0.2 and 0.5. To determine if the inclusion 
of an additional housekeeping gene was required, the cut-off value for variation was set at 
0.2. GAPDH and β-actin were used as housekeeping genes for the hepatic samples; HPRT and 
RPL7 were the most stable housekeeping genes for the intestine. The genes of interest 
(CYP1A4, CYP1A5, CYP3A37, MDR1 and MRP2) were quantified using real-time quantitative 
PCR. PCR reactions were carried out in 96-well plates with the appropriate forward and 
reverse primers (500 nM), 5 µL of iQTM SYBR®Green  Supermix (Biorad Laboratories) and 1 µL 
of the fivefold diluted cDNA template. Thermocycling parameters were used according to 
the manufacturer’s instructions and included 40 cycles of 20 s at 95°C, 30 s at 60°C, 30 s at 
72°C. For the validation of the qPCR assays following criteria were applied: slope between -
3.6 and -3.1, efficiency between 90 and 110 %, R2 > 0.99. The threshold cycle values (Ct) 
were first normalized to the geometric means of appropriate reference mRNAs and the 
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normalized mRNA levels were calculated according to 2-ΔΔCt method (Livak and Schmittgen, 
2001).   
Table 1. List of genes and sequences of the primers used for quantitative PCR analysis. 
 
                                                                                                                                                                                                                                                                                                                                                                                                    
Analysis of CYP3A activity 
 
For the preparation of hepatic microsomes, a process of differential ultracentrifugation was 
used (Wilson et al., 2003). Liver tissues were first minced and afterwards homogenized in 
homogenization buffer (4 mL/gram tissue: pH 7.25, 0.25 M phosphate buffer, 1.15% KCl). 
The supernatant recovered after an initial centrifugation step (10000 g, 15 minutes, 4°C), 
was subsequently centrifuged at 100000 g for 75 minutes (4°C). Between centrifugation 
steps, tissue was held on ice. The microsomal pellet was washed in homogenization buffer 
and again centrifuged following the last conditions. The final pellet was then resuspended in 
resuspension buffer (1 mL/gram tissue: pH 7.25, 0.25 M phosphate buffer, 1.15% KCl, 30% 
glycerol). Finally, the microsomes were quickly frozen in liquid nitrogen and stored at -80°C 
until further analysis. 
Gene name Forward primer (5’→3’) Reverse primer  (5’→3’) Accession number 
β-actin CACAGATCATGTTTGAGACCTT CATCACAATACCAGTGGTACG NM_205518 
GAPDH  GGCACGCCATCACTATC CCTGCATCTGCCCATTT NM_204305 
HPRT CCCAAACATTATGCAGACGA TGTCCTGTCCATGATGAGC NM_204848 
RPL7 ACATGTACAGACAGGAGATCCGCA AAGCTGTAACACCTTCCGGACCTT NM_001006345 
CYP1A4 AGGACGGAGGCTGACAAG CAGGATGGTGGTGAGGAAGA NW_003763853 
CYP1A5 TCACCATCCCGCACAGCA AAGTCATCACCTTCTCCGCATC NW_003763826 
CYP3A37 CGAATCCCAGAAATCAGA AGCCAGGTAACCAAGTGT NW_003763931 
MDR1 GCTGTTGTATTTCCTGCTATGG ACAAACAAGTGGGCTGCTG NM_204894 
MRP2 CTGCAGCAAAATGAGAGGACAATG CAGAAGCGCAGAGAAGAAGACCAC XM_421698 
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For the preparation of intestinal microsomes the mincing method was applied as published 
in a previous paper (Osselaere et al., 2012) In brief, the sample was minced with scissors and 
homogenized using an automated Potter-Elvehjem system (500 rpm, 7 up and down 
movements) in homogenization buffer (4 mL/gram tissue: pH 7.4, 50 mM KH2PO4, 50 mM 
K2HPO4, 1 mM EDTA and 1 tablet protease inhibitor cocktail /10 mL). The homogenate was 
centrifuged (18000 g, 15 minutes, 4°C) and the resulting supernatant was centrifuged 
(100000 g, 60 minutes, 4°C). Afterwards the microsomal pellet was washed with 
resuspension buffer (pH 7.5, 125 mM KH2PO4, 125 mM K2HPO4, 1.25 mM EDTA, 20% 
glycerol and 1 tablet protease inhibitor cocktail /10 mL) and centrifuged (100000 g, 60 
minutes, 4°C). Finally, the pellet was resuspended in 1 mL resuspension buffer per gram 
tissue. The microsomes were immediately frozen in liquid nitrogen and stored at -80°C until 
activity measurements.  
Protein concentration of all microsomes was measured using the method described by 
Bradford(Bradford, 1976). Microsomes were incubated in a heating block at 41°C, 
corresponding to the body temperature of poultry. A preheated mixture (41°C) with 1.15% 
KCl, 0.05 M phosphate buffer (pH 7.4) and midazolam (final concentration of 25 µM) and 
NADPH (1 mM) was pre-incubated for 3 minutes. The incubation reaction started after the 
addition of the microsomal dilution. The incubations were performed with 0.3 mg protein / 
mL. The enzymatic reactions were terminated after exactly 20 minutes by the addition of a 
stop reagent (water/acetonitrile/formic acid (42/55/3, (v/v/v)) containing the internal 
standard chlorpropamide (final concentration 0.072 µM). Afterwards, the samples were 
vortexed, cooled on ice and centrifuged at 20000 g for 10 minutes (4°C). Supernatants were 
stored at -20°C until analysis. 
Amounts of 1-OH midazolam formed during the incubations were quantified using a 
validated UPLC-MS/MS method (De Bock et al., 2012). Data were analyzed with MassLynx 
software (v4.1). 
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Data analysis 
The differences in mRNA expression and enzymatic activity among groups were assessed by 
performing ANOVA (SPSS® 19.0 software for Windows, IBM, USA) after determination of 
normality and variance homogeneity. Multiple comparisons were performed using LSD post-
hoc test. Significance level was set at 0.05.  
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RESULTS 
A reduced body weight gain in broilers was observed after 3 weeks feeding T-2 at 752 µg T-
2/kg feed 
During the whole experiment animals were observed for possible clinical signs. No 
symptoms of T-2 mycotoxicosis were observed. One animal died in the group with the 
highest concentration of T-2, already after 4h feeding. No lesions were observed during 
autopsy.  The group receiving 752 µg T-2/kg feed, showed a significantly decreased BW gain 
compared to the control group and the group receiving T-2 at a lower level (68 µg T-2/kg 
feed) (Table 2). No significant differences were observed in organ weights and length of the 
small intestine between the different dietary groups (data not shown).   
Table 2. Mean (± SD) body weight (BW) before and after prolonged exposure to T-2 and 
body weight gain. 
 
 control 68 µg T-2 /kg feed 752 µg T-2 /kg feed 
BW d 11 (g) 287 ± 64 307 ± 24 312 ± 31 
BW d 33 (g) 2037 ± 295 2088 ± 136 1774 ± 142* 
    
BW gain (g) 1750 ± 248 1780 ± 147 1464 ± 127* 
 
After an acclimatization period of ten days the animals were divided in three different groups each receiving 
different diets (control or T-2 contaminated feed). Broilers were exposed to T-2 at two different concentration 
level (68 µg/kg and 752 µg/kg). The animals were weighed at the end of the acclimatization period (d 11) and 
on the day of the euthanasia (d 33). BW gain was measured as the difference between BW day 33 and BW day 
11. * refers to a significantly lower BW or BW gain compared to the other dietary groups (p<0.05). 
 
 
T-2 down-regulates CYP3A37, CYP1A4, CYP1A5 and MRP2 mRNA expression in liver, but 
not in the small intestine of broilers 
 
In the intestine no significant differences between the dietary groups could be found 
regarding the expression of the different genes in the broilers (data not shown). However, in 
the liver the three CYP-genes were significantly down-regulated in the group exposed to 752 
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µg T-2/kg feed. For CYP1A4 also a down-regulation was observed in the animals receiving 
feed contaminated at 68 µg T-2/kg feed (Figure 1). In the liver also a significant down-
regulation in the mRNA expression of MRP2 was noticed as illustrated in Figure 1. On the 
other hand, for MDR1 mRNA expression level, only a decreasing trend could be observed in 
the liver. 
 
Figure 1. Fold change in CYP, MDR1 and MRP2-genes expression levels in broilers’ livers after 
dietary T-2 exposure relative to the control group. Broilers were exposed to T-2 at two 
different concentration levels (68 µg/kg and 752 µg/kg). After three weeks of feeding the 
experimental diets, mRNA expression levels in liver were examined. Data represent the 
normalized target gene amount relative to control which is considered 1. Data are presented 
as mean + standard deviation for a total of 8 animals per dietary group, except for the group 
receiving 752 µg T-2/kg feed (n=7). Bars marked with * indicate significantly different 
responses compared to the control group (p<0.05). 
 
 
 
CYP3A enzymatic activity is up-regulated in the liver and ileum of broilers after three 
weeks exposure to T-2 at 752 µg T-2/kg feed 
T-2 exposure during three weeks at a contamination level of 752 µg/kg feed resulted in a 
significant increased activity of CYP3A in the liver of broilers. Results are shown in Figure 2. 
Feed contaminated at a lower level of T-2 (68 µg/kg feed) didn’t cause significant up- or 
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down-regulation of CYP3A activity compared to the control group. T-2 influence on CYP3A 
activity was also investigated at three different sampling sites in the small intestines of the 
animals. CYP3A activity was measured in duodenum and jejunum, but no effects of T-2 
exposure were detected at these sites. However, in the ileum CYP3A activity was 
significantly increased, but again only in the group receiving 752 µg/kg feed compared to the 
group fed an uncontaminated diet. Results are shown in Figure 3. 
 
Figure 2. Effect of dietary exposure to T-2 on hepatic CYP3A activity in broilers. After three 
weeks of feeding the experimental diets, liver microsomes were prepared and incubated 
with midazolam to measure CYP3A activity. Results are presented as the mean + standard 
deviation of the hepatic activity for a total of 8 animals per dietary group, except for the 
group receiving 752 µg T-2/kg feed (n=7). Bars marked with different letters indicate 
significantly different activity (p< 0.05). 
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Figure 3. Effect of dietary exposure to T-2 toxin on CYP3A activity in the ileum of broilers. 
After three weeks of feeding the experimental diets, intestinal microsomes were prepared 
and incubated with midazolam to measure CYP3A activity. Results are presented as the 
mean + standard deviation of the intestinal activity for a total of 8 animals per dietary group, 
except for the group receiving 752 µg T-2/kg feed (n=7). Bars marked with different letters 
indicate significantly different activity (p< 0.05). 
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DISCUSSION    
The aim of this study was to characterize the effects of T-2 toxin on hepatic and intestinal 
drug metabolizing enzymes (CYP450) when fed during three weeks to broilers. In addition, 
the effects of T-2 on drug transporter systems (MDR1 and MRP2) were also studied in the 
same organs. The lower dose of T-2 contaminated feed (68 μg/kg feed) is situated between 
the minimum (10 μg/kg feed) and maximum (112 μg/kg feed) levels observed in the survey 
of Monbaliu et al. (2010). In this study 67 contaminated feed samples were analyzed with a 
multi-mycotoxin LC-MS/MS method (Monbaliu et al., 2010). The higher dose (752 µg/kg 
feed) can also be considered of practical relevance, as even higher levels have been reported 
in a study in Germany (Schollenberger et al., 2006). However, the generally accepted NOAEL 
value for T-2 in poultry is 0.5 mg/kg feed (Eriksen and Pettersson, 2004). 
At the higher contamination level (752 µg/kg feed) CYP1A4, CYP1A5 and CYP3A37 mRNA 
expression was significantly down-regulated in the liver. Hepatic CYP1A4 was even down-
regulated at a contamination of 68 µg T-2/kg feed. To our knowledge, no other studies were 
performed in poultry to investigate the effect of T-2 on CYP mRNA expression. Most studies 
investigated the effect of T-2 toxin in vitro in man or pigs (Verbrugghe et al., 2012). The 
results of these in vitro experiments are in contrast with our results. T-2 was noticed to be a 
CYP1A1 inducer in human intestinal epithelial cells from the colon after acute exposure to a 
dose of 0.03 µg/mL (Kruber et al., 2011). In pigs, hepatocyte CYP3A22 mRNA expression was 
induced 2.5-fold after 48h exposure to T-2 toxin at a concentration of 0.1 µg/mL (Ge et al., 
2010). In a recent study, mRNA levels of CYP1A were similar in the control group and T-2 
treatment groups in porcine primary hepatocytes, but porcine CYP3As were induced in the 
T-2 treatment groups. Also in the latter study, primary hepatocytes were exposed during 
only 48h at doses of 0.02, 0.05 and 0.1 µg/mL (Wang et al., 2011). The discrepancy between 
our study and the in vitro studies can be explained by variance among the different 
experimental models. In vitro cell response of a given trichothecene is not always an 
accurate predictor of toxicity in whole animals (Rocha et al., 2005). The toxicity of T-2 is 
known to be affected by factors such as administration route, time of exposure and dosage 
(Sokolovic et al., 2008). On the other hand, CYP3A is highly conserved in eutheria, but not in 
chickens and reptiles (Antonovic and Martinez, 2011; Qiu et al., 2008.  
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Effect of chronic in vivo exposure of T-2 on CYP enzymes was studied in the livers of rat, 
rabbits and pigs. Results of these studies are in accordance with our results. Guerre et al. 
reported a dose-dependent decrease of CYP1A1, CYP1A2, CYP2A1 and CYP2B4 protein 
expression in white rabbits after 5-days oral treatment with T-2 at doses of 0.5, 0.25 and 0.1 
mg T-2/kg feed (Guerre et al., 2000). A similar decreasing trend was observed in young rats 
after 1, 4 or 8 days exposure to 1.0 mg/kg body weight (Galtier et al., 1989). The longest 
exposure experiment was performed by Meissonnier et al. in pigs. After 28-days of feeding 
T-2 (2102 µg/kg feed), hepatic CYP1A showed a significantly lower expression compared to 
the control group. For CYP2B, CYP2C and CYP3A protein expression a decreasing trend was 
observed in the pigs, but no significant differences were noticed (Meissonnier et al., 2008). A 
possible explanation could be the sesquiterpenoid structure of the trichothecenes. Some 
sesquiterpenoid molecules are substrates of CYP450 sub-families and are responsible for the 
up- or down-regulation of the expression or biotransformation activities in both rodent and 
human models (Usia et al., 2004). In addition, T-2 is a lipophilic molecule, which can explain 
the sensitivity of CYP enzymes to T-2 toxicosis. CYP450 enzymes are embedded in the bilayer 
of the smooth endoplasmatic reticulum and are thus easily accessible for the toxin 
(Meissonnier et al., 2008). Moreover, T-2 is known to be a potent inhibitor of the RNA 
synthesis, which can explain the reduced mRNA expression (Rocha et al., 2005; Sokolovic et 
al., 2008).  
The effect of dietary exposure to T-2 on MDR1 and MRP2 genes was also analyzed during 
our study. MRP2 was reduced significantly but hepatic MDR1 not, maybe due to the fact that 
MRP2 is more present in the liver of healthy broilers compared to MDR1 (Haritova et al., 
2010). MRP2 has a protective role against accumulation of drugs and toxins (Elias and Mills, 
2007).   
Both CYP and drug transporter systems are regulated at the transcriptional level by nuclear 
receptors, such as the Pregnane X receptor (PXR), which is highly expressed in the liver 
(Beigneux et al., 2002; Honkakoski and Negishi, 2000). Expression of PXR can be influenced 
by different factors such as drugs and toxins, but also several diseases can have an influence. 
This can be a possible pathway to explain the reduction of both CYP and MRP2 expression 
after prolonged exposure to T-2.  
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In our study, the effect of T-2 on CYP, MDR1 and MRP2 expression in the small intestine was 
also investigated. However, no significant differences were observed along the different 
parts of the digestive tract. A possible explanation could be that the liver plays a major role 
in the metabolism of T-2 before biliary excretion in the intestine (Chi et al., 1978; Wu et al., 
2010).  
Besides mRNA expression, the CYP3A enzymatic activity was also studied using midazolam as 
a substrate. Midazolam has already been reported to be a good substrate for CYP3A in 
human (Watkins, 1994), but also in poultry (Cortright and Craigmill, 2006). Another 
important characteristic of midazolam is that it is not transported by P-gp and relatively few 
drugs have been reported in this regard (Schmiedlin-Ren et al., 1997). Remarkably, both liver 
and ileum showed a higher activity of CYP3A in the T-2 treatment group with the higher 
contamination level (752 µg/kg feed) compared to the control group. A possible explanation 
for the higher CYP3A activity can be the presence of compensation mechanisms for the 
reduced expression of CYP3A. Another possibility is post-transcriptional or even post-
translational regulation of CYP3A activity. It is essential to distinguish between mRNA and 
protein expression, and understand that mRNA expression does not necessarily correlate to 
activity. This has been observed after administration of ionophores in broilers (Zhang et al., 
2010). Another possible explanation for the discrepancy between the CYP3A37 mRNA 
expression and the CYP3A activity, is that the existence of the other CYP3A isoforms in 
chickens can’t be excluded for which midazolam can be a substrate (Ourlin et al., 2000). 
Lown et al. (1994) also observed a poor correlation between the intestinal CYP3A mRNA 
expression and activity in humans. However, a good correlation was obtained between the 
protein expression and the protein activity of CYP3A (Lown et al., 1994). In our study, the 
protein expression could not be studied. Immunoblot and ELISA analyses were performed 
with a polyclonal rabbit anti-human antibody, but no signal could be obtained despite 
several assays. A possibility for the lack of CYP3A detection is that the rabbit anti-human 
antibody does not cross-react with chicken proteins due to differences in the antigenic 
determinants of avian species.  
In conclusion, prolonged exposure to practically relevant doses of T-2 toxin could interfere 
with the normal CYP-mediated metabolism of endogenous or xenobiotic substances. In 
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addition, drug transporter mechanisms, with substrates such as tetracyclines antibiotics 
(Mealey, 2004), could also be influenced by the presence of the mycotoxin T-2. This may be 
of importance for the animal, for the pharmacokinetics and efficacy of therapeutic drug 
substrates used, and consequently for the withdrawal time of these drugs. 
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The occurrence of mycotoxins is a worldwide problem which can affect both human and 
animal health. The main difficulty in assessing the risk of exposure is the multiplicity of 
factors affecting the production or presence of mycotoxins. Good agricultural practice is 
necessary to minimize crop contamination (Paterson and Lima, 2010). It is generally 
accepted that although actions are undertaken to reduce contamination, the presence of 
mycotoxins can not totally be excluded. In European moderate climate regions, three 
Fusarium mycotoxins are important, namely the trichothecenes deoxynivalenol (DON) and T-
2 toxin (T-2), and zearalenone (ZEN). Different studies already reported DON being the 
mycotoxin with the highest prevalence in European feed samples (Binder 2007; Monbaliu et 
al., 2010). T-2, on the other hand looks to be the most acute toxic mycotoxin (Edwards et al., 
2009). Zearalenone is known to have a particular affinity for the oestrogen receptor (Bennett 
and Klich, 2003) and therefore, it is generally accepted that ZEN mainly influences the 
fertility which is of greater importance for the broiler breeders industry or laying hens than 
for broiler chickens raised exclusively for the production of meat. 
Several studies reported the effects of chronic feeding of trichothecenes on technical 
parameters in farm animals, and poultry has been reported to be one of the most resistant 
species. On the other hand, it is not because clinical signs are rarely observed in broiler 
chickens that the mycotoxins do not act at the molecular level (Pestka, 2008). 
Trichothecenes are inhibitors of the RNA, DNA and protein synthesis. Cells with high 
proliferation rate and high turn-over are known to be the main targets of DON and T-2. Both 
liver and intestine have these characteristics and in addition, these organs are the first to be 
encountered after intake of contaminated feed. Therefore, the principal aim of this thesis 
was to investigate if DON and/or T-2 can cause detrimental effects on the intestinal barrier 
and liver function.  
In practice, mycotoxin detoxifiers are frequently used feed additives to reduce the risk of 
mycotoxicosis. Based on their mode of action, mycotoxin detoxifying agents can be divided 
in two different classes: adsorbing and biotransforming agents. However, there is a lack of 
knowledge concerning their efficacy and safety in vivo. Therefore, another goal of this thesis 
was to evaluate the efficacy of detoxifiers using the European Food Safety Authority (EFSA) 
guidelines and proposed end-points (Anonymous, 2009).  
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What are good biomarkers to evaluate the exposure to mycotoxins in broiler chickens? 
Literature reports different in vivo studies mentioning the effects of DON or T-2 on the feed 
intake and growth of broiler chickens. For DON the European Commission recommends 5 
mg/kg feed as a maximum level for complementary and complete feedstuffs such as poultry 
feed (Anonymous, 2006). In older studies mainly the effects of higher doses were 
investigated, while more recent experiments respect this guidance level (Awad et al., 2006b; 
Awad et al., 2011; Dänicke et al., 2007; Yunus et al., 2012b). However, some disagreement 
can be observed between the results of these different in vivo experiments and in addition, 
no clear dose-response relationship can be observed. In our study, no detrimental effects of 
DON on feed intake and body weight could be observed in broiler chickens exposed to 7.5 
mg DON/kg feed for three weeks. These results are in contrast with other studies, which 
demonstrated negative effects of DON on the animal body condition after exposure to lower 
concentrations of the toxin compared to our study (Dänicke et al., 2007; Yunus et al., 
2012b). Experimental studies to observe the effects of T-2 on the condition of the animals 
were also conducted in a wide concentration range, again without a clear dose-response 
relationship. During our study with 68 and 752 µg T-2/kg feed, no clinical symptoms of T-2 
mycotoxicosis such as oral lesions and feather alterations were observed. However, the 
broilers fed 752 µg T-2/kg feed showed a decreased weight gain compared to the control 
group. The group receiving a lower dose of 68 µg T-2/kg feed did not present significant 
differences concerning B.W. and feed intake with the control group. Our results are in 
discrepancy with the study of Sklan et al. (2001) who did not observe decreased body 
weights in broiler chickens after chronic feeding T-2 at a concentration of 1050 µg T-2/kg 
feed. Therefore, we suggest that performance parameters are not suitable to evaluate the 
negative effects of exposure to mycotoxins. Both feed intake and body weight gain are also 
always influenced by other factors such as environmental and genetic factors. Naturally 
contaminated feed generally causes more pronounced effects, mainly due to the presence 
of other mycotoxins (Rotter et al., 1996; Smith et al., 1997). In addition, the presence of 
masked mycotoxins can not be neglected. The effects of mycotoxins are also influenced by 
the exposure time and the age of the animals. All these influencing factors make it difficult 
to standardize studies and thus to compare different studies.  
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In this thesis we investigated if the plasma levels of DON and its metabolites can be used to 
determine the dietary exposure to DON. However, our results revealed that plasma levels 
above the limit of quantification of 1.25 ng/ml only could be observed when feeding DON at 
a concentration higher than the maximum recommended level of 5 mg/kg feed. The 
metabolite deepoxy-deoxynivalenol (DOM-1) was not detected in any of the samples, using 
also a limit of quantification of 1.25 ng/ml. During our toxicokinetic study of DON a low oral 
bioavailability of 19.3% was observed, which can explain the low plasma levels observed 
during our feeding trial. Also for T-2 and ZEN, toxicokinetic studies were conducted which 
reported even lower oral bioavailabilities for these toxins as no plasma levels of T-2 or ZEN 
could be observed after a single oral bolus. From these results, we can conclude that plasma 
levels of the tested toxins are not good biomarkers for poultry and thus they can also not be 
considered as suitable end-points to evaluate the efficacy of mycotoxin detoxifiers in vivo in 
broiler chickens. Nevertheless, EFSA recommends that plasma samples of DON or ZEN and 
their main metabolites have to be analyzed to determine the efficacy of detoxifiers 
(Anonymous, 2010). However, the EFSA recommendations may be suitable for other animal 
species, such as pigs. 
The question remains which other biomarkers can be used in practice to evaluate dietary 
exposure to trichothecenes? A possibility is the analysis of faeces or urine for the presence 
of the toxin and its metabolites. In humans, urine has already been reported to be a good 
biomarker for DON exposure (Turner et al., 2008). However, in chicken no difference can be 
made between urine and faeces since urine flows from the ureters into the coprodeum, 
rectum and ceca (Goldstein and Skadhauge, 2000). In addition, a recent study reported that 
only 6% of the ingested DON is recovered in the excreta of poultry (Awad et al., 2011). DON 
is namely converted to DOM-1 in the proximal part of the small intestines, mostly before 
absorption (Rotter et al., 1996; Swanson et al., 1988). In poultry, the intestinal flora is also 
able to convert DON to DOM-1 which makes it even more difficult to find DON in the excreta 
of chickens (He et al., 1992; Lun et al., 1988; Lun et al., 1986). Recovery of DOM-1 in the 
faeces was also reported to be poor (Awad et al., 2009), suggesting intestinal absorption 
and/or that DOM-1 may be further transformed to other compounds by the microbial flora 
of the gut. T-2 on the other hand is characterized by a very short half-life as reported in our 
toxicokinetic study. In addition, T-2 is rapidly metabolized to more polar metabolites, but 
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there are still derivates of T-2 which have not been identified and the toxicity of all these 
metabolites is still not well understood (Li et al., 2011). Also in humans, biomarkers for T-2 
are not well developed (Anonymous, 2011a). These facts confirm that it still remains difficult 
to diagnose DON or T-2 mycotoxicosis in poultry flocks in vivo.  
Diagnosis after necropsy is also an option. Beside macroscopic evaluation of possible lesions, 
histological examination of the intestines and the liver can be done. Evaluation of the length 
of intestinal villi and crypt after feeding DON was studied in this thesis and revealed that 
exposure to DON is characterized by shorter villi and reduced crypt depths. For the liver, 
both a macroscopic and microscopic evaluation can be performed in order to look for 
necrosis. However, caution is needed to be sure that the observed lesions are solely due to 
the exposure to mycotoxins. The analysis of the bile fluid as a possible diagnostic tool for 
DON has also been investigated in this thesis. Results revealed that levels of DON above the 
limit of quantification of 1.25 ng/ml could only be observed in the bile when feeding DON at 
concentrations higher than the maximum recommended level of 5 mg/kg. DOM-1, on the 
other hand, could be observed in all the groups receiving DON even at concentrations lower 
than 5 mg/kg feed suggesting DOM-1 in bile could be a valuable post-mortem biomarker in 
broilers. However, nor guidance levels for bile fluid nor ‘background’ contamination levels 
are available up till now. Analyses of residues in organs such as liver and kidneys were also 
performed in the same study, but no levels above the limit of quantification could be 
detected. Furthermore, it is also important to mention that all these analyses are expensive 
and that diagnosis is thereby mostly confirmed at a stage that the animals may already have 
suffered damage.  
Generally, it can be concluded that the diagnosis of mycotoxicosis is still based on suspicions 
or by exclusion of other pathologies. Therefore, the monitoring of feed before 
administration to the animals still remains a very important aspect of risk assessment in 
combination with Good Agricultural Practices.  
General discussion 
 
  
185  
 
Are broiler chickens really as resistant to mycotoxins as claimed? 
It is generally considered that chickens are one of the most resistant farm animal species to 
mycotoxins (Devegowda and Murthy, 2005). Symptoms mainly occur after exposure to much 
higher mycotoxin levels compared to other animals. Different hypotheses have already been 
reported in the literature concerning the resistance of poultry. The differential capacity 
among species to transform trichothecenes in the intestine is probably the factor of greatest 
importance concerning the detoxification of these mycotoxins in the different species. For 
example, poultry are known to transform DON to DOM-1 in the proximal part of the 
intestine, before absorption (Rotter et al., 1996; Swanson et al., 1988). This is confirmed in 
our study. We demonstrated that DON causes damage in the proximal parts of the small 
intestine, but not in the ileum. Hereby, poultry are more resistant to DON compared to pigs 
that transform DON to DOM-1 in the distal parts of the small intestine. In addition, we found 
in our toxicokinetic study an absolute oral bioavailability of 19.3% for DON in broiler 
chickens, while in pigs the oral bioavailability is around 80% (Prelusky et al., 1988).  
Besides, we observed during our studies a possible adaptation mechanism to the negative 
effects of DON in broiler chickens. After three weeks of feeding DON, no plasma levels could 
be observed above the limit of quantification in none of the experimental groups. These 
observations were confirmed by a recent study which describes that the plasma level of DON 
linearly decreased with the level of previous exposure (Yunus et al., 2012a). The main 
mechanism responsible for this kind of adaptation or tolerance still needs to be elucidated.  
The molecular mode of action of DON in broiler chickens has been investigated poorly until 
now. Probably due to the fact that chickens are considered to be relatively tolerant. 
However, during our studies we proved that DON is able to damage the intestinal barrier 
without clinical symptoms and without influence on the feed intake or body weight gain. T-2 
could also reduce the mRNA expression of CYP1A4 at a concentration that does not affect 
the feed intake or the body weight gain of the broiler chickens. These results underline that 
the action of trichothecenes at the molecular level is frequently underestimated as the 
effects on the hepatic and intestinal barrier are not always associated with clearly reduced 
performance.  
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What are the possible consequences of the effects of DON on the intestinal barrier 
function? 
The intestinal barrier is responsible for two major processes. The first one is the absorption 
of nutrients, xenobiotics and fluids. Second, the intestinal epithelial monolayer is responsible 
for the protection against harmful pathogens and xenobiotics (Oswald, 2006). The integrity 
of the intestinal epithelium is critical in maintaining a physical selective barrier between 
external and internal environments. 
Histological examination of the duodenal and jejunal segments revealed shortened villi and 
crypts in the broiler chickens exposed to 7.5 mg/kg DON. These results indicate that DON is 
able to reduce the absorption surface of the intestinal monolayer and thus may lead to a 
reduced absorption of nutrients. However, no effects on the body weight gain were 
observed during our investigations with DON. The reduced crypt depth can be indicative of a 
reduced regeneration of the barrier with possible negative effects on the barrier function. 
Tight junctions are the backbone of the paracellular barrier. Both chemical and physical 
factors can damage the structure and function of the tight junctions. We demonstrated the 
ability of DON to interact selectively with claudin 5, which may suggest a higher permeability 
of the intestinal barrier. Loss of the tight junctions integrity can lead to invasion of 
pathogens via the paracellular pathway. This was illustrated in our research by a higher 
mRNA expression of TLR4, which acts as a rapid pathogen sensor, in broiler chickens after 
three weeks of feeding DON.  Beside barrier disruption as an etiological factor, the ribotoxic 
stress-induced cellular response as was seen in our experiments after intake of DON 
contaminated feed can also be related to the induction of epithelial inflammation. This has 
previously also been reported in pigs (Vandenbroucke et al., 2011). In humans a correlation 
has already been pointed out between the presence of DON as a food contaminant and 
different chronic intestinal inflammatory diseases, such as coeliac and Crohn’s disease or 
ulcerative colitis (Maresca and Fantini, 2010).  
The regulation of the uptake of xenobiotics is also an important function. In pigs DON was 
able to increase the paracellular flux of the tracer [(3)H]-mannitol along with a reduced 
protein expression of claudin 4 (Van de Walle et al., 2010). Of particular interest is the effect 
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of the higher permeability of the gut wall on the absorption of frequently used drugs and 
coccidiostats in the poultry industry. In pigs, intestinal barrier disruption caused by DON and 
T-2 was shown to promote the transepithelial passage of antibiotics such as doxycycline and 
paromomycin (Goossens et al., 2012). Major concern is the question whether dose-
adaptation is necessary for these drugs? As a consequence of the higher permeability, a 
greater oral bioavailability of drugs may be observed with the possibility to reach higher 
levels, which could have consequences for the treated animal or even for the consumer of 
the edible tissues due to higher residues and prolonged withdrawal time. Special attention 
has to be paid to the coccidiostats belonging to the class of the ionophores. Toxic syndromes 
such as anorexia, diarrhea, ataxia, depression, recumbency and death have been reported 
due to the uptake of too high doses of monensin in poultry (Novilla, 1992). Beside a negative 
effect for the animal, human health could also be affected due to residues of the drugs in 
tissues and organs for human consumption. In order to fully understand these 
consequences, appropriate residue depletion studies should be conducted in the target 
animal species. 
 
What are the possible consequences of the effects of T-2 toxin on the liver and intestinal 
barrier function? 
Once xenobiotics are absorbed from the intestine after oral administration, metabolism of 
xenobiotics in various organs plays an important role in their disposition in the animal. The 
main organ for drug metabolism is generally considered to be the liver (Wang and Tompkins, 
2011). However, our study concerning the expression and activity of CYP3A proved that the 
role of the small intestine could be equally or even more important compared to the liver in 
broiler chickens.  
When xenobiotics reach the intestinal or liver cells, they are converted by various phase I 
and/or phase II enzymes to more hydrophilic metabolites, which can be excreted via kidney 
and other excretion routes. If a molecule is still taken up by the intestinal cells, transporter 
proteins can efflux it back to the intestinal lumen to increase the chances that the xenobiotic 
encounters one of the metabolizing enzymes. T-2 is able to alter the activities of several 
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hepatic enzymes such as glucuronyltransferase and glutathione S-transferase (Galtier et al., 
1989; Suneja et al., 1989). CYP450 enzymes play a dominant role in the biotransformation of 
xenobiotics. T-2 may also affect them. The effect of T-2 on hepatic CYP has already been 
described in rats, rabbits and pigs in vivo (Galtier et al., 1989; Guerre et al., 2000; 
Meissonnier et al., 2008; Goossens et al., 2013). However, extrapolation between species 
can not be made for CYP proteins (Nebbia et al., 2001). We demonstrated T-2 to be able to 
influence both the mRNA expression and activity of different hepatic CYP proteins and the 
activity of CYP proteins in the ileum. This fact underlines the role of the intestine in 
detoxification. In addition, we also investigated the impact of T-2 on two efflux transporters. 
However, a significant effect was only seen on hepatic MRP2 and not on P-gp which suggests 
that not all the transporter systems may be as sensitive to mycotoxins and that not all the 
efflux transporters react in the same way. This emphasizes that more research is needed 
concerning this issue. A reduced expression of efflux pumps is associated with higher levels 
of xenobiotics in the animal body, which can be a possible explanation for the reduced body 
weight gain observed in our study. 
At the mRNA level we demonstrated a down-regulation of CYP genes, but the activity of the 
enzymes was enhanced. We conclude that the effect of T-2 at the different levels, i.e. gene 
expression, protein expression and protein activity is not the same. Discrepancies between 
the results of different techniques might be explained by post-transcriptional or post-
translational regulation of CYP proteins and differences in sensitivity of the techniques. In 
addition, low correlations between mRNA expression, protein concentration and activity 
have been reported in different animal species. A possible explanation could be the 
substrate change or loss of selectivity toward the drug metabolizing enzymes. In animal 
species there is also a lack for suitable antibodies to perform immunoblotting or 
immunochemistry and only a few substrates have been investigated to establish their 
usefulness by the measurement of Km and Vmax. 
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Role of mycotoxin binders? 
The ubiquitous distribution of mycotoxins, together with their resistance to processing, 
enables toxins to persist in the human and animal food and feed supply. In practice the use 
of mycotoxin detoxifying agents has therefore become common. Two important factors have 
to be evaluated concerning these feed additives, namely their safety and their efficacy in 
vivo. 
In the literature different studies reported the beneficial effects of these detoxifiers on 
production parameters of broiler chickens (Awad et al., 2006a; Dänicke et al., 2003). 
However, according to EFSA the end-point to test their efficacy is to measure the plasma 
levels of DON and ZEN and their main metabolites (Anonymous, 2009). In this thesis, we 
demonstrated that blood is not a useful sample to test the efficacy of detoxifiers against 
DON in broilers when the maximum recommended levels are respected. This is in line with 
the low absolute oral bioavailability of DON observed during a toxicokinetic study. In 
addition, the observed tolerance or adaptation to DON may also reduce the plasma levels 
after prolonged exposure. As we reported even lower oral bioavailabilities for T-2 and ZEN in 
our toxicokinetic studies, we can question if plasma levels of these parent toxins are a 
suitable end-point for DON, T-2 or ZEN in poultry as stated by EFSA. However, after feeding 
three weeks DON at a concentration of 7.5 mg/kg feed, which is higher than the 
recommended level of 5 mg/kg feed, remarkably higher plasma concentrations of DON were 
observed in the groups receiving an adsorbing or a biotransforming agent. No positive 
effects were thus demonstrated concerning the detoxifiers on plasma levels, questioning 
their efficacy. Nevertheless, when looking at the molecular level a positive effect of the 
adsorbing agent could be observed in the jejunum. The observed up-regulation of claudin 5 
due to three weeks feeding DON-contaminated feed to broiler chickens was not so high in 
the group receiving an adsorbing agent in combination with DON. Although this is a 
significant positive effect of the adsorbing agent, the levels could not be reduced to the 
levels of the control group in the jejunum. Furthermore, we demonstrated that the 
adsorbing agents shifted the negative effects of DON to the more distal ileum.  
Regarding the possible interaction of mycotoxin detoxifiers with veterinary drugs, we 
demonstrated that the plasma concentration of amoxicillin and oxytetracycline can be 
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increased by the presence of detoxifiers. As a possible explanation, histological examination 
revealed that the use of an adsorbing agent leads to longer villi even in combination with 
DON. The biotransforming agent even resulted in significant higher residues of 
oxytetracycline in the kidneys compared to the control group. These observations underline 
the need for the evaluation of the safety of frequently used drugs in poultry in combination 
with mycotoxin detoxifiers. For bentonite the interactions with tylosin or with coccidiostats 
have already been reported (Anonymous, 1992; Anonymous, 2011b, Devreese et al., 2012). 
The investigated adsorbing agent in this thesis was composed of a smectite-type clay mineral 
(illite-ambrosite) and the biotransforming agent was a bentonite-montmorillonite upgraded 
with a yeast. We may thus conclude that bentonite can interact with more components than 
actually officially reported, and on the other hand other detoxifiers can apparently also 
influence the oral bioavailability of antibiotics. In this thesis we only focused on the effects 
of detoxifiers on orally administered drugs, but attention also has to be paid in the future to 
the interactions with nutrients, vitamins and other feed additives.  
 
 
Future research perspectives 
Evaluation of possible effect of trichothecenes on transporter proteins and 
biotransformation mechanisms at the protein level 
Our results indicate that chronic exposure to T-2 can reduce the mRNA expression of CYP 
genes in broiler chickens. On the other hand, we also reported that the activity of the 
enzyme CYP3A is enhanced in the same animals. We only observed the effects of T-2 at the 
mRNA level by qRT-PCR and at the functional level by ex vivo studies with the substrate drug 
midazolam. However, we were not able to evaluate the effects at the protein level as no 
suitable antibodies are available to perform western blot analyses or ELISA. Therefore, an 
immunohistochemistry method could be developed for the evaluation of CYP expression in 
broiler chickens. In this way, one could distinguish between post-transcriptional or post-
translational regulation of CYP proteins in broiler chickens. For the efflux pumps MDR1 and 
MRP2 on the other hand, the effects of T-2 were only evaluated at the mRNA level. In the 
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future, immunohistochemical demonstration of the effects of T-2 would be useful in 
combination with an in vivo study using a substrate to evaluate their protein expression and 
activity, respectively. Beside T-2, the effects of DON on transporter proteins and 
biotransformation enzymes should also be investigated in broiler chickens.  
 
Development of a rapid screening method for the detection of possible interactions 
between mycotoxin detoxifying agents and veterinary drugs or other feed additives 
The results of this thesis indicate that mycotoxin detoxifying agents can influence the 
pharmacokinetic profiles of oxytetracycline and amoxicillin in broiler chickens. We 
demonstrated that this interaction could lead to a higher oral bioavailability of these drugs, 
which indicates that dosage adaptation could be necessary when antibiotics and detoxifiers 
are administered simultaneously. However, in this thesis only two different detoxifiers were 
tested, while in practice several types of detoxifying agents are frequently used in the 
poultry industry (Anonymous, 2009). In addition, interactions with other antibiotics but also 
with other feed additives such as coccidiostats may be possible. In vivo testing of all the 
detoxifying agents in combination with different frequently applied drugs in poultry is 
impossible and not acceptable from an ethical point of view. Therefore, we suggest the need 
for the development of suitable in vitro methods for the rapid screening of possible 
interactions. These methods should not only be applicable for poultry, but also for other 
species as interspecies extrapolation is difficult. A method using Transwell® cell culture 
inserts in combination with species specific intestinal epithelial cell lines could be used to 
mimic the animal intestines. If from the results of the screening method possible 
interactions are suggested, in vivo studies can be done to confirm the findings, e.g. by 
studying the pharmacokinetic parameters of the compound in the particular species.  
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The production of mycotoxins by fungi may depend on a lot of factors and thus good 
management comprises all stages from ‘farm to fork’. Despite different prevention 
measures, animal nutritionists have to cope with a given level of contamination. In the 
European moderate climate regions Fusarium mycotoxins are the main contaminants. For 
deoxynivalenol (DON) the European Union recommends a concentration of 5 mg/kg feed as 
a maximum guidance value for poultry feed. For zearalenone (ZEN), maximum levels were 
set at 2 mg/kg feed for cereals and cereal products and at 3 mg/kg feed for maize by-
products. For T-2 toxin (T-2) in Belgium, the Federal Agency for the Safety of the Food Chain 
currently imposes a limit of 0.4 mg/kg feed for T-2 and HT-2 in poultry feed. Only very 
recently, the European Commission Recommendation of 27 March 2013 sets a level of 0.25 
mg/kg feed for the sum of T-2 and HT-2 in compound feed. 
Poultry is generally accepted to be one of the most resistant species to mycotoxicosis as 
symptoms mainly occur after exposure to very high mycotoxin concentrations. However, 
little data is available about the toxicokinetic profiles of Fusarium mycotoxins in poultry. The 
diagnosis of mycotoxicosis in the poultry industry is frequently based on suspicions or by 
exclusion of other pathologies, mainly due to a lack of suitable biomarkers. In practice, 
mycotoxin detoxifying agents are frequently used feed additives to reduce the risk of 
mycotoxicosis. Following their mode of action, detoxifiers can be divided in two groups, 
namely adsorbing and biotransforming agents. Adsorbing agents bind mycotoxins, while 
biotransforming agents are responsible for the degradation of mycotoxins into less or non-
toxic metabolites in the gastrointestinal tract of the animal. The European Food Safety 
Authority (EFSA) implements the investigation of the safety and efficacy of these detoxifiers. 
Therefore, in Chapter 1, toxicokinetic studies of DON, T-2 and ZEN were described in order 
to evaluate their absolute oral bioavailability and toxicokinetic parameters in broiler 
chickens. Toxins were administered intravenously and orally in a two-way cross-over design. 
For DON a bolus of 0.75 mg/kg body weight (BW) was administered, for T-2 0.02 mg/kg BW 
and for ZEN 0.3 mg/kg BW. The plasma levels of the toxins and their main metabolites were 
quantified using validated LC-MS/MS methods. An absolute oral bioavailability of 19.3% was 
observed for DON in broiler chickens, while for T-2 and ZEN even no plasma levels above the 
limit of quantification of 2.5 ng/ml and 1 ng/ml respectively, could be observed after a single 
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oral bolus. The shortest elimination half-life after intravenous administration was detected 
for T-2 (3.9 min), followed by DON (27.9 min) and ZEN (31.8 min).  
In Chapter 2, an animal trial was described in order to evaluate different parameters as 
suitable biomarkers to assess DON exposure. Broiler chickens were exposed to a 
concentration of DON below the guidance level of 5 mg/kg feed, namely 2.4 mg/kg feed, or 
to a higher concentration of 7.5 mg/kg feed for three weeks. In addition, adsorbing and 
biotransforming agents were evaluated concerning their efficacy. No detrimental effects of 
DON on the feed intake or the body weight gain of the animals were observed. Analyses of 
plasma levels of DON and its main metabolite deepoxy-deoxynivalenol (DOM-1) were 
performed with a validated LC-MS/MS method. DON could only be detected in the plasma of 
the animals receiving the highest DON concentration of 7.5 mg/kg feed. DOM-1 could not be 
detected in plasma of the animals. These results indicate that plasma concentrations of DON 
and DOM-1, as stated by the EFSA, are not reliable end-points to evaluate the efficacy of 
mycotoxin detoxifying agents against DON in broiler chickens. In an effort to look for 
possible other biomarkers, the concentrations of DON and DOM-1 were also determined in 
liver, kidneys and bile fluid. No residues of DON or DOM-1 could be detected in the organs 
above the limit of quantification of 1.2 ng/g. However, in the bile fluid DON and DOM-1 were 
detected in the animals receiving DON at a concentration of 7.5 mg/kg feed and DOM-1 was 
even detected in the animals fed DON at 2.4 mg/kg feed. From these findings, we can 
conclude that analysis of the bile fluid can be a suitable tool for post-mortem diagnosis in 
broiler chickens. However, no correlation with in feed concentrations could be recorded and 
nor guidance levels in bile nor ‘background’ contamination levels are available up till now. 
For the evaluation of possible interaction of the administered adsorbing and biotransforming 
agents with other components such as drugs, another in vivo trial was performed with 
broiler chickens. The animals received blank feed as such or blank feed supplemented with 
an adsorbing or a biotransforming agent. The adsorbing agent was a smectite-type clay 
mineral (illite-ambrosite) and the biotransforming agent was a bentonite-montmorillonite 
clay upgraded with a yeast. After three weeks of feeding the experimental diets, two 
different frequently used antibiotics in the poultry industry were administered to the 
animals. Both a pharmacokinetic study and a residue study were performed for 
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oxytetracycline and amoxicillin, separately. For amoxicillin, the plasma concentrations were 
significantly higher for broilers receiving an adsorbing agent in comparison to birds receiving 
the biotransformation agent, but both groups with detoxifiers were not significantly 
different to the control group. The residue levels of amoxicillin in the liver and the kidneys 
were lower than the limit of quantification of 12.5 ng/g in all the birds. The plasma and 
kidney tissue concentrations of oxytetracycline were significantly higher in broilers receiving 
a biotransforming agent in the feed compared with control birds and the birds receiving an 
adsorbing agent. We can conclude that detoxifiers can interact with the oral bioavailability 
of antibiotics depending on the type of detoxifier and antibiotics.  
Although poultry may be more resistant to mycotoxicosis, effects of trichothecenes such as 
DON and T-2 at the molecular level may not be underestimated. The inhibition of the RNA, 
DNA and protein synthesis and the activation of mitogen-activated protein kinases, are 
underlying mechanisms of their toxicity which can affect numerous organs and tissues. 
Especially the intestinal and hepatic cells are the first to be exposed to DON or T-2. 
Therefore, an important aim of this research was to evaluate if DON and T-2 damage the 
intestinal barrier and/or liver function in broiler chickens. 
The anatomy and histological structure of the digestive tract are constituted to guarantee its 
barrier function. The surface of the intestines is characterized by a large area for absorption 
of nutrients and xenobiotics. But, intestinal cells also create a barrier against invading 
pathogens and xenobiotics. These absorbing epithelial cells are strongly joined together by 
tight junctions. In pigs, DON was demonstrated to be able to interact with the gut wall 
morphology and to act selectively on components of these tight junctions. After intestinal 
absorption occurred, mycotoxins may reach the liver as the gate-way of the portal blood 
draining of the gastrointestinal tract and thus provoke hepatic lesions.  
In another study, described in Chapter 3, we thus investigated the possible effects of DON 
on the intestinal and hepatic barrier functions. Tissue samples of the animals of the study 
described in Chapter 2 were used, i.e. the group receiving blank feed, the group receiving 
DON contaminated feed at a level of 7.5 mg/kg feed, the group receiving DON contaminated 
feed in combination with an adsorbing agent and a fourth group receiving the control feed 
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supplemented with an adsorbing agent. Histological examination of the gut wall morphology 
in these different groups showed shorter villi and smaller crypts due to chronic DON 
exposure. These observations were reported both in the duodenum and jejunum. The use of 
an adsorbing agent resulted in longer villi over the entire length of the intestines even in 
combination with DON, which can be an explanation for the higher plasma concentrations of 
xenobiotics observed in Chapter 2. The crypt depth was partially restored when DON 
contaminated feed was fed in combination with an adsorbing agent. No effects of DON on 
the gut wall morphology were observed in the ileum. A qRT-PCR method was used to study 
the effects of DON on different tight junction components, more precisely on the mRNA 
expression of claudin 1, claudin 5, zona occludens 1 and zona occludens 2. Remarkably, DON 
caused a selective up-regulation of claudin 5 mRNA and this only at the level of the jejunum. 
When DON and an adsorbing agent were administered simultaneously, the effect of DON in 
the jejunum was less pronounced but mRNA expression of claudin 5 was still significantly up-
regulated compared to the control group. However, in the animals receiving DON in 
combination with an adsorbing agent, DON caused damage in the ileum and not specific on 
one gene, but the mRNA expression of all the investigated genes was up-regulated in this 
segment. We can therefore conclude that the adsorbing agent is able to shift the effects of 
DON to more distal parts of the small intestines. DON was also able to induce inflammatory 
reactions in both the duodenum and jejunum, but when DON was fed in combination with 
the adsorbing agent, up-regulation of pro-inflammatory Toll-like receptor 4 was only 
observed in the ileum. A shift towards distal parts could also be observed concerning the 
genes encoding for oxidative stress. This study also showed that not only DON but also the 
adsorbing agent alone were able to alter the mRNA expression of oxidative stress markers in 
hepatocytes of broiler chickens.  
Cytochrome P450 (CYP450) enzymes play a dominant role in the process of oxidative 
biotransformation of xenobiotics. Both the small intestines and the liver can be involved in 
these processes. CYP enzymes have mainly been studied in humans and laboratory animals. 
In humans, mainly CYP3A4 is responsible for drug metabolism. The presence of CYP3A4 has 
been confirmed in chickens since an isoform, CYP3A37, which is 60% homologous to human, 
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has been cloned. No information was available at the start of this PhD research concerning 
the gene expression of CYP3A37 and the activity of CYP3A enzymes in broilers. 
Consequently, in Chapter 4, hepatic and intestinal CYP3A expression and activity in healthy 
broiler chickens were investigated. A qRT-PCR method was developed for the absolute 
quantification of CYP3A37 at the mRNA level in broiler chickens. For this study, livers and 
small intestines of healthy chickens were collected. These chickens were fed with 
uncontaminated feed. A significant higher expression was observed in the jejunum 
compared to the ileum and the liver. Prior CYP3A activity measurements, a method for 
preparation of intestinal microsomes was developed. Activity of CYP3A was determined in 
hepatic and intestinal microsomes using midazolam as a substrate drug. The highest CYP3A 
activity was noticed in the proximal part of the small intestines with a decreasing trend 
towards distal. Duodenal and hepatic activities were comparable. We can conclude that the 
intestinal CYP3A proteins can have an equal or maybe even higher importance for the 
substrate drug metabolism than the hepatic ones.  
Beside the superfamily of CYP450, active efflux transporter systems also play a role in the 
protection against xenobiotics. Most of these drug transporters are members of the ABC 
family or the adenosine-tri-phosphate (ATP)-binding cassette protein family. Members of 
this family are present in both the liver and small intestines, where they are able to remove 
xenobiotics from intestinal and hepatic cells.  
Both drug metabolism and drug efflux transport can be influenced by feed, nutrients, drugs 
and contaminants. Therefore, in Chapter 5, an in vivo experiment was performed to evaluate 
the toxic effects of chronic dietary exposure to T-2 in broiler chickens. Beside the study of 
animal performance, principal aims were to investigate the effects of this toxin on intestinal 
and hepatic biotransformation enzymes (CYP450), but also on drug transporter systems such 
as P-glycoprotein or MDR1 and multidrug resistance-associated protein 2 (MRP2). One group 
of birds received uncontaminated feed while the other animals received two different 
concentrations of T-2, namely 68 μg T-2/kg feed and 752 μg T-2/kg feed. The animals 
receiving the highest concentration of T-2 had a lower body weight gain compared to the 
other groups after three weeks of feeding. A qRT-PCR method was developed to analyze 
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mRNA expression of CYP1A4, CYP1A5, CYP3A37, MDR1 and MRP2 genes. Results revealed 
that T-2 did not have a significant effect on the expression of the different genes in the small 
intestines. In the liver on the other hand, exposure to 752 μg T-2/kg feed led to down-
regulation of CYP1A4, CYP1A5 and CYP3A37. For CYP1A4 even a down-regulation could be 
observed in the animals receiving the lowest T-2 concentration of 68 μg T-2/kg feed. CYP3A 
enzymatic activity was up-regulated in the liver and ileum of broiler chickens after three 
weeks exposure to T-2 at a concentration of 752 μg T-2/kg feed compared to the control 
group and the animals receiving the lower T-2 dose. No effects of T-2 on CYP3A activity were 
observed in duodenum or jejunum. In conclusion, prolonged exposure to practical relevant 
doses of T-2 toxin could thus interfere with CYP-mediated metabolism of xenobiotics and 
with drug transporter systems which can have an impact on the pharmacokinetic 
parameters of substrate drugs.  
The general conclusion may be that the effects of trichothecenes in poultry may be 
underestimated, mainly due to the absence of clear visible clinical signs. Although, we 
demonstrated that DON and T-2 are characterized by low absolute oral bioavailabilities in 
broiler chickens, serious effects at the molecular level do occur. Both mycotoxins are indeed 
able to affect the intestinal and hepatic barrier function which can have consequences for 
the animal health. In addition, we also demonstrated that more research is needed 
concerning the efficacy and safety of mycotoxin detoxifying agents with respect to 
interactions with the oral absorption of veterinary drugs. 
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De productie van mycotoxines door schimmels wordt beïnvloed door diverse factoren. Goed 
management bij het principe van ‘riek tot vork’ is daarom onontbeerlijk. Ondanks allerlei 
voorzorgsmaatregelen moet men toch altijd rekening houden met een mogelijke 
contaminatiegraad. Gezien het gematigd klimaat in Europa, zijn voornamelijk Fusarium 
mycotoxines belangrijk. Zo voorziet de Europese Unie maximum toegelaten concentraties 
voor deoxynivalenol (DON) in kippenvoeder, namelijk 5 mg/kg voeder. Voor zearalenone 
(ZEN) is het maximum gehalte voor granen en graanproducten vastgelegd op 2 mg/kg 
voeder, terwijl in maïs gehaltes tot 3 mg/kg voeder toegelaten zijn. Voor het mycotoxine T-2 
adviseert het Belgisch Federaal Agentschap voor de veiligheid van de voedselketen (FAVV) 
een grenswaarde van 0.4 mg/kg voeder voor de som van T-2 en HT-2 in kippenvoeder te 
respecteren. Sinds 27 maart 2013 adviseert de Europese Commissie een indicatieve waarde 
voor de som van T-2 en HT-2 van 0.25 mg/kg voor mengvoeders. 
Kippen worden algemeen beschouwd als zijnde één van de meest resistente diersoorten 
aangezien ze slechts klinische symptomen vertonen na blootstelling aan zeer hoge 
mycotoxine concentraties. Er zijn echter weinig gegevens beschikbaar over de 
toxicokinetische eigenschappen van Fusarium mycotoxines in pluimvee. De diagnose van 
mycotoxicoses in de pluimveeindustrie is tot op heden voornamelijk gebaseerd op een 
vermoeden van intoxicatie ofwel door uitsluiting van andere pathologieën. Dit is het gevolg 
van een gebrek aan geschikte biomerkers voor het stellen van de diagnose. In de praktijk 
worden mycotoxine binders of modifiers frequent aangewend om het risico op 
mycotoxicoses te reduceren. Mycotoxine binders binden de mycotoxines in het 
spijsverteringsstelsel van het dier, terwijl modifiers de mycotoxines in het dier omzetten tot 
minder of niet-toxische metabolieten. De Europese Autoriteit voor Voedselveiligheid (EFSA) 
benadrukt dat de efficaciteit en veiligheid van deze voederadditieven moeten onderzocht 
worden. 
In Hoofdstuk 1 werden daarom toxicokinetische studies voor DON, T-2 en ZEN beschreven 
met als doel de absolute orale biologische beschikbaarheid en de toxicokinetische 
parameters voor deze mycotoxines te bepalen in vleeskippen. De mycotoxines werden oraal 
en intraveneus toegediend in een two-way cross-over design. Voor DON werd een bolus van 
0.75 mg/kg lichaamsgewicht (LG) toegediend, voor T-2 0.02 mg/kg LG en voor ZEN 0.3 mg/kg 
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LG. Vervolgens werden de plasmaconcentraties van de mycotoxines en hun belangrijkste 
metabolieten bepaald aan de hand van gevalideerde LC-MS/MS methodes. Er werd een 
absolute orale biologische beschikbaarheid van 19.3% vastgesteld voor DON, terwijl voor T-2 
en ZEN zelfs geen plasmaconcentraties boven de kwantificatielimiet van respectievelijk 2.5 
ng/ml en 2 ng/ml, konden worden teruggevonden na toediening van een éénmalige orale 
bolus. De kortste eliminatie halfwaardetijd na intraveneuze toediening werd berekend voor 
T-2 (3.9 min), gevolgd door DON (27.9 min) en ZEN (31.8 min).  
In Hoofdstuk 2 werd een dierproef beschreven met als doel verschillende biomerkers te 
evalueren om DON blootstelling te diagnosticeren. Hiervoor werden vleeskippen gedurende 
drie weken gevoederd met enerzijds 2.4 mg DON/kg voeder, wat lager is dan het maximum 
toegelaten gehalte (5 mg/kg voeder), en anderzijds met een hogere concentratie van 7.5 mg 
DON/kg voeder. Daarnaast werden ook een mycotoxine binder en een modifier ingemengd 
in het voeder om hun efficaciteit te beoordelen. DON had geen invloed op de groei of de 
voederopname van de dieren. De plasmaconcentraties van DON en zijn voornaamste 
metaboliet deepoxy-deoxynivalenol (DOM-1) werden gekwantificeerd met behulp van een 
gevalideerde LC-MS/MS methode. Er werd enkel DON teruggevonden in het plasma van de 
dieren die DON kregen aan een concentratie van 7.5 mg/kg voeder. DOM-1 kon niet worden 
gedetecteerd in het plasma van de kippen. Hieruit kunnen we besluiten dat de bepalingen 
van DON en DOM-1 in plasma van vleeskippen, zoals opgelegd door EFSA, geen goede 
merkers zijn om de efficaciteit van mycotoxine detoxifiers na te gaan. DON en DOM-1 
werden ook gekwantificeerd in de lever, de nieren en de gal van de dieren. In de organen 
werd noch DON noch DOM-1 gedetecteerd boven de kwantificatielimiet van 1.2 ng/g. Zowel 
DON als DOM-1 werden echter wel teruggevonden in de gal van de dieren die DON verstrekt 
kregen aan een concentratie van 7.5 mg/kg voeder. DOM-1 werd zelfs teruggevonden in de 
gal van de kippen die 2.4 mg DON/kg voeder kregen. Uit deze resultaten kunnen we 
besluiten dat analyse van DON en DOM-1 kan gebruikt worden voor post-mortem diagnose 
in vleeskippen. Een correlatie met de gehaltes in het voeder kan evenwel niet worden 
vastgelegd. Bovendien zijn er geen richtwaarden voor gehaltes in gal, noch voor 
‘achtergrond’contaminatie gehaltes beschikbaar. 
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Er werd een andere dierproef met vleeskippen uitgevoerd teneinde na te gaan of de 
toegediende mycotoxine binder en modifier mogelijks interageren met andere 
componenten zoals bijvoorbeeld geneesmiddelen. De dieren kregen ofwel niet 
gecontamineerd voeder ofwel niet gecontamineerd voeder gesupplementeerd met de 
binder of modifier. De mycotoxine binder die gebruikt werd was een klei mineraal, meer 
bepaald een smectiet (illiet-ambrosiet). De modifier was een bentoniet-montmorilloniet 
kleimineraal in combinatie met een gist. De verschillende voeders werden gedurende drie 
weken aan de kippen toegediend. Daarna werden twee frequent aangewende antibiotica in 
de pluimveesector verstrekt aan de kippen. Voor zowel amoxicilline als oxytetracycline 
werden twee onafhankelijke farmacokinetiek en residustudies uitgevoerd. De 
plasmaconcentraties van amoxicilline waren significant hoger in de dieren die de binder 
toegediend kregen in vergelijking met de modifier, maar beide niet significant verschillend 
ten opzichte van de controlegroep. De residuen van amoxicillin in de lever en de nieren 
waren voor alle kippen lager dan de kwantificatielimiet van 12.5 ng/g weefsel. Voor 
oxytetracycline waren zowel de plasmaconcentraties als de gehaltes in de nieren significant 
hoger in de kippen die de modifier kregen in vergelijking met de controledieren en de dieren 
die de binder gevoederd kregen. Hieruit kunnen we dus besluiten dat er interactie mogelijk 
is tussen antibiotica en mycotoxine detoxifiers, maar dat de effecten verschillend zijn 
afhankelijk van het type antibioticum en de detoxifier. 
Ondanks het feit dat pluimvee als relatief resistent beschouwd wordt, mogen de effecten 
van DON en T-2 op moleculair niveau toch niet onderschat worden. Zowel DON als T-2 zijn 
potente inhibitoren van de RNA, DNA en eiwitsynthese. Daarnaast kunnen ze mitogeen-
geactiveerde proteine kinasen activeren. Het is dus duidelijk dat verschillende organen hun 
doelwit kunnen zijn, maar het zijn vooral de dunne darm en de lever die het eerst in contact 
komen met mycotoxines. Daarom was een ander belangrijk doel van dit onderzoek om na te 
gaan of DON of T-2 mogelijk schade kunnen toebrengen aan de darmbarrière en/of de 
leverfunctie van vleeskippen. 
De anatomie en de histologische structuur van het spijsverteringsstelsel is dusdanig dat ook 
een belangrijke barrièrefunctie van de darm kan gegarandeerd worden. Het darmoppervlak 
is gekenmerkt door een groot contactoppervlak voor de absorptie van nutrienten en 
Samenvatting 
 
  
210  
 
xenobiotica, maar tegelijkertijd moet de invasie van mogelijke darmpathogenen en 
schadelijke componenten worden tegengegaan. Darmcellen zijn met elkaar verbonden door 
tight junctions. Onderzoek in varkens toonde eerder aan dat DON in staat is om selectief in 
te werken op de verschillende bouwstenen van deze tight junctions. Nadat intestinale 
absorptie zich heeft voorgedaan, bereiken mycotoxines de lever via de portale vene en 
kunnen mycotoxines mogelijks ook hepatische beschadiging uitlokken. 
In Hoofdstuk 3, werden daarom mogelijke effecten van DON op de darm- en leverbarrière 
onderzocht. Hiervoor werden stalen gebruikt van dieren uit de studie beschreven in 
Hoofdstuk 2, met name de blanco groep, de groep met DON gecontamineerd voeder aan 
een concentratie van 7.5 mg DON/kg voeder, hetzelfde DON gecontamineerd voeder 
gesupplementeerd met een mycotoxine binder en blanco voeder gesupplementeerd met de 
mycotoxine binder. Histologisch onderzoek van de darmpreparaten van deze verschillende 
diergroepen toonde duidelijk aan dat chronische DON blootstelling leidt tot kortere villi en 
kleinere cryptes. Deze bevindingen werden zowel voor het duodenum als het jejunum 
opgemerkt. Het gebruik van een mycotoxine binder leidde daarentegen tot langere villi over 
de hele darmlengte, zelfs in combinatie met DON, welke mogelijks een verklaring kan zijn 
voor de hogere plasmaconcentraties van xenobiotica beschreven in Hoofdstuk 2. De schade 
toegebracht door DON aan de crypten werd gedeeltelijk beperkt door de mycotoxine binder. 
Er werd histologisch geen schade door DON vastgesteld in het ileum.  Aan de hand van een 
qRT-PCR methode werd het effect van DON gemeten op verschillende tight junction 
bouwstenen, meer bepaald de mRNA expressie van claudine 1, claudine 5, zona occludens 1 
en zona occludens 2 werden gemeten. Opmerkelijk was de significante up-regulatie van 
claudine 5 mRNA na DON blootstelling en dit enkel ter hoogte van het jejunum. Dit werd 
uitsluitend voor dit eiwit geregistreerd. Na het voederen van DON in combinatie met de 
mycotoxine binder, werd er ook een significante up-regulatie van claudine 5 opgemerkt in 
het jejunum, maar echter niet zo uitgesproken als in de dieren die enkel DON kregen. 
Daarentegen gaf DON in combinatie met de binder wel aanleiding tot schade in het ileum, 
gekenmerkt door niet alleen een up-regulatie van claudine 5 maar ook van alle andere 
bestudeerde genen, met name claudine 1 en zona occludens 1 en 2. Dit in tegenstelling tot 
DON alleen. De resultaten wijzen erop dat de binder het effect van DON naar meer distaal 
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gelegen darmgedeeltes kan verschuiven. Daarnaast kan ook opgemerkt worden dat DON 
een inflammatoire respons veroorzaakte in zowel het duodenum als het jejunum, aangezien 
DON een up-regulatie van de pro-inflammatoire Toll-like receptor 4 veroorzaakte. Ook hier 
leidde de combinatie DON en mycotoxine binder eerder tot schade in het ileum, wat ook 
aantoont dat het effect van DON opgeschoven wordt naar meer distaal door de 
aanwezigheid van de mycotoxine binder. Dezelfde trend werd ook gezien voor de genen die 
coderen voor oxidatieve stress. In dezelfde studie werd ook aangetoond dat niet alleen DON, 
maar ook de binder in staat is om de mRNA expressie van merkers voor oxidatieve stress te 
beïnvloeden in de lever van kippen. 
Cytochroom P450 (CYP450) enzymes zijn belangrijk voor de oxidatieve biotransformatie van 
xenobiotica. Zowel de darm als de lever spelen hierin een rol. CYP eiwitten werden 
hoofdzakelijk bestudeerd bij de mens en in laboratoriumdieren. De humane CYP3A4 is het 
belangrijkste eiwit voor geneesmiddel metabolisatie. In kippen werd CYP3A37, zijnde een 
60% homoloog van het humane CYP3A4, gekloond. Bij de start van dit doctoraatsonderzoek 
was er echter geen informatie voorhanden betreffende de expressie van CYP3A37 en de 
activiteit van CYP3A enzymes in vleeskippen. 
Er werd bijgevolg, zoals beschreven in Hoofdstuk 4, een studie uitgevoerd om de expressie 
en de activiteit van CYP3A na te gaan in vleeskippen. Een qRT-PCR methode werd ontwikkeld 
voor de absolute kwantificatie van CYP3A37 op mRNA niveau in vleeskippen. Levers en 
darmen van gezonde en met een niet-gecontamineerd dieet gevoederde vleeskippen 
werden hiervoor verzameld. Uit de resultaten van deze studie bleek dat de CYP3A37 mRNA 
expressie significant hoger is in het jejunum in vergelijking met het ileum en de lever. 
Teneinde de CYP3A activiteit na te gaan in de verschillende darmsegmenten, werd er eerst 
een methode op punt gesteld om darmmicrosomen aan te maken. Zowel de hepatische als 
de intestinale CYP3A activiteit werden vervolgens gemeten met behulp van midazolam als 
substraat. De hoogste CYP3A activiteit werd teruggevonden in de proximale delen van de 
dunne darm met een dalende trend naar de distale gedeeltes. De hepatische activiteit van 
CYP3A was vergelijkbaar met de activiteit in het duodenum. Het is dus duidelijk dat 
intestinale CYP3A eiwitten minstens even of misschien zelfs belangrijker kunnen zijn dan 
hepatische voor de metabolisatie van substraten van CYP3A. 
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Naast CYP450 eiwitten, bieden ook efflux transporter systemen een bescherming tegen 
opname van xenobiotica. De meeste van deze efflux transporters zijn lid van de ABC familie 
of adenosine-trifosfaat (ATP)-binding cassette eiwitfamilie. Leden van deze familie zijn zowel 
in de lever als darm aanwezig, waar zij verantwoordelijk zijn voor het terugpompen van 
xenobiotica uit de intestinale en hepatische cellen.  
Zowel metabolisatie als efflux transport van farmaca kan beïnvloed worden door  voeder, 
nutriënten, geneesmiddelen en contaminanten. Daarom werd een in vivo proef uitgevoerd 
om de toxische effecten van chronisch voederen van T-2 te evalueren in vleeskippen, welke 
wordt beschreven in Hoofdstuk 5. Naast de studie van de productieparameters, was het 
hoofddoel van de studie om de effecten van het T-2 toxine op intestinale en hepatische 
biotransformatie enzymes (CYP450) na te gaan, alsook op transporter eiwitten zoals P-
glycoproteine of MDR1 en multidrug resistance-associated protein 2 (MRP2). De dieren 
werden onderverdeeld in verschillende groepen volgens het type experimenteel voeder, 
namelijk niet gecontamineerd voeder, gecontamineerd voeder met 68 μg T-2/kg voeder of 
752 μg T-2/kg voeder. De dieren die gevoederd werden met de hoogste T-2 concentratie 
hadden een significant lagere gewichtstoename in vergelijking met de andere twee groepen 
na drie weken voederen. Een qRT-PCR methode werd ontwikkeld om de mRNA expressie na 
te gaan van de volgende genen: CYP1A4, CYP1A5, CYP3A37, MDR1 en MRP2. Uit de 
resultaten bleek dat T-2 geen significant effect had op de expressie van deze verschillende 
genen in de dunne darm. In de lever daarentegen, gaf het voederen van 752 μg T-2/kg 
voeder aanleiding tot een significante down-regulatie van CYP1A4, CYP1A5 en CYP3A37 
mRNA. Een significante down-regulatie van CYP1A4 mRNA werd zelfs vastgesteld in de 
dieren die de laagste T-2 concentratie (68 μg T-2/kg voeder) toegediend kregen. De 
enzymatische activiteit van CYP3A was significant up-gereguleerd in het ileum en de lever 
van de vleeskippen die drie weken gecontamineerd voeder kregen aan een concentratie van 
752 μg T-2/kg voeder, en dit in vergelijking met de dieren die de lagere T-2 dosis of niet 
gecontamineerd voeder kregen. Er konden geen effecten van T-2 op de CYP3A activiteit 
worden opgemerkt in het duodenum of het jejunum. Als besluit kunnen we stellen dat 
langdurige blootstelling aan relevante dosissen van T-2 een invloed kan hebben op de CYP-
gemedieerde metabolisatie van xenobiotica en op de werking van efflux eiwitten. Dit kan 
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mogelijks een invloed hebben op de farmacokinetische parameters van 
substraatgeneesmiddelen. 
Het algemeen besluit zou kunnen zijn dat het negatief effect van trichothecenen in 
vleeskippen onderschat wordt, ten gevolge van de afwezigheid van een duidelijk 
ziektebeeld. Ondanks het feit dat zowel DON en T-2 gekenmerkt zijn door een lage absolute 
orale biologische beschikbaarheid, konden we aantonen dat deze mycotoxinen in staat zijn 
om ernstige schade te veroorzaken op moleculair niveau. Beide mycotoxines zijn in staat om 
de darm- en leverbarrière te beschadigen met negatieve gevolgen voor de gezondheid van 
het dier. Daarnaast kunnen we uit de resultaten van deze thesis ook concluderen dat meer 
onderzoek nodig is om de efficaciteit en veiligheid van mycotoxine detoxifiers na te gaan. 
Ook hun interactie met de absorptie van oraal toegediende farmaca dient te worden 
bestudeerd. 
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Het laatste hoofdstuk, het dankwoord, is zeker niet minder belangrijk dan alle voorafgaande 
hoofdstukken. Een doctoraatsthesis verwezenlijk je immers niet alleen en daarom had ik 
graag iedereen die ertoe bijgedragen heeft op gepaste wijze bedankt. 
Vooreerst zou ik mijn beide promotoren Prof. S. Croubels en Prof. P. De Backer willen 
bedanken. Siska, hartelijk dank dat ik deel uit mocht maken van uw mycotoxine-team.  
Professor De Backer zou ik willen bedanken voor zijn hulp in de niet altijd even gemakkelijke 
interpretatie van mijn resultaten. Deze doctoraatsjaren hebben mij veel wetenschappelijke 
kennis bijgebracht alsook enkele belangrijke levenslessen. 
De leden van de begeleidings- en examencommissie, Prof. dr. Gasthuys, Prof. dr. Dacasto, dr. 
Vancraeynest, Prof. dr. Boussery, Prof. dr. Ducatelle en Prof. dr. Martel wil ik graag 
bedanken voor hun zeer nuttige opmerkingen en suggesties. Prof. dr. Dacasto thank you for 
making time to come over from Italy to attend my PhD defense.    
Het uitvoeren van dierproeven is een meervoudig stappenplan dat haast onmogelijk zou zijn 
zonder de nauwe samenwerking met de MYTOX Associatieonderzoeksgroep. De 
personeelsleden van het labo van Prof. Eeckhout evenals Prof. Eeckhout zelf zou ik willen 
bedanken voor hun altijd enthousiaste hulp bij het aanmaken en inmengen van het voeder. 
Professor De Saeger en Christ’l hartelijk dank voor de analyse van het kippenvoeder! Dr. ir. 
Kris Audenaert en zijn team bezorgde ons de DON voor onze eerste voederproef, bedankt 
hiervoor! Op de mycotoxine congressen leerde ik heel wat fijne doctoraatstudenten kennen 
van de MYTOX groep, ik wens iedereen van de MYTOX Associatieonderzoeksgroep dan ook 
heel veel succes met hun verder onderzoek! 
Professor J. Van Bocxlaer en Prof. K. Boussery ben ik heel erg dankbaar dat ik welkom was in 
hun labo om mijn stalen te analyseren. Vooral Lies zou ik in de bloemetjes willen zetten! 
Ongelooflijk hoe jij mij geholpen hebt en vooral bijgestaan hebt om stalen te blijven 
homogeniseren ondanks mijn zwangerschapskwaaltjes ! Ik wens je heel veel succes met 
het afronden van je doctoraat en natuurlijk heel veel geluk met je gezinnetje! Huybrecht, 
Pieter, Julie en Sofie dikke merci voor de fijne momenten samen!  
De collega’s van de vakgroep Pathologie, Bacteriologie en Pluimveeziekten stonden altijd 
klaar om te helpen, om histologie stalen te verwerken, PCR problemen te verhelpen, … 
iedereen hartelijk dank hiervoor! 
En dan op naar de eigen ‘mycotoxine-buro’... Virginie, de senior, ook al mag ik je zo niet 
noemen :-)! Ik weet nog dat je net uit zwangerschapsverlof kwam als ik begon aan mijn 
doctoraat... fiere mama van Andreas en toch zo gefocust op je werk! Ik stond altijd 
verwonderd hoe je dat allemaal geregeld kreeg en kijk vorig jaar was de cirkel rond, jij legde 
je doctoraat af enkele dagen nadat ik bevallen was! Ik wens je nog heel veel geluk met je 
twee stoere mannen en in je verdere carrière! Joline, wij hebben veel leed en vreugde 
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gedeeld de afgelopen jaren, maar vandaag kunnen we eindelijk alletwee zeggen dat het ons 
gelukt is! De aanhouder wint, en dat heb jij meer dan eens bewezen in de afgelopen jaren! 
Heel veel succes in je verdere onderzoek en in jullie nieuwe woonst natuurlijk! Een andere 
ancien, Anja! Bedankt voor jouw enorme bijdrage aan mijn dierproeven, op eender welk 
moment van de dag was je altijd bereid om te helpen! Elin, jouw gedrevenheid en passie 
voor de wetenschap zijn bewonderenswaardig, veel succes nog met je post-doc! In de loop 
der jaren veranderde het mycotoxine-team van vrouwen- naar een mannen-team. Gunther, 
Mathias, Nathan en Thomas nog heel veel succes met jullie onderzoek! Sophie, jij kwam er 
als laatste bij, maar ik ben er zeker van dat je je mannetje wel zal kunnen staan! 
Op naar het LPS-team! Elke, Anneleen en Heidi, bij jullie kon ik altijd terecht voor een fijne 
babbel! Elke, ik zal onze uitstapjes met de vrachtwagen missen! Anneleen, bedankt voor de 
fijne kippen-momenten! Heidi blijf je varkentjes verwennen met appeltjes . Bedankt voor 
de hele fijne samenwerking en nog heel veel succes met jullie onderzoek!   
Siegrid bedankt voor de ontwikkeling van talrijke analysemethodes en ook voor je hulp en 
raad! Kris B., jouw wijze woorden brachten altijd raad! Ann S. dankzij jou weet ik hoe 
belangrijk GLP is! An M. dankzij jouw ligt alles altijd op zijn plaats in het labo ook al moest je 
hier regelmatig eens voor aan onze oren trekken! Marc, ik zal jouw fluit-deuntjes missen! 
Jelle, geef me een seintje als je op jumping Mechelen of Wieze bent dan kunnen we nog wat 
bijpraten! Nathalie, bedankt voor al die administratie die je voor me deed! 
De collega’s van de biochemie. Donna bedankt voor alle fijne babbels en heel veel succes 
met de laatste rechte lijn! Kristel bedankt voor de lessen ‘western blotting’! Jorien je mag 
altijd je recept voor chocoladecake doorsturen! Koen, de muizenkweker , succes met je 
experimenten in de toekomst! Jella, onze liefde voor paarden deed een ware vriendschap 
ontstaan. Ondertussen hebben we met onze (b)engeltjes nog veel meer gemeen! Op naar 
ons volgend uitstapje ! Professor Meyer bedankt voor uw interesse in mijn onderzoek. 
Dieter en Bert bedankt voor de fijne samenwerking! 
Mijn oude medestudenten: Inge, Inne, Sophie, Soetkin, Charlotte en Eline, wat een 
ongelooflijk fijne jaren in Gent samen! Ik wens jullie veel succes met al jullie 
toekomstplannen! 
Nathalie en Liesbeth, de tanti’s van Camille, al jaar en dag kan ik op jullie rekenen, echt super 
dikke merci hiervoor! Nu dit allemaal achter de rug is, is het hoogtijd voor een uitstapje 
samen! 
De allerlaatste zinnen gaan uit naar mijn familie. Peter, Meter en Tonton (alias Halve Meter), 
1 telefoontje volstaat en jullie staan klaar voor mij! Bedankt voor jullie steun en Tonton 
dikke merci om je zondagochtend op te offeren om kippen te komen wegen ! Mijn 
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schoonouders, Luc en Linda, zou ik ook in de bloemetjes willen zetten. Bedankt dat jullie 
altijd klaarstaan om voor Camille te zorgen alsook voor de goede zorgen voor mijn paarden!  
Mama, ik weet hoe hard je naar deze dag hebt uitgekeken... Bedankt om mij de kans te 
geven deze studies te doen alsook om altijd in mij te blijven geloven! Nu dit achter de rug is, 
kan je je volledig in de rol van Mamy meter storten!  
De laatste zinnen zijn voorbehouden voor mijn lieve echtgenoot, Thomas. Bedankt voor je 
onvoorwaardelijke steun, je geduld en liefde. Ik kijk ernaar uit om samen met ons dochtertje 
Camille in ons nieuw huis te gaan wonen en samen verder aan de toekomst te bouwen… 
 
 
 
 
